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APC   antigen presenting cell 
BSA  bovine serum albumin 
BSE   bovine spongiform encephalopathy 
CD  cluster of differentiation 
CD40L CD40 ligand 
CJD   Creutzfeldt-Jacob Disease 
CNS  central nervous system 
CWD   chronic wasting disease 
DC  dendritic cell 
ddH2O  double distilled water 
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d.p.i.  days post infection 
DTR   Diphtheria toxin receptor 
DTX  Diphtheria toxin 
EGFP   enhanced green fluorescent protein 
FCS   foetal calf serum 
FDC   follicular dendritic cell 
GFP   green fluorescent protein 
Hbegf  heparin binding EGF-like growth factor 
H & E  haematoxylin and eosin 
i.c.   intra-cerebral 
i.p.  intra-peritoneal 
iLN   inguinal lymph node 
hr    hours 
Kbp  kilobase pairs 
kDa  kiloDaltons 
LC   Langerhans cell 
LN  lymph node 
LRS   lymphoreticular system 
mAb  monoclonal antibody 
min  minutes 
MNP  mononuclear phagocyte 
NB  normal brain 
PAT   perinodal adipose tissue 
pAb   polyclonal antibody 
PB    phosphate buffer  
PBS   phosphate buffered saline 
PET  paraffin embedded tissue 
PFA   paraformaldehyde 
PK  proteinase K 
pLN   popliteal lymph node 
PLP  periodate-lysine-paraformaldehyde 
PMCA  protein misfolding cyclic amplification 
PMN  polymorphonuclear leukocytes 
PP   Peyer’s patch 
Prnp  murine PrP gene 
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PrP  prion protein 
PrP
c
  cellular (normal) form of the prion protein 
PrP
d
  disease-associated form of the prion protein 
PrP
Sc
  scrapie-specific form of the prion protein 
RT  room temperature 
s  seconds 
SAF  scrapie associated fibril 
SCS   subcapsular sinus 
SEM  standard error of the mean 
TME   transmissible mink encephalopathy 
TSE   transmissible spongiform encephalopathy 
vCJD  variant Creutzfeldt-Jacob disease 




Transmissible spongiform encephalopathies (TSEs), or prion diseases, are fatal 
neurodegenerative diseases that affect several species, such as scrapie in sheep or 
goats and CJD in humans. In several species, neurological disease is preceded by 
TSE agent accumulation in lymphoid tissues prior to neuroinvasion. While oral 
transmission is considered the most common route for scrapie, transmission can also 
occur through lesions to the skin or mucosa, for example in the mouth or 
gastrointestinal tract due to rough feed, or birth associated skin damage. Scrapie has 
also been experimentally transmitted through skin scarification in mice. Following 
scrapie infection via skin scarification, PrP
Sc
 accumulates in the draining lymph node 
(LN) before spreading to other organs in the lymphoreticular system. It is not yet 
known by what means the scrapie agent is transported from the skin to the draining 
LN. Dendritic cells (DCs) in the skin have been found to transport viruses, such as 
HIV or Dengue, from the skin, thereby raising the question whether DCs or 
Langerhans cells (LCs), located within the epidermis, play a role in the uptake and 
transport of the TSE agent from the skin to the draining LN. 
 
CD11c is a cell surface marker traditionally used to identify or isolate DCs from 
other cell types. Mice and rats are naturally resistant to Diphtheria toxin (DTX). A 
transgenic mouse line was created where the Diphtheria toxin receptor (DTR) was 
expressed on CD11c
+
 cells. The presence of this receptor on CD11c
+
 cells allowed 
for the temporary conditional depletion of CD11c
+
 cells following a single injection 
of DTX. The cells repopulate the tissues within a time frame specific to the tissues 
the cells are located in. These mice were used to determine whether the absence of 
CD11c
+
 cells at the time of scrapie infection via the skin had an effect on the early 
accumulation of PrP
Sc
 within the lymphoid tissues and on disease progression. 
Immunohistochemical analysis demonstrated that early PrP
Sc
 accumulation in the 
draining LNs was delayed following depletion of CD11c
+
 cells, indicating that their 
potential role in the transport of the scrapie agent from the skin. Scrapie incubation 
period was not affected by the absence of the CD11c
+
 cells at the time of infection.  
 
Recent findings show that CD11c is not exclusive to DCs and is also expressed on 
macrophage populations. Following DTX-mediated depletion, DCs repopulate the 
tissues much faster than CD11c
+
 macrophages. Scrapie infection was carried out in 
the skin in DTX treated mice after DCs had repopulated the tissues but before 
macrophage numbers had returned, to determine whether macrophages rather than 
DCs played a role in the early accumulation of PrP
Sc
 in the draining LNs. No 
differences in PrP
Sc
 accumulation were observed in mice depleted of macrophages 
compared to controls and there was no effect on disease incubation period.  
 





 DCs in the dermis), allowed for their temporary depletion 
through DTX treatment. Following langerin
+
 cell depletion, increased PrP
Sc
 
accumulation was observed in the draining LNs 7 weeks post infection, but did not 
affect the incubation period of disease. These results indicate that the absence of LCs 
somehow accelerated PrP
Sc
 accumulation, and that LCs might play a preventative 
role in early stages after infection.  
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Histopathological analysis was used to complement microarray studies aimed to 
determine what immune responses were associated with scarification and DTX-
mediated depletion of cells within the skin and whether these responses might be 
linked to disease transmission.  
 
DCs and LCs in the skin appear to play different roles in the early stages following 
scrapie infection via the skin, but the lack of effect on incubation period does not rule 
out the involvement of other cell types or cell-free mechanisms of scrapie agent 
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1.1. Transmissible spongiform encephalopathies (TSEs) 
1.1.1. What are TSEs? 
The TSEs are a group of fatal neurodegenerative diseases that affect both humans 
and animals. These diseases can occur under several different forms: spontaneous, 
genetic, or acquired through various routes of exposure. Examples of the main 
disease forms and the species they affect are listed in Table 1.1. Some forms of 
disease, such as scrapie, have been around for centuries (McGowan, 1922), while 
other forms such as bovine spongiform encephalopathy (BSE) (Taylor, 1993; Taylor 
and Woodgate, 1997) emerged in the 1980s, and have caused the emergence of vCJD 
(Bruce et al., 1997; Will et al., 1996), as well as being linked to the emergence of 
feline spongiform encephalopathy (FSE) in non-domestic cats (Sigurdson and Miller, 
2003). Chronic wasting disease (CWD) is a growing problem in North America, as it 
spreads between farmed as well as wild deer, elk and moose (Angers et al., 2009; 
Keane et al., 2009; Keane et al., 2008; Mathiason et al., 2006; Sigurdson et al., 1999; 
Spraker et al., 2004; Spraker et al., 2009). TSE disease is characteristically 
associated with vacuolation in the brain (spongiform pathology), neuronal loss, glial 
cell activation and amyloid deposits of the disease-associated form of prion protein 
(PrP), and lead to neurodegeneration and death. 
 
Despite being a neurodegenerative disease, natural transmission often occurs via the 
periphery before spreading to the central nervous system (CNS). In some 
experimental and natural TSEs, such as natural sheep scrapie, disease is characterised 
by early TSE agent accumulation in the peripheral lymphoid system (Brown et al., 
2000; Bruce et al., 2000). It is worth noting that even within a single species such as 
sheep, the strain of the TSE agent or the PRNP genotype (which encodes the cellular  
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Table 1.1. TSE diseases. 
TSE Disease Affected Species Route of Transmission 
Iatrogenic Creutzfeldt-
Jacob Disease 
Human Accidental medical exposure to CJD-
contaminated tissues or tissue products 
Sporadic Creutzfeldt-
Jacob Disease (sCJD) 
Human Unknown. Somatic mutation or 







Human Ingestion of BSE-contaminated food or 




Human Germline mutations of the PRNP gene 
Gerstmann-Straussler-
Scheinker syndrome 
Human Germline mutations of the PRNP gene 
Kuru Human Ritualistic cannibalism 
Fatal familial insomnia Human Germline mutations of the PRNP gene 
Bovine Spongiform 
encephalopathy 
Cattle Ingested feed 
Scrapie Sheep, Goats Acquired, ingestion, horizontal 
transmission, vertical transmission 
unclear 
Chronic wasting disease Deer, Elk, Moose Acquired, ingestion, horizontal 









Ingestion of BSE-contaminated food 
Exotic ungulate 
encephalopathy 





) of the animal can significantly influence disease pathogenesis 
(Andréoletti et al., 2000; Heggebø et al., 2002), and some sheep genotypes are 
completely devoid of lymphoreticular system (LRS) involvement (Schreuder et al., 
1998). Other forms of the disease, such as BSE in cattle, appear not to be associated 
with early TSE agent replication in the peripheral lymphoid tissue of cattle 
(Somerville et al., 1997), but PrP
Sc
 and/or infectivity have been detected in the gut of 
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experimentally and naturally infected cattle (Buschmann and Groschup, 2005; 
Hoffmann et al., 2011; Iwata et al., 2006; Terry et al., 2003; Wells et al., 1994). This 
difference between TSE agent strain targeting in host tissues is interesting since 
when BSE is transmitted to humans, agent accumulation in the lymphoid tissues is a 




PrP is a 253 amino acid (Riesner, 2003) glycolipid-anchored surface protein (Bolton 
et al., 1985; Shyng et al., 1995). PrP arises in two different forms: the host encoded 
protease sensitive form, PrP
c





 found in tissues of TSE-affected hosts (Lawson et al., 2005). 
The normal cellular form of PrP, PrP
c
, has a mainly α-helical structure (Pan et al., 
1993) and is protease sensitive. PrP
c
 is a 30-35 kDa glycoprotein which is anchored 
to the outer layer of the cell membrane through a glycosylphosphatidylinositol (GPI) 
anchor (Stahl et al., 1987). 
 
The replication of TSE agents by host cells is critically dependent upon the 





 is endogenous and is expressed on a large range of different cell 
types in many organs throughout the body (Brown et al., 1999; Horiuchi et al., 1995; 
Mabbott et al., 1998). Some examples are Langerhans cells (LCs) and keratinocytes 
in the skin (Sugaya et al., 2002), dendritic cells (DCs) (Burthem et al., 2001), B 
lymphocytes (Li et al., 2001), T lymphocytes (Mabbott et al., 1997), FDCs (Brown 




The protein has been associated with normal physiological functions of the nervous 
system (Martins et al., 2010), including amongst other things, normal synaptic 
function, memory and maintenance of circadian rhythms and sleep patterns (Mabbott 
et al., 1998). Although early studies determined that PrP
c
 deficient mice do not 
appear to be adversely affected by the absence of the protein (Bueler et al., 1992), 
are not wholly immunodeficient (Isaacs et al., 2006), and are developmentally 
normal (Manson et al., 1994), more recent studies have used PrP-deficient mice to 
determine, for example, that PrP
c
 is associated with suppression of cognitive function 
caused by brain-derived amyloid-β in Alzheimer’s disease (Gimbel et al., 2010), as 
well as blocking pain receptors (Gadotti and Zamponi, 2011). The protein’s 
protective function is also associated with epilepsy (Martins et al., 2010; Walz et al., 
1999), and Martins et al present the view that as well as playing a role in ‘loss-of-
function components’ in prion diseases, PrP
c
 might also be a component in the 
pathogenesis of other neurodegenerative disease (Martins et al., 2010). In addition 
there has been some speculation about the function of PrP
c
 in the immune system. 
For example, PrP
c
 may provide cell survival signals in certain circumstances such as 
rapid memory cell expansion (Isaacs et al., 2006), and T lymphocyte activation (Li et 
al., 2001; Mabbott et al., 1997; Mattei et al., 2004). 
 
1.1.3. Nature of the TSE agent 
Many different hypotheses were made about the causal agent of TSEs. Prusiner 
coined the term “Prion”, for proteinaceous infectious particles (Prusiner, 1982) 
arguing that the scrapie causing agent was of protein rather than viral origin. In the 
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past, TSEs have been referred to as a slow virus (Gajdusek, 1967). Some speculation 
existed about whether nucleic acids were also a part of the infectious agent, although 
experiments conducted to determine the structure and composition of the infectious 
agent had found it to be resistant to inactivation by most procedures that inactivate 
nucleic acids (Prusiner, 1982). Bolton et al, identified a protein in the brains of 
scrapie-infected animals which copurified with the infectious scrapie agent. This 
protein was absent in brains of uninoculated hamsters (Bolton et al., 1982). It was 
later determined that this protein, which they designated as Prion protein, PrP, was, 
in fact, a component of the scrapie prion (McKinley et al., 1983). Quaking-induced 
conversion (QUIC) (Atarashi et al., 2008) and protein misfolding cyclic 
amplification (PMCA) (Saborio et al., 2001) are methods which allow for the 
amplification of protein, in a similar manner to DNA amplification by polymerase 
chain reaction (PCR) (Soto et al., 2002). These techniques have enabled propagation 
of infectious PrP using infected brain-derived or recombinant PrP. As well as 
studying PrP conversion, these techniques have allowed for the detection of 
infectious TSE agents in various tissues at dilutions previously undetected by other 
methods. This had only been carried out in the presence of additional cofactors such 
as nucleic acids and lipids, but recently, infectious prions were generated by PMCA 
from recombinant hamster prion protein without any apparent cofactors (other than 
buffer salts and detergent) (Kim et al., 2010). The results generated by using these 
two techniques lend further weight to the argument of a protein hypothesis in disease 




TSE diseases are characteristically associated with the accumulation of insoluble 
aggregates of the disease-specific, abnormal form of PrP within the CNS and, in 
some cases, within the LRS. This abnormal form of the protein is a relatively 
protease resistant, predominantly β-pleated sheet isoform, termed PrP
Sc 
(Pan et al., 
1993). Fourier transform infrared microspectroscopy was used to study protein 
conformational changes within the dorsal root ganglia at various stage of disease 
development. This allowed for in situ observation of the increase in β-sheet protein 
content as disease progressed, some, but not all of which was associated with PrP
Sc
  
(Kretlow et al., 2008).  Both the host-encoded and disease associated forms of the 
protein are associated with 3 different isoforms that are glycosylated at one, both, or 
neither of the protein’s two possible glycosylation sites. These sites are situated at 
residues 181 and 197 of human PrP, while on murine PrP these sites are at residues 
180 and 196 (Lawson et al., 2005). 
 
1.1.4. Scrapie agent strains 
The earliest recorded evidence of scrapie in Britain goes as far back as 1732 
(McGowan, 1922). Back in the 18
th
 century the disease was known under several 
different names, representative of the symptoms observed, such as ‘goggles’, 
‘rubbers’, or ‘shakings’, but ‘scrapie’ was the name that prevailed (McGowan, 1922). 
Cuillé and Chelle successfully carried out experimental scrapie transmission in sheep 
for the first time in 1936 (Cuillé and Chelle, 1936). They suspected previous attempts 
had failed due to the short duration of experiments, and that the long incubation 
period in naturally infected animals (1.5 to 2 years) was key. Longer experimental 
times (Cuillé and Chelle, 1936) resulted in sheep that succumbed to symptoms 
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characteristic of scrapie 16 and 22 months post-inoculation. Serial passage of scrapie 
in goats (Pattison et al., 1959), revealed different symptoms in some goats compared 
to others. These symptoms were separated into two distinct categories: the scratching 
syndrome and the nervous syndrome (Pattison and Millson, 1961). 
  
Chandler was the first to carry out experimental transmission of scrapie in laboratory 
mice (Chandler, 1961). Having dubbed the nervous form of goat scrapie as ‘drowsy’, 
C.57black, C.B.A brindle, and Swiss white mice were inoculated with brain material 
from either the ‘scratching’ or the ‘drowsy’ goat (Chandler, 1961). Only the Swiss 
white mice inoculated from the ‘drowsy’ inoculum went on to show nervous 
symptoms 7.5 to 9 months post inoculation. The symptoms were not identical to 
those observed in sheep and goats, but they concluded that the similarities were close 
enough to prove a link, and that scrapie had been successfully transmitted to mice. 
The two distinct disease manifestations are the first indication of strain variation in 
scrapie. The fact that only one mouse strain developed disease, also indicates that 
mouse strains have varying susceptibility to the scrapie agent. For example, serial 
mouse passage of material from the ‘drowsy’ goat source has led to the isolation of 
the 139A strain of scrapie (Dickinson et al., 1984). 
 
 The ME7 strain of scrapie, as it is used in this study, was originally isolated in a 
series of experiments studying experimental transmission of scrapie in mice (Zlotnik 
and Rennie, 1963). The ME.7 strain, was isolated from mouse experiment 7, where 
mice were intragastrically inoculated with a spleen pool prepared from Suffolk sheep 
infected with natural scrapie. These mice had not developed clinical symptoms by 13 
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months post-inoculation. Yet, creating a brain pool from these mice, to transmit to a 
second group of mice resulted in clinical symptoms after 5 months. ME7 has since 
been repeatedly isolated at The Roslin Institute, Neurobiology Division (formerly the 
Neuropathogenesis Unit) in Edinburgh, by passaging scrapie material from Suffolk 




Dickinson et al (Dickinson et al., 1968) identified a single gene which was 
responsible for the incubation period of scrapie in mice, which they designated as 
Sinc (scrapie incubation). They suggested that Sinc was an autosomal gene with a 
single pair of alleles, without obvious dominance, and with very little evidence that 
any other genes are involved in controlling incubation time (Dickinson et al., 1968). 
The two alleles were designated as s7 for the allele that shortens incubation time, and 
p7 for the allele that prolongs incubation time. As such, there are three different 
possibilities for mouse genotypes: s7s7, p7p7, or s7p7, which helps explain why 
some mouse strains succumb to scrapie much faster than others. 
 
It has since been determined that the Sinc gene is linked to Prnp, the gene which 
encodes for PrP, where Prnp alleles ‘express two distinct PrP protein variants, PrP A 
and PrP B which arise from codon 108L/F and 189T/V dimorphisms’ (Moore et al., 
1998). Moore et al went on to show that the Sinc and Prnp genes were congruent 













In addition to the presence of this gene, which regulates scrapie incubation period in 
mice, each individual scrapie strain that has been isolated has its own distinct 
incubation period between different mouse lines. Each scrapie strain has a different 
incubation period within the one mouse line. For example, intracerebrally inoculated 









), the incubation period 








), the incubation period is almost right in the middle of the two 
incubation periods, at 250 days (Bruce, 1993).  
 
1.1.5. Routes of transmission 
As was mentioned earlier, TSEs have several identified routes of transmission. TSE 
studies have been carried out in mice since Chandler successfully transmitted scrapie 
to mice in 1961 (Chandler, 1961), but prior to this sheep were successfully 
experimentally infected with scrapie (Cuillé and Chelle, 1936). Since then 
experimental transmission has been successful in animals through different injection 
routes, for example intraperitoneal (Brown et al., 2000), intracerebral (Taylor et al., 
1996) or intravenous (Taylor et al., 1996) or via blood transfusion in sheep (Halliday 
et al., 2005; Houston et al., 2000; Houston et al., 2008; McCutcheon et al., 2011). 
Accidental transmission of vCJD in humans has occurred via blood transfusion 
(Llewelyn et al., 2004; Peden et al., 2004; Wroe et al., 2006), or ingestion of BSE-
contaminated meat (Bruce et al., 1997; Will et al., 1996), which is also linked to 
feline spongiform encephalopathy (Sigurdson and Miller, 2003). BSE is equally 
thought to develop from ingestion of contaminated food (Taylor, 1993; Taylor and 
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Woodgate, 1997). Oral TSE transmission has therefore been experimentally studied 
at length both in sheep and mice (Andréoletti et al., 2000; Glaysher and Mabbott, 
2007b; Huang et al., 2002; Prinz et al., 2003; Raymond et al., 2007).  
 
TSE agents can be readily experimentally transmitted via lesions to the skin 
(Glaysher and Mabbott, 2007a; Mohan et al., 2004; Mohan et al., 2005b; Taylor et 
al., 1996) and oral mucosa (Bartz et al., 2003; Carp, 1982; Denkers et al., 2011). 
Thus, natural TSE infections might also occur via lesions in the mouth and 
gastrointestinal tract through consumption of rough feed or birth-associated lesions 
to the skin or mucus membranes.  Furthermore, TSE agents have also been identified 
in the skin (Cunningham et al., 2004; Notari et al., 2010; Thomzig et al., 2007), as 
well as in antler velvet (Angers et al., 2009), as determined by Western blotting or 
bioassays from the target sites.  
 
Disease may also be transmitted horizontally, in CWD or scrapie (Gough and 
Maddison, 2010; Saunders et al., 2008). For example, infectivity has been detected in 
several excreta of CWD-infected cervids (Haley et al., 2011; Haley et al., 2009; 
Mathiason et al., 2006), nasal secretions from both experimentally and naturally 
infected animals (Gough and Maddison, 2010), milk from scrapie infected sheep 
(Ligios et al., 2011), as well as in the urine of scrapie-infected mice (Seeger et al., 
2005) or hamsters (Kariv-Inbal et al., 2006). PrP
Sc
 was also detected in urine 
(Murayama et al., 2007) and faeces (Krüger et al., 2009) of hamsters orally infected 
with scrapie in the days following infection. PrP
Sc
 was identified in the urine at the 
terminal stage of disease (Murayama et al., 2007) but was only identified in faeces at 
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the terminal stage following PMCA amplification (Krüger et al., 2009). The fact that 
TSEs can be transmitted through wounds in the skin or through the gastro-intestinal 
tract are therefore of importance when taking into consideration the presence of 
infectivity in the environment. One of the symptoms of scrapie-affected sheep or 
goats is the rubbing or scratching (Chelle, 1945). If this is occurring in the field, 
knowing that infectivity can be present in the skin or excreta and that scrapie can be 
transmitted through wounds, it is probable that some cases of horizontal transmission 
might occur through minor skin lesions. Added to this are also the presence of 
disease specific PrP in tissues such as muscle (Cardone et al., 2009), or TSE agent 
infectivity in fat (Race et al., 2008; Race et al., 2009), both of which are regularly 
consumed by animals and humans. Especially in the case of CWD, where animals 
can be hunted in the wild, the meat is often consumed by the same group of people 
over an extended period (Race et al., 2009). While personal protective equipment is 
worn by at risk groups during surgery, or in the laboratory when exposed to TSE-
infected materials, it is not certain that the average hunter will take the same 
measures, and small cuts or abrasions may often occur on hands etc, highlighting 
another potential risk.  
 
Scarification of the skin, as a route of pathogen exposure, has been used in many 
contexts. In the 1950’s it was used for various diagnostic methods such as for malaria 
(van den Berghe and Chardome, 1951) or tuberculosis (Frappier and Guy, 1950). 
Skin scarification was first used as a method of  TSE transmission by Carp et al 
(Carp, 1982) where gingival scarification was carried out in mice before application 
of inoculum, leading to the development of scrapie in these mice. Since then, Taylor 
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et al (Taylor et al., 1996) developed a technique for TSE transmission, via 
scarification of the skin of the thigh. They established that scarification is as effective 
for transmitting scrapie to mice as other routes of peripheral transmission, with 
comparable incubation periods (dependent on volume and concentration of 
inoculum), and equally, different sites of scarification also give comparable results 
(Taylor et al., 1996). This is the method of TSE agent infection which has been used 
and described in this thesis. 
 
1.1.6. Prions and the immune system 
PrP
Sc
 accumulation within the LRS occurs in a number of species. LRS involvement 
was determined through splenectomy in scrapie infected mice, which significantly 
delayed the development of disease (Fraser and Dickinson, 1978), suggesting that the 
spleen was essential for successful disease progression. Other lymphoid tissues have 
been associated with PrP
Sc
 accumulation, dependent on the route of transmission. 
Scrapie infection through skin scarification highlighted the role of the draining 
lymph nodes (LNs) in disease (Glaysher and Mabbott, 2007a). Lymphoid tissues in 
the gut, such as Peyer’s patches (PP) have been implicated in disease through oral 
transmission (Andréoletti et al., 2000; Glaysher and Mabbott, 2007b; Heggebø et al., 
2002; Prinz et al., 2003; Raymond et al., 2007; Sigurdson et al., 1999). 
 
An important question surrounding these diseases is how the TSE agent is 
transported from the site of infection to the LRS and onwards into the CNS, as this 
knowledge might provide targets for successful therapeutic intervention. Much 
speculation has surrounded the issue of whether the TSE agent is transported via cell-
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associated or cell-free mechanisms. Studies in certain species show that when LRS 
involvement occurs during the early stages of TSE infection, PrP
Sc
 accumulates first 
on PrP
c
-expressing follicular dendritic cells (FDCs) (Andréoletti et al., 2000; 
Glaysher and Mabbott, 2007b; Hilton et al., 1998; Mabbott et al., 2003; Prinz et al., 
2003; Sigurdson et al., 1999). FDCs are stromal-derived, tissue resident cells, found 
in the germinal centres of lymphoid follicles (Mabbott et al., 2011). These cells 
express high levels of PrP
c
 on their surface, and are clearly associated with PrP
Sc
 
accumulation in peripheral lymphoid tissues (Jeffrey et al., 2000a). The FDC has 
since been identified as an important site of TSE agent accumulation and replication 
in the LRS (Brown et al., 1999; Mabbott et al., 2000; McCulloch et al., 2011; 
Montrasio et al., 2000). Furthermore, in the absence of FDCs, TSE agent 
neuroinvasion is impaired and disease susceptibility reduced. FDCs are considered to 
amplify TSE agents above the threshold required for neuroinvasion.   
 
TSE transmission studies in severe combined immunodeficient (SCID) mice 
highlighted the need for a functional immune system in order to successfully transmit 
the disease (Fraser et al., 1996; Lasmézas et al., 1996; O'Rourke et al., 1994). So, in 
contrast to other pathogens, which exploit the lack of a fully functioning immune 
system, TSEs that feature a replicative stage in the LRS, require a functioning 
immune system to establish disease. However, traditional immune responses, such as 
antibody production are not associated with this infection, possibly due to immune 
tolerance to host PrP
c
 (Isaacs et al., 2006). There is growing evidence for  localised 
immune responses occurring within the lymphoid tissues, for example through 
changes in the germinal centers of the spleen, as detected by electron microscopy 
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(McGovern et al., 2004). Following SSBP/1 scrapie infection in sheep, 
transcriptional analysis identified downregulation of genes linked to inflammation 
and oxidative stress, and the up-regulation of genes related to apoptosis in lymphoid 
tissues (Gossner et al., 2011). These data suggest that TSE agent accumulation 
affects the local environment in the LRS. 
 
1.2. Cells of the immune system and their influence on TSE pathogenesis  
1.2.1. DCs vs Macrophages 
Even though peripheral lymphoid tissues, and the FDCs within them, have been 
identified as important sites of TSE agent replication prior to neuroinvasion, little is 
known of how TSE agents are transported to these sites or what, if any, cells are 
involved. Mononuclear phagocytes (MNPs) are a diverse group of 
haematopoietically-derived phagocytic cells which includes classical DCs and 
macrophages, but also LCs in the epidermis of the skin and microglia in the brain.  
The distribution of these cells at the body’s surfaces (intestine, skin, mucosa etc.) and 
their ability to phagocytose antigens and deliver them to draining lymphoid tissues 
suggests MNPs may either destroy TSE agents or transport them within the host. 
 
The precise ontogeny of classical DCs and macrophages is the subject of much 
debate. Indeed, there is growing evidence that these two cells types are not as distinct 
from each other as was once thought (Bradford et al., 2011; Hume, 2008; Mabbott et 
al., 2010). These cells are often identified or isolated based solely on the expression 
of a small set of cell surface markers, such as CD11c/Itgax for DCs (Austin, 1999). 
and CD207/langerin (Cd207) for LCs (Takahara et al., 2002; Valladeau et al., 2002; 
Valladeau et al., 1999; Valladeau et al., 2000). Even under the traditional ‘umbrella 
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terms’ of DCs and macrophages, more distinct cellular subsets have been described 
based on the expression of a long list of different markers. However, the expression 
of these and other markers has been shown to be less specific than was originally 
considered (Bradford et al., 2011; Probst et al., 2005). For example, the temporary 
depletion of CD11c
+
 cells in CD11c-DTR transgenic mice, originally considered to 
specifically deplete DCs (Jung et al., 2002), has been shown to also deplete many 
other macrophage subsets, such as the CD169
+
 macrophages in the spleen and LNs 
(Bradford et al., 2011; Probst et al., 2005). Much of the data described in this review 
was generated from in vitro experiments utilizing bone marrow-derived DCs. 
However, the recent meta-analysis of a large collection of gene expression data from 
a range of mouse leukocyte lineages shows bone marrow-DCs were clearly identified 
as phagocytes (macrophages) and were transcriptionally distinct from tissue classical 
DCs. Indeed, there are few mRNA markers that clearly distinguish classical DCs 
from macrophages other than low expression of those required for phagocytosis 
(Mabbott et al., 2010). Clearly, without also testing their biological properties 
(phagocytosis, ability to stimulate naïve T cells etc.) it is difficult to accurately 
distinguish between classical DCs and macrophages based solely on the expression 
of a limited set of surface markers.  This is especially true in immunohistochemistry-
based studies.  While it is important to highlight the ambiguity surrounding the 
discrimination of individual MNP populations, this thesis will stick to the traditional 









CD11c is an integrin (Lai et al., 1998), also known as integrin alpha X (Itgax) and 
encoded by the Itgax gene. Integrins are heterodimeric integral membrane proteins 
composed of an alpha chain and a beta chain. CD11c combines with the beta 2 chain 
(ITGB2) to form a leukocyte-specific integrin referred to as inactivated-C3b (iC3b) 
receptor 4 (CR4). The Itgax complex appears to share the properties of Itgam 
(CD11b) that are involved in neutrophil and monocyte adherence to stimulated 
endothelial cells, as well as in the phagocytosis of complement coated particles 
(http://www.ncbi.nlm.nih.gov/gene/3687). 
 
CD11c was thought to be a good marker for most if not all DCs in mouse lymphoid 
tissues (Austin, 1999), although in epidermal LCs it is only expressed as 
CD11c
negative-low
, until it gets upregulated when they mature (Jung et al., 2002) and 
migrate to the draining LNs. CD11c has been widely used as a marker for the 
identification and isolation of DC subsets. CD11c identification on a number of 
macrophage subsets means that this marker is not expressed exclusively on DCs (Fig. 
1.1.), as was once thought (Hume, 2008). Therefore any research that targets CD11c
+
 
cells is targeting DCs as well as macrophages. 
 
1.2.3. Langerin 
CD207 or langerin (encoded by the Cd207 gene) is a C-type lectin, originally 
thought to be specific to LCs (Kissenpfennig et al., 2005a; Valladeau et al., 1999; 
Valladeau et al., 2000). It has been found to induce the formation of Birbeck 
granules (Valladeau et al., 2000). These are tennis racquet-shaped, cytoplasmic 
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organelles specific to LCs (Birbeck et al., 1961; Valladeau et al., 2000; Wolff, 1967). 
Langerin is a C-type lectin, which plays a role in binding sulfated and mannosylated 
glycans via a single C-type carbohydrate recognition domain (Tateno et al., 2010). 
The molecule appears to be internalised into the Birbeck granules, and langerin is 
thought to cause the internalisation of antigen into the Birbeck granules, which is 
believed to provide access to a non-classical antigen-processing pathway (Valladeau 
et al., 2000). LCs appear to play an important role in the uptake of lectin-binding 
antibodies under vaccination conditions (Flacher et al., 2009), further supporting the 
role of langerin in immune responses. Langerin expression was previously believed 
to be exclusive to LCs, and a useful tool for the identification or isolation of these 
cells (Valladeau et al., 1999). It has since been identified on a number of other cell 
types both within the LRS and in other organs (Douillard et al., 2005; Valladeau et 
al., 2002) (Fig. 1.1.). Like CD11c, it is not an exclusive marker for cellular 
identification, but in the skin, it is useful for the identification of langerin
+
 cells.  
 
LCs are the DCs of the skin. They are distinct from other DC subsets, as they are 
radioresistant (Merad et al., 2002), have a much longer life-span than other DC 
subsets (Lucas and MacPherson, 2002), and only express CD11c at very low levels 
(Jung et al., 2002). CD11c expression on LCs is upregulated as they migrate to the 
draining LNs. These cells function as the antigen presenting cells (APC) of the 
epidermis, and as such are considered to play a role in the immune response to 
foreign antigen in the skin, through their migration to the draining inguinal LNs 




Figure 1.1. Comparison of Itgax and Cd207 expression by mononuclear phagocyte subsets. Analysis of probeset expression across 81 individual 
microarray data sets (Affymetrix MOE430-2.0) representing peritoneal macrophages, splenic, and LN classical DC and plasmacytoid DCs. Itgax (CD11c) is expressed 
at varying levels across these cell populations; Cd207 (langerin) is expressed on a few cell types, but highest on LCs. MmXX represents individual microarray sample 







1.2.4. MNPs and their role in TSEs 
Haematopoietic, classical DCs are a distinct cell type from mesenchymal-derived 
FDCs (Mabbott et al., 2011). Classical DCs are APCs and as such they sample their 
natural environment for foreign antigens, which they process and transport to the 
nearest lymphoid tissues to initiate a specific immune response. Classical DCs take 
up antigen through endocytosis or sometimes macropinocytosis (Sallusto et al., 
1995). Classical DCs travel via the lymphatic system to the secondary lymphoid 
organs in response to chemokine stimulation where they present antigen to 
lymphocytes (Steinman, 1991). Although the primary role of DCs is to present 
antigens to T-cells, they are also capable of presenting them to B-cells. This 
sometimes occurs in the form of intact antigen, in contrast to processed antigen, 
which is presented to T-cells (MacPherson et al., 1999). Interestingly, recent studies 
have identified PrP
Sc
 associated with a subset of B cells in the blood of scrapie 
infected sheep (Edwards et al., 2010). These characteristics therefore identify 
classical DCs as possible candidates for the transport of the intact TSE agents from 
the site of exposure to the peripheral lymphoid system.  Studies show the retention of 
PrP
Sc
 within bone marrow derived DCs 72 hours after in vitro exposure to PrP
Sc
-
enriched scrapie associated fibrils (Huang et al., 2002). However, another study has 
also suggested that bone marrow-derived DCs rapidly degrade PrP
Sc
 (Lai et al., 
1998; Luhr et al., 2002). Whether these cells are a good representation of tissue 
classical DCs is uncertain. Meta-analysis of their transcriptomes shows bone 





Classical DCs could influence TSE pathogenesis at a variety of stages in the disease 
process:  transport from the site of infection to the LRS in the case of LRS 
involvement; transport between cells within the lymphoid tissues; or the transfer 
between the lymphoid tissues and the nervous system (neuroinvasion). The argument 
for a DC-related role in TSE pathogenesis is strengthened by the evidence that the 
prion protein fragment 106-126 functions as a chemoattractant to immature 
monocyte-derived DCs (Kaneider et al., 2003). Evidence for a possible role of DCs 
in the delivery of TSE agents to lymphoid tissues was provided by using a transgenic 
mouse model in which CD11c
+





(Sethi et al., 2007) cells were significantly reduced. The absence of 
these cells at the time of intraperitoneal scrapie infection significantly prolonged the 
incubation period of the disease when compared to wildtype controls (Cordier-
Dirikoc and Chabry, 2008; Sethi et al., 2007). 
 
1.3. The skin 
1.3.1. DC subsets within the skin 
As has been previously mentioned, TSE agents can be readily transmitted via lesions 
to the skin (Glaysher and Mabbott, 2007a; Mohan et al., 2004; Mohan et al., 2005b; 
Taylor et al., 1996) and oral mucosa (Bartz et al., 2003; Carp, 1982; Denkers et al., 
2011), and  TSE agent infectivity has been identified within in skin (Cunningham et 
al., 2004; Notari et al., 2010; Thomzig et al., 2007) and antler velvet (Angers et al., 
2009). These findings further highlight the skin or oral and reproductive mucosa as 





The skin provides a first line of defence against infection and is therefore the primary 
site of residence for a number of MNPs that help to maintain this barrier. These 
MNPs include LCs in the epidermis and classical DCs and macrophages in the 
dermis (Fig. 1.2. and Fig. 1.3.). Classical DCs have been suggested to transport 
viruses such as HIV (de Jong and Geijtenbeek, 2010), Dengue (Palucka, 2000; Wu et 
al., 2000), or Influenza virus following infection, from the skin, which raises the 
question whether skin-derived MNPs also play a role in the uptake and transport of 
the TSE agent from the skin to the LRS. 
 
Following scrapie infection via skin scarification in the mouse, agent infectivity and 
PrP
Sc
 accumulation occurs first in the skin draining LN soon after exposure 
(Glaysher and Mabbott, 2007a; Mohan et al., 2005a; Mohan et al., 2005b). 
Experimental scrapie transmission in sheep via the skin failed to find a conclusive 
link between DCs and the transport of PrP
Sc
 (Gossner et al., 2006). Neutrophils were 
found to associate with PrP
Sc
. Definite involvement of skin resident MNPs in TSE 
agent transmission from the skin remains to be determined. Early research in mice 
also implied the lack of LC involvement (Mohan et al., 2005b; Mohan et al., 2005c). 
 
The use of transgenic mouse models that allow for temporary depletion of LCs, 
CD11c
+
 classical DCs or macrophages (Jung et al., 2002; Kissenpfennig et al., 
2005b) prior to scrapie infection will help determine which, if any, of these cell 
populations play a role in TSE transmission from the skin as suggested after oral 
exposure (Andréoletti et al., 2000; Glaysher and Mabbott, 2007b; Huang et al., 2002; 




or macrophages in TSE transmission needs to be put into the context of the LC 




Figure 1.2. Schematic representation of the MNPs in the skin of the mouse. LCs are 
found in the epidermis. The dermis is situated below the epidermis and contains langerin
+
 as well as 
langerin
-
 DCs and various macrophage populations. These cells continually migrate through the skin 
and to the draining LN, and therefore may play a potential role in the transport of the TSE agent from 




Figure 1.3. Distribution of LCs and langerin
+
 dermal DCs (dDC) in the mouse ear. A LCs 
form a dense network of cells within the epidermis. B Langerin
+
 dDCs are less frequent within the 
dermis than LCs in the epidermis. A small number of these cells may also be migrating LCs (modified 




Substantial heterogeneity has been revealed between MNP subtypes in different 
inbred mouse stains (Flacher et al., 2008). For example, LC density in the epidermis 
is much lower in C57BL/6 mice when compared to BALB/c, 129/Sv, and CBA mice. 
Such differences could significantly contribute to the differing results observed in 
many host species exposed to TSE agents.  
 
1.3.2. The LC paradigm 
The ‘LC paradigm’ arose from the often contradictory results generated by research 
in skin immunology. One explanation for this may be due to the heterogeneity 
between mouse strains, as described above (Flacher et al., 2008). In addition to the 
difference observed in LC density between mouse strains, Flacher et al identified two 
different langerin expressing cellular subsets in the skin draining LN of BALB/c 
mice compared to mainly one subset in the C57BL/6. There may be further 
differences in the frequencies of different cell subsets. There are probably many 
further such differences between mouse lines, husbandry conditions in different 
animal units, and also between different animal species, which could help explain 
differing results in many diseases, including prion diseases.  
 
In 2007 an important novel cell type was identified in the mouse dermis: the 
langerin
+
 dermal DC (dDC) (Bursch et al., 2007; Ginhoux et al., 2007; Poulin et al., 
2007) (Fig. 1.2.). The use of a transgenic mouse model (langerin-EGFP-DTR mice) 
where langerin
+
 cells were temporarily depleted through injection of Diphtheria toxin 
(DTX), identified langerin
+
 cells that repopulated the skin draining LNs at different 








dDCs, in addition to the LCs of the epidermis. These langerin
+
 dDCs have a much 
higher turnover rate than LCs and repopulate the skin several weeks faster than the 
epidermal LCs following DTX-mediated depletion (Bennett et al., 2005; 
Kissenpfennig et al., 2005b; Nagao et al., 2009). Upon activation, for example by 
skin immunization, these dDCs migrate from the skin to the skin draining LNs faster 
than the LCs (Eidsmo et al., 2009; Kissenpfennig et al., 2005b).  
 
Since the identification of langerin
+
 dDCs, a number of publications have questioned 
the role of LCs in skin immunity (Fukunaga et al., 2008; Shklovskaya et al., 2008), 
in particular the suggestion that they are the only APCs of the skin. Indeed, langerin
+
 
dDCs have been shown to be fully capable of cross-presenting antigens regardless of 
whether LCs are present or not (Bedoui et al., 2009; Henri et al., 2010). Experiments 
where LC migration from the epidermis was blocked, in CD40L
-/-
 mice or via 
caspase-1 inhibition, were previously used to determine whether LCs played a role in 
the transport of the scrapie agent from the skin to the draining LNs (Mohan et al., 
2005b). While the early accumulation of TSE agent infectivity was not affected in 
the draining LNs, the incubation period of disease was significantly shortened in the 
CD40L
-/-
 mice. These data implied that instead of aiding pathogenesis by 
transporting TSE agents from the skin, LCs may impede pathogenesis by 
phagocytosing and degrading them (Mohan et al., 2005b; Mohan et al., 2005c). In 
light of recent findings, further experiments are necessary to distinguish the influence 
of LCs and langerin
+





Closer examination of the cellular subsets within the skin, have identified no fewer 
than 5 DC subsets in the dermis, in addition to the epidermal LCs (Heath and 
Carbone, 2009; Henri et al., 2010) through their differing expression levels of 
markers such as langerin, CD11b, and CD103. Efficient isolation and identification 
of these different cell populations requires careful cell sorting. However, the research 
in this thesis focuses on the epidermal LCs, and the two dDC populations that can be 
distinguished by their expression of langerin. 
 
1.4. Other possible mechanisms in TSE pathogenesis 
1.4.1. Subcapsular sinus (SCS) macrophages 
FDCs trap and retain antigen on their surfaces (Kosco-Vilbois, 2003) in the form of 
immune complexes (Mabbott, 2004). Complement receptors on the FDCs bind these 
complexes in naïve mice, whereas in immunised mice they are also bound via 
antibody Fc receptors (van den Berg et al., 1995). Complement receptors, as well as 
complement components C1q and C3 are considered to play an important role in 





SCS macrophages are a distinct, poorly endocytic and 
degradative macrophage subset (Phan et al., 2009). These unique cells, located 
within the SCS of LNs, capture antigen-containing immune complexes arriving in 
the LN via their cell processes that they extend into the lumen of the SCS (Carrasco 
and Batista, 2007; Junt et al., 2007; Phan et al., 2009; Phan et al., 2007; Roozendaal 
et al., 2009). In contrast to other macrophage subsets, SCS macrophages retain 
immune complexes on their surfaces for rapid translocation through the floor of the 
SCS to underlying, non-cognate (non-specific) follicular B cells (Phan et al., 2009). 




and deliver them to FDCs.  The higher immune complex-binding affinities of FDCs 
most likely relieve the B cells of their cargo.  Thus, the SCS macrophage-B cell 
immune complex relay represents an efficient route through which antigens are 
delivered to FDCs (Carrasco and Batista, 2007; Junt et al., 2007; Phan et al., 2009; 
Phan et al., 2007; Roozendaal et al., 2009). The demonstration that SCS 
macrophages in LNs (and their spleen counterparts) play a key role in the delivery of 
complement-bound immune complexes to FDCs raises the possibility that these cells 
also play an important role in the transport of complement-opsonized TSE agents to 
FDCs within lymphoid tissues. PrP
d
 has been detected within the SCS macrophages 





SCS macrophages directly cross-present antigen captured from subcutaneous 
injection, after it arrives into the draining LN via the lymph (Asano et al., 2011). 
 
1.4.2. Other macrophages populations involved in TSEs 
As well as the SCS macrophages mentioned above, there is evidence for the 
involvement of other macrophage subsets in TSE disease. However, it is not yet clear 
whether these cells might play a preventative role in disease, or whether, like DCs, 
they might play a role in disease progression. Macrophages typically phagocytose 
and degrade protein antigens more rapidly than classical DCs (Bergtold et al., 2005; 
Delamarre et al., 2005), which can retain some protein antigens in their native form 
up to 36 hours after exposure (Wykes et al., 1998). Data from in vitro studies 
likewise suggest that macrophages also phagocytose and degrade TSE agents 
including scrapie and BSE (Carp and Callahan, 1981; Carp and Callahan, 1982; 




infection increased the accumulation of the scrapie agent in the spleen and 
accelerated disease pathogenesis (Beringue et al., 2000). Within the macrophage, 
PrP
Sc
 was also found to colocalize with lysosomal and proteasomal proteins (Sassa et 
al., 2010b), implying that, consistent with their biological characteristics, 
macrophages might play a preventative role in TSE disease when compared to 
classical DCs.  However, data also imply that macrophages might transport orally 
acquired TSE agents within the gut associated lymphoid tissues (Takakura et al., 
2011). Whether the cells described are macrophages or classical DCs is uncertain. As 
highlighted earlier, it is difficult to classify these cells by immunohistochemistry 
based on the expression of cell surface markers alone. 
 
Tingible body macrophages are found in close association with FDCs within the 
germinal centers of follicles within lymphoid tissues, where they clear proteins and 
apoptotic lymphocytes (tingible bodies) (Swartzendruber and Congdon, 1963). Data 
from ultrastructural studies show high levels of PrP
Sc
 within tingible body 
macrophages in lymphoid tissues of scrapie-affected mice and sheep (Jeffrey et al., 
2001b; Jeffrey et al., 2000b; Ryder et al., 2009). Deposition of PrP
d
 within tingible 
body macrophages in lymphoid tissues of patients with vCJD have also been 
described (Hilton et al., 2004). Recent data suggests tingible body macrophages 
scavenge and degrade PrP
Sc
 following synthesis on other infected cells such as FDCs 
(McCulloch et al., 2011).   
 
Microglia are the macrophages of the CNS.  Gliosis, involving astrocytes and 




Microglia are the main source of the inflammatory response that is associated with 
TSE disease, and microglial activation is directly linked to the patterns of PrP
Sc
 
deposition in the brain, and precedes neuronal cell death (Perry et al., 2002; Rezaie 
and Lantos, 2001). Significant vacuolar degeneration has been detected in the 
microglia/macrophages of two vCJD patients (Rezaie and Al-Sarraj, 2007). 
Microglia and astrocytes have been associated with granular PrP
d
 deposits, leading 
speculation that these cells play a role in processing, degrading or removing PrP
Sc 
(Kovács et al., 2005). The in vitro exposure of microglia to murine scrapie brain 
homogenate or PrP(106-126) severely affected their phagocytic activity (Ciesielski-
Treska et al., 2004). In contrast, microglia from ME7-scrapie affected mice were 
capable of phagocytosis, but were not able to clear PrP
Sc
 (Hughes et al., 2010). 
Within TSE-affected brains the pro-inflammatory activity of microglia is specifically 
modulated by the anti-inflammatory cytokine TGFβ1.  This cytokine appears to play 
a critical role in the down-regulation of pro-inflammatory microglial responses 
minimizing brain inflammation and thus avoiding exacerbation of brain damage 
(Boche et al., 2006). Whether systemic infections and inflammation lead to the dis-
regulation of this control and the exacerbation of neurodegeneration remains to be 
determined (Perry et al., 2007).   
 
A recently identified brain DC population, morphologically similar to microglia is 
considered to be a new member of the heterogeneous microglia population (Bulloch 
et al., 2008). However, it is uncertain whether these cells are a unique subset of 
classical DCs. These data indicate that, as in the other tissues discussed in this thesis, 




pathogenesis in the brain depending on the circumstances.  Some data might relate to 
a particular subset of cells, rather than to the entirety of MNPs within the brain. 
 
1.4.3. Dissemination of TSE agents from the LRS 
As well as being involved in the transport of the TSE agent from the periphery to the 
LRS, classical DCs may have a role in the act of neuroinvasion within the lymphoid 
tissues, for example, the transport of TSE agents to peripheral nerves. Studies show 
evidence of the intercellular transport of PrP
Sc
 through tunnelling nanotubules from 
DCs to cultured neuronal cells (Gousset et al., 2009). In some TSE diseases where 
there appears to be little or no LRS involvement (such as BSE in cattle, or sheep of 
certain PRNP genotypes infected with scrapie) neuroinvasion occurs by an 
unidentified process.  Whether classical DCs fulfil this role as implied in the Gousset 
study (Gousset et al., 2009) is uncertain.  However, studies carried out in scrapie 
infected, FDC-deficient, TNFR1
-/-
 mice, determined that MNPs were unlikely to 
have directly infected peripheral nerves within lymphoid tissues, as these mice failed 
to develop disease when injected with scrapie-infected CD11c
+
 cells (classical DCs) 
(Raymond and Mabbott, 2007). These results were in contrast to previous studies in 
FDC-deficient RAG
-/-
 mice, where scrapie disease was successfully transmitted 
(Aucouturier et al., 2001). The discrepancies between these two studies may possibly 
be due to much higher levels of innervation in the RAG
-/-
 mouse spleens when 
compared to those from TNFR1
-/-
 mice (Raymond and Mabbott, 2007).  
 
1.4.4. A possible cell-free mechanism of transport? 
Current data suggest MNPs may exhibit a diverse range of roles in TSE disease from 




protectors of neuropathology in the brain.  Much of the research described above 
studies the influence of MNPs on TSE pathogenesis during steady-state conditions.  
However, under inflammatory conditions MNPs may exacerbate TSE pathogenesis 
for example through the release of neurotoxic mediators in the brain (Perry et al., 
2007). While some MNPs may play important roles in TSE pathogenesis, it is 
equally likely that in some circumstances their involvement is minimal.  The route of 
TSE infection, strain of TSE agent and host species may all influence the role of 
MNPs in disease pathogenesis.  Indeed, it is equally probable that in some instances 
TSE agents reach the draining lymphoid tissues via a cell-free mechanism such as in 
a complement-bound immune complex or via the conduit system (Roozendaal et al., 
2009).  Equally the transport of the TSE agent from the site of infection to the CNS 
may well also occur through cell-free mechanisms, for example in species where the 
LRS does not play a role in TSE pathogenesis. 
 
1.5. DTX-mediated conditional cell depletion 
DTX is an extracellular protein produced by the organism Corynebacterium 
diphtheria, which inhibits protein synthesis and kills susceptible cells (Holmes, 
2000). The toxin is composed of two distinct fragments. The N-terminal fragment A 
specifically inhibits protein synthesis within the cell, whereas the C-terminal 
fragment B is required for the recognition of surface markers on the membranes of 
cells susceptible to infection (Pappenheimer, 1977). Most mammals, such as humans, 
monkey, and rabbit (Gabliks and Falconer, 1966), are sensitive to diphtheria toxin, 
except for mice and rats (Morris and Saelinger, 1983). These animals tolerate doses 




because surface markers on murine and rat cells do not bind fragment B (Mitamura 
et al., 1995).  
 
This phenomenon was utilised to establish murine models for the conditional 
depletion of a specific cell type. This work was first carried out by Saito et al (Saito 
et al., 2001). They established several transgenic mouse models where the diphtheria 
toxin receptor (DTR) was expressed on the surface of hepatocytes. They tested a 
wide range of DTX doses. They found that low-dose injections into the mouse 
caused hepatocyte-specific cell death, without adversely affecting other cells or 
tissues (Saito et al., 2001). 
 
1.6. Transgenic mouse lines 
DTX-mediated ablation has proved a popular method for targeted cell depletion 
because of its lack of effect on the mouse, it suffers no infection, inflammation etc. 
Following on from Saito et al a number of different transgenic mouse lines have 
been established using similar techniques. Two different such transgenic mouse lines 
were used in this thesis, they are described below. 
 
1.6.1. The CD11c-GFP-DTR mouse line 
As described above, the mouse’s natural resistance to DTX, through their lack of 
expression of a DTR, has been employed to create transgenic mouse lines, where 
specific, targeted, cells can be transiently depleted, using a simian DTR transgene, 
coupled to a gene, whose expression is specific to the target cells. Jung et al (Jung et 




transgene encoding the simian DTR-green fluorescent protein (GFP) fusion protein 
to a CD11c vector, they were able to produce the CD11c-GFP-DTR transgenic 
mouse line (Fig. 1.4.) (Jung et al., 2002). CD11c is a marker that was previously 
used to identify DCs, and the presence of the DTR transgene on CD11c
+
 cells was 
intended to deplete CD11c
+
 DCs. However, as CD11c is expressed on a number of 
different cell subsets, targeted depletion in these mice affects more than just DCs 
(Table 1.2) (Bradford et al., 2011; Probst et al., 2005).  
 
The CD11c-DTR model has previously been used to study the effect of CD11c
+
 cell 
depletion on scrapie uptake from the gut (Raymond et al., 2007), providing a useful 
reference for the time course of depletion and repopulation of the cells. However, 
this model has not yet been used with regards to the skin, and the effect of depletion 
needed to be analysed in the skin and the skin draining LNs. The study highlighted 
the depletion of other cell types such as MOMA-2-binding cells in the sub-epithelial 
domes of PPs (Raymond et al., 2007), marginal zone and metallophillic macrophages 
in the spleen (Probst et al., 2005), as well as colony stimulating factor 1 receptor 
(Csf1r)
+
 cells within the small intestine (Bradford et al., 2011). These characteristics 
need to be taken into account in the studies using CD11c-DTR mice. 
 
LCs, in contrast to other MNPs, are radioresistant and will remain of host origin up 
to 18 months after bone marrow reconstitution in lethally γ-irradiated mice (Merad et 
al., 2002). Lethal γ-irradiation of C57BL/6 wildtype mice prior to reconstitution with 
bone marrow from CD11c-GFP-DTR mice (CD11c-GFP-DTR→WT) yields bone 
marrow chimeric mice where host-derived LCs do not express the DTR transgene.
 
 
      Table 1.2. Summary table of transgenic mouse lines and depletion status of cell types described within the thesis. 
 Depletion status 






























WT WT yes d2 no no no no no no 
WT CD11c-DTR yes d2 yes yes yes yes yes no 
WT CD11c-DTR no no no no no no no 









WT CD11c-DTR no no no no no no no 
WT n/a yes d2 no no no no no no 
langerin-DTR n/a yes d2 no no yes no yes yes 
langerin-DTR n/a no no no no no no no 
WT langerin-DTR yes d2 no no yes no yes no 
WT langerin-DTR no no no no no no no 
langerin-DTR WT yes d2 no no no no no yes 










 cellular subsets are donor derived, and express the DTR transgene. 
DTX injection depleted CD11c
+
, donor-derived cells, without affecting LCs (Table 
1.2. and Fig. 1.5.). Both CD11c-DTR transgenic mice, and CD11c-DTR bone 
marrow chimeric mice (Table 1.2) were used in this thesis to characterise the 
depletion of CD11c
+
 cells, and to determine whether depletion of CD11c
+
 cells prior 
to scrapie infection via skin scarification would affect disease progression. 
 
1.6.2. The langerin-EGFP-DTR mouse line 
Based on the method used by Jung et al, another DTR-transgenic mouse line was 
created, the langerin-EGFP-DTR mouse. Here, Kissenpfennig et al (Kissenpfennig et 
al., 2005b) used a human DTR and enhanced green fluorescent protein (EGFP) to 
create the transgene, which was coupled to langerin (Cd207 gene) (Fig. 1.4.).  
 
Langerin is expressed on LCs in the epidermis and langerin
+
 dDCs in the dermis, but 
there also exists a langerin
-
 dDC subset. Both these cellular subsets migrate from the 
skin to the skin draining LNs, where they can still be identified through their langerin 
expression. A number of other cell types have also been found to express langerin 
outside of skin draining lymphoid tissues, such as the spleen and thymus (Douillard 
et al., 2005), or the lung, and liver (Valladeau et al., 2002). This mouse line, 
therefore allowed for the transient conditional depletion of langerin
+
 cells within the 






Figure 1.4. Diagram of transgene constructs, modified from Kissenpfennig et al, 2005; 
and Jung et al, 2002. The EGFP-DTR transgene was coupled to the Cd207 (langerin) gene 
creating the langerin-EGFP-DTR transgene (Kissenpfennig et al., 2005b). The GFP-DTR transgene 






 cells targeted by DTX in the C57BL/6 wildtype mouse reconstituted 
with CD11c-DTR bone marrow. CD11c+ cells within the skin and the skin draining LNs, 
including subcapsular sinus macrophages are temporarily depleted following DTX treatment  in the 





As was mentioned above (section 1.2.3.), LCs are radioresistant, and will remain of 
host origin following irradiation and bone marrow reconstitution, in contrast to other 
DC subsets. By lethally γ-irradiating C57BL/6 wildtype mice prior to reconstitution 
with langerin-EGFP-DTR bone marrow, it is possible to generate a mouse where 
5’ 3’ 
Cd207 
IRES DTR EGFP Cre-neo auto-deleter 
5’ 







 dDCs express the DTR in the skin (Table 1.2). Inversely, 
reconstitution of lethally γ-irradiated langerin-EGFP-DTR mice with C57BL/6 
wildtype bone marrow creates a mouse where only the epidermal LCs express DTR 
(Table 1.2), and are susceptible to DTX-mediated conditional depletion. These sets 
of mice were used in this thesis to characterise the depletion of langerin
+
 cells (Table 
1.2), and to determine whether depletion of langerin
+
 cells prior to scrapie infection 





 cells targeted by DTX in the langerin-DTR mouse. Langerin+ cells 




1.7. Thesis aims 
Studies addressing the MNPs that influence TSE transmission from the skin have 




2005c) or by blocking LC migration from the skin through the absence of CD40L 
(CD40L
-/-
 mice) or caspase-1 inhibition (Mohan et al., 2005b). CD40L is expressed 
on B lymphocytes, macrophages, DCs and endothelial cells, so therefore CD40L 
deficiency is likely to affect the activities of many cells other than LCs. The 
development of transgenic mice where it is possible to temporarily deplete individual 
MNP cell types provides a more useful tool for determining whether specific cell 
types play a role in the transport of the TSE agent from the skin to the draining iLN. 
By using lethal γ-irradiation and bone marrow reconstitution it is further possible to 
target individual cell types for DTX-mediated depletion. 
 
The main aim of this thesis was to test the hypothesis that individual skin-resident 
MNP subsets play a role in the transport of the scrapie agent from the skin. To do so, 
experiments were designed where individual MNP subsets were temporarily depleted 
from the skin or skin draining LNs prior to scrapie infection via skin scarification, to 
determine whether the absence of the different cell types at time of infection had an 
effect on early scrapie agent transport from the skin to the draining iLN. The aim of 
this thesis was also to determine whether the absence of these cell types at the time 
of infection, via skin scarification, had an effect on the incubation period of disease.  
Further aims were to use histopathological and gene profile analysis to study how the 
effects of skin scarification or DTX-mediated cell depletion might influence scrapie 
disease. The thesis further aimed to determine whether fluorescent tagging of PrP
Sc
 
would allow for in vivo visualisation of the PrP
Sc 
in the skin and draining iLN soon 
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All experiments were conducted under an appropriate home office project licence 
within the regulations of the Animals (Scientific Procedures) Act 1986.  All 
individual experiments were scrutinised by the Neurobiology Division’s ethical 
review process prior to commencement. 
 
2.1.1. CD11c-GFP-DTR 
The CD11c-green fluorescent protein-diphtheria toxin receptor (CD11c-GFP-DTR) 
transgenic mouse line, hereafter referred to as CD11c-DTR, were kindly gifted by S. 
Jung, Weizmann Institute of Science, Rehovot, Israel (Jung et al., 2002). Mice were 
maintained on a C57BL/6 background. Age matched C57BL/6 were used as non-
transgenic controls throughout the experiments. 
 
2.1.2. Langerin-EGFP-DTR 
The langerin-enhanced green fluorescent protein-diphtheria toxin receptor transgenic 
(langerin-EGFP-DTR) mouse line (Kissenpfennig et al., 2005b), hereafter referred to 
as langerin-DTR, were maintained on a C57BL/6 background. Age matched 
C57BL/6 were used as non-transgenic controls throughout the experiments. 
 
2.1.3. Housing 
Mouse lines were maintained in a conventional animal facility with a 12 hour light 
and 12 hour dark cycle under specific pathogen free conditions at The Roslin 






2.2. Mouse genotype confirmation 
Mice from both transgenic lines were routinely genotyped before inclusion into any 
experiment. DNA was extracted from tail or ear punches using the DNeasy kit 
(Qiagen, Crawley, UK) as indicated. Following PCR amplification, PCR products 
were viewed by running on a 1.5 % agarose gel, containing 0.001 % ethidium 
bromide (Sigma-Aldrich, Dorset, UK). 
 
2.2.1. Determination of the CD11c-DTR genotype by PCR 
PCR for the CD11c-DTR transgenic mice was carried out using the following DTR-
specific oligonucleotides (Eurofins MWG/Operon, Ebersberg, Germany), which 
gave a band of 625 base pairs:                  
DTR 1: 5’- GCC ACC ATG AAG CTG CTG CCG - 3’ 
DTR 2: 5’- TCA GTG GGA ATT AGT CAT GCC - 3’ 
Using the following conditions: 1 cycle: 94 C 5 min 
    39 cycles: 95 C 1min 
                             58 C 1min 
                             72 C 1 min 
   1 cycle:    72 C 5 min 
                                                              hold at 4 C 
 
2.2.2. Determination of the langerin-DTR genotype by PCR 
PCR for the langerin-DTR transgenic mice was carried out using the following DTR 




pairs for the wildtype Cd207 gene (langerin), and 866 base pairs for the DTR 
transgene was coupled to the Cd207 gene: 
lang EGFP 1: 5’- GAA TGA CAG ATC TGG CCT GAG CTC G - 3’ 
lang EGFP 2: 5’- GTA GCT TTT ATA TGG TCA GCC AAG G - 3’ 
Dtox up4: 5’- TTC CAG CAG CTA GCC CTC TCC GAA - 3’ 
Using the following conditions: 1 cycle: 94 °C 3 min 
    30 cycles: 94 °C 45 s 
         63.5 °C 45 s 
         72 °C 1 min 
     1 cycle: 72 °C 5 min 
                             hold at 10 °C  
 
2.2.3. Determination of the PrP genotype by PCR 
PCR for the Prnp gene was carried out on experimental bone marrow chimeric mice 
using the A044 and A045 oligonucleotides, which produced a PCR product with a 
band size of 765 base pairs: 
A044:  TCA TCC CAC GAT CAG GAA GAT GAG 
A045:  ATG GCG AAC CTT GGC TAC TGG CTG 
Using the following conditions: 1 cycle: 94
o
C for 3min 
    30 cycles: 94 
o
C for 30 s 
              62
 o
C for 30 s 
              72 
o
C for 1 min 
    1 cycle: 72 
o
C for 10 min 




2.3. Pre-scrapie inoculation treatments 
2.3.1. Temporary conditional cell depletion 
Diphtheria toxin receptor (DTR) (Sigma-Aldrich, Dorset, UK) was suspended in 5 % 
lactose in 10 mM phosphate buffer (PB).  CD11c-DTR mice were given a single 
intraperitoneal (i.p.) injection of 100 ng/mouse DTX, to deplete their CD11c
+
 cells.  
Langerin-DTR mice were injected i.p. with 1 μg/mouse DTX to deplete their 
langerin
+
 cells.  Some mice were injected with PB as a control. 
 
2.3.2. Lethal γ-irradiation and bone marrow reconstitution 
C57BL/6 wildtype mice were lethally γ-irradiated (1000 rad) with caesium
137
 24 hr 
prior to bone marrow reconstitution. Bone marrow single cell suspensions were 
prepared from the femurs of age and sex matched adult C57BL/6, and CD11c-DTR 
or langerin-DTR mice in Hank’s balanced salt solution (HBSS; Invitrogen, Paisley, 
UK). Recipient mice were reconstituted with 100 μl bone marrow (3 x 10
7 
- 4 x 10
7
 
cells/recipient mouse) injection into the tail vein. Mice were housed in individually 
ventilated cages, to prevent opportunistic infection, and used in subsequent 
experiments as described. 
 
2.4. Inoculation with the scrapie agent 
2.4.1. The ME7 scrapie agent strain 
All scrapie pathogenesis studies described in this thesis were conducted using the 
ME7 scrapie agent strain (Zlotnik and Rennie, 1963). Mice were inoculated with 
brain homogenates prepared from terminally scrapie-affected mice or uninfected 
mice as described below. Two routes of inoculation were used in these experiments: 




(section 2.4.4.). Mice were monitored following inoculation and any animals 
showing adverse reactions during the course of the experiment were killed using 
Schedule 1 procedure.  
 
2.4.2. Purification of scrapie associated fibrils (SAF) for fluorescent labelling 
with Alexa-Fluor®546 succinimidyl ester 
SAF Preparation: Brains from ME7 terminal mice were thawed, pooled, 
homogenised in Dounce homogenisers with 10 ml brain lysis buffer (0.01 M sodium 
phosphate pH 7.4, 10 % sarcosine), and topped up to 25 ml before transfer to Oak 
Ridge centrifuge tubes (Thermo Scientific Nalgene, Loughborough, UK). Tubes 
were centrifuged in the RC-5B centrifuge (Sorvall, DJB Labcare Ltd, Newport 
Pagnell, UK), using the SS34 rotor at 22,000 x g at 10 ºC for 30 min. 
 
Supernatant was transferred into Beckman polycarbonate centrifuge bottles, with cap 
assembly (355618, Beckman Instruments, USA). Samples were centrifuged in the 
L8-60 Ultra centrifuge (Beckman), using the Ti70 rotor at 215,000 x g at 10 ºC for 2 
hr 30.  Supernatants were discarded and pellets suspended in 3 ml water, and 
incubated at room temperature (RT) for 1 hr. 6 ml iodide solution (0.9 M potassium 
iodide, 9 mM sodium thiosulphate, 15 mM sodium phosphate pH 8.5 with HCl, 1 % 
sarcosine) was added to samples and carefully layered onto a 3 ml sucrose cushion 
(20 % sucrose in iodide solution) in Beckman Ultraclear tubes (344059, Beckman) 
and centrifuged in the L8-60 Ultra centrifuge, in the SW41 rotor at 285,000 x g at 10 
ºC for 90 min. Supernatants were carefully discarded, and tubes were left upside 
down overnight at RT on absorbent paper to dry off any excess fluid. Pellets were 




in a benchtop microfuge at 16,000 x g at RT for 30 min. Pellets were suspended in 20 
μl 0.1 % Sarkosyl/ PBS (approximately 1 μg/μl). To aid suspension, samples were 
sonicated (Sonicator, Ultrasonic Processor XL, Heat Systems)  with 10 s bursts.  
 
Fluorescent tagging of the SAF with Alexa-Fluor®546 succinimidyl ester: 2 μl 
Alexa-Fluor®546 succinimidyl ester (Invitrogen) was added to each sample (1 
volume to 10 volumes of sample) and incubated at RT for 1 hr with constant 
agitation (in the dark). The reaction was quenched overnight at 4 ºC by adding 1 
volume of 1.5 M hydroxylamine (pH 8.5) for 10 volumes of dye reaction. Labelled 
samples were washed in excess of 5 times in 0.1 % Sarkosyl/ PBS at RT for 10 min 
at 18,700 x g, ensuring that the supernatant of the final wash was clear and 
colourless. Pellets were suspended in 20 μl of 0.1 % Sarkosyl/ PBS, sonicated with 
10 s bursts to aid suspension, and stored at - 20 ºC. 
 
Preparation of the SAF-Alexa-Fluor®546 inoculum: Samples were thawed and 
sonicated with 10 s bursts, before separating into two aliquots. Proteinase K (Roche 
Diagnostics Ltd., UK) was diluted 1:10 to make a 2000 μg/ml solution. Proteinase K 
was added 1:20 to the samples to give a working concentration of 100 ng/ml. 
Samples were incubated at 37 ºC for 1 hr with agitation or 100 mM PMSF 
(phenylmethanesulfonylfluoride) (Sigma-Aldrich) was diluted 5-fold, and 2 μl (2 
mM final concentration) was added to the other half of samples and incubated on ice 
for 1 hr, to block protein degradation. Proteinase K treated samples were treated with 
PMSF for 10 min, to inhibit proteinase K activity. Samples were topped up to 1 ml 




Samples were diluted to a final volume of 760 μl, separated into two equal volumes 
of 380 μl and sonicated with 10 s bursts to aid suspension, and stored at - 20 ºC, 
ready for use. 
 
Gel electrophoresis of SAF-Alexa-Fluor®546 inoculum: Alexa-Fluor®546-SAF 
samples were resuspended in 50 µl sample buffer, and denatured at 90 ºC for 10 min. 
Samples were  loaded equally onto two pre-cast gels (Invitrogen) for electrophoresis 
according to manufacturer’s instructions. 
 
Fluorograph analysis and silver stain of the SAF-Alexa-Fluor®546 inoculum:  
Following electrophoresis, one gel was fixed in ‘fluorofix’ (40 % ethanol, 2 % acetic 
acid in double distilled water (ddH2O)), prior to fluorescent imaging on a Typhoon 
Imager (GE Healthcare). Gel was fixed overnight with constant agitation, prior to 
sensitising (30 ml ethanol, 0.5 ml 25 % glutaraldehyde, 0.2 g sodium thiosulphate, 
6.8 g sodium acetate, in 100 ml ddH2O) for 1hr. The gel was washed 4 x 15 min in 
dH2O, before adding silver solution (0.25 g silver nitrate, 40 µl 38 % formaldehyde, 
added just prior to use, in 100 ml ddH2O) and incubating with constant agitation for 
1 hr. Two 1 min washes preceded developing (2.5 g sodium carbonate, 80 µl 38 % 
formaldehyde, added just prior to use, in 100 ml ddH2O) until desired intensity was 
reached. Developing was stopped by addition of 1.46 g EDTA sodium salt in 100 ml 
ddH2O, prior to scanning.  
 
Western blotting of the SAF-Alexa-Fluor®546 inoculum: One gel was transferred 




dry blotter, according to manufacturer’s instructions. The blot was washed in Tris 
buffered saline (TBS)- 0.05 % Tween and blocked in 5 % Marvel- TBS- 0.05 % 
Tween for 1 hr, prior to probing with mouse anti-PrP monoclonal antibody (mAb), 
8H4 1/4000 (Abcam, UK)  in 1 % Marvel- TBS- 0.05 % Tween overnight at RT. 
Blot received 3 x 10 min TBS- 0.05 % Tween, and 2 x 10 min 5 % Marvel- TBS- 
0.05 % Tween block before probing with goat anti mouse-HRP antibody (Sigma-
Aldrich) for 1 hr. The blot received four 15 min washes before addition of Pierce 
(Thermo scientific) enhanced chemiluminescence (ECL) substrate (Table 2.4.). 
Detection film was exposed to blots for predetermined lengths of time and developed 
using a medical film processor (Konica Minolta SRX-101A). 
 
2.4.3. Intra-cerebral inoculation 
For i.c. injection, mice were anaesthetised with 3 % fluorothane gas (delivered in 
oxygen) prior to inoculation. 20 μl brain homogenate from C57BL/Dk mice 
terminally affected with the ME7 scrapie agent strain was injected into the right mid-
temporal cortex using a 1 ml syringe with a 26 gauge needle. To ensure accuracy the 
needle was sheathed to expose 2 mm length for injection. Scrapie-affected brain 
homogenate was used at 1 % dilution in physiological saline.  
 
2.4.4. Inoculation through skin scarification 
Mice were scarified on the medial surface of the left inner thigh as previously 
described, (Glaysher and Mabbott, 2007a; Mohan et al., 2004; Mohan et al., 2005a; 
Taylor et al., 1996). 24 hours prior to inoculation, a 1 cm
2
 area of hair was shaved 
from the inner left thigh. A 23 gauge needle was used to create an approximately 0.3 




drop (approximately 6 μl) of 1 % scrapie inoculum was dropped onto the 
scarification site by means of a 26 gauge needle and carefully worked into the site 
with sweeping strokes. The wound was sealed with Op-Site (Smith and Nephew 
Medical Limited, Hull, UK).  
 
2.4.5. Determination of scrapie incubation period 
The scrapie incubation period is defined as the time elapsed (in days) between the 
day of inoculation and the clinical endpoint of the disease, incubation period was 
only confirmed when both clinical and pathological scores were positive. All mice 
were clinically monitored by experienced animal technicians. Mice were assessed 
weekly on the same day and given a rating as follows: ‘unaffected’, ‘possibly 
affected’, or ‘definitely affected’. 
The clinical endpoint is defined in one of four ways: 
1. The day on which the mouse receives a third consecutive ‘definite’ rating; 
2. The day on which the mouse is culled in extremis, or; 
3. The mouse is found dead in its cage after receiving a ‘definite’ rating at the time of 
scoring the previous week.  
Once the clinical end-point had been defined animals were culled humanely and 
tissues collected for further analysis. This system has been used for many years at 
The Roslin Institute and has been applied to a wide range of TSE experiments. 
 
2.4.6. Assessment of scrapie pathology in the brain by lesion profiles 
Whole brains were cut into five defined areas (Fraser and Dickinson, 1968), fixed in 
2% periodate-lysine-paraformaldehyde (PLP) (0.1 M periodate; 0.075 M D-L 




processor before embedding in paraffin wax. 6 µm sections were cut using a 
microtome and stained with Harris haematoxylin and eosin. Sections were examined 
by experienced staff to determine the degree of scrapie-specific vacuolation in the 
neuropil. Vacuolation in the brain was scored on a scale of 0-5 in the following grey 
matter (G1-G9) areas (Bruce and Fraser, 1982): G1, dorsal medulla; G2, cerebellar 
cortex; G3, superior colliculus; G4, hypothalamus; G5, thalamus; G6, hippocampus; 
G7, septum; G8, retrosplenial and adjacent motor cortex; G9, cingulate and adjacent 
motor cortex (Fraser and Dickinson, 1967; Fraser and Dickinson, 1968). 
 
2.4.7. Histological analysis of skin after scarification 
Serial 8 μm sections were cut from snap-frozen tissues at - 20 ºC, using a Leica 
CM1900 cryostat machine (Leica). Sections were thawed and fixed in 10 % formal 
saline prior to staining with Harris haematoxylin and eosin (Surgipath). 
 
Analysis was carried out with assistance of a board-certified pathologist. Tissues 
were examined for evidence of inflammatory infiltrate following scarification with or 
without scrapie inoculation, and compared alongside fluorescence microscopic 
analysis for cells indicative of inflammation or of SAF- Alexa-Fluor®546 inoculated 
tissues. 
 
2.5. Ex-vivo analysis 
2.5.1. Immunofluorescent histochemistry of epidermal and dermal sheets 
Where indicated, ears were separated into dorsal and ventral halves. Subcutaneous 
fat and cartilage was removed. Skin was floated on 3.8 % ammonium thiocyanate 




min at 37 °C. Epidermal and dermal sheets were separated before fixation in acetone 
at -20 °C for 15 min (Nagao et al., 2009), before carrying out immunofluorescence 
histochemistry. 
 
2.5.2. Epidermal sheet separation for tight junction analysis 
Dorsal and ventral sides of the ear were separated as before. Ventral sides were 
floated out, cartilage side down, in PBS containing 0.7 mM Ca
2+
 (important for 
maintaining tight junction structure). Subcutaneous fat and cartilage were removed 
and tissues floated out in 95 % ethanol on ice and incubated for 30 min. Ears were 
dabbed lightly on the surface of PBS to rinse, before being floated out epidermis side 
up onto 3.8 % ammonium thiocyanate (as above) prewarmed to 37 °C, and incubated 
at 37 °C for 17-18 min. Tissues were floated out in PBS and transferred onto glass 
slides (Superfrost slides, Thermo Scientific, UK) to separate the epidermis from the 
dermis, and immunofluorescence histochemistry was carried out. 
 
2.5.3. Immunohistochemistry and immunofluorescence histochemistry of 
frozen tissues  
Tissue preparation: Thigh skin (hair shaved prior to analysis), ears, spleen, iLN and 
popliteal LN (Løvik et al., 2007) were fixed in 3 % PFA for 3 hr, or snap frozen in 
liquid nitrogen and stored at - 150 °C. Following fixation, tissues were washed in 
PBS, transferred to a 30 % sucrose solution and stored at 4 ºC overnight. Tissues 




 (Bayer Plc., Newbury, UK), 









sections were cut from snap-frozen and PFA-fixed tissues at - 20 ºC, using a Leica 
CM1900 cryostat machine. 
 
Intracellular labelling: Snap-frozen and PFA-fixed tissue sections were thawed for 
30 min, permeabilised for 15 min in 0.1 % saponin, 5 % FCS in PBS, incubated with 
antibody (Table 2.1.) diluted in the above buffer for 30 min, and washed with the 
same buffer. Antibodies were detected with appropriate fluorescence-labelled 
secondary antibodies (Table 2.2.). Sections were mounted using fluorescent 
mounting medium (Dako, Cambridgeshire, UK). 
 
Immunohistochemistry and Immunofluorescence histochemistry: Snap-frozen 
tissues were thawed for 30 min, acetone fixed for 10 min and air dried for 15 min. 
Sections were blocked with appropriate non-specific serum. Antibody was diluted in 
PBS/ 1 % bovine serum albumin (BSA) (Sigma-Aldrich). For fluorescence labelling, 
sections were washed with PBS/BSA and antibodies were detected with 
fluorescence-labelled secondary antibodies (Table 2.2.) and mounted as above. A 
TSA tyramide amplification kit (Invitrogen) was used to enhance CD11c 
immunolabelling in skin. For light level imaging, sections were washed in TBS/BSA, 
labelled with biotinylated secondary antibody (Table 2.2.), VECTASTAIN ABC-AP 
KIT (Standard*) (Vector Labs, UK) as a tertiary step, followed by VECTOR
®
 Red 
Alkaline Phosphatase Substrate Kit (Vector Labs). Sections were counterstained with 
haematoxylin Z to distinguish cell nuclei, and mounted using VectaMount™ AQ 
Mounting Medium (Vector Labs). Tissues from animals scarified with SAF-Alexa-




2.5.4. Immunohistochemistry of paraffin embedded tissue (PET) blots 
Spleen, LN, or brain were fixed in 2 % PLP and embedded in paraffin wax. 6 μm 
sections were cut on a microtome and mounted onto Superfrost
®
 Plus slides. Tissue 
sections were deparaffinised before immunolabelling with primary antibody (Table 
2.3). Sections were washed in TBS/BSA, labelled with biotinylated secondary 
antibody (Table 2.2.), VECTASTAIN ABC-AP KIT (Standard*) as a tertiary step, 
followed by VECTOR
®
 Red Alkaline Phosphatase Substrate Kit. Alternatively, 
sections were washed in PBS/BSA, labelled with biotinylated secondary antibody 
(Table 2.2.), VECTASTAIN Elite ABC Kit (Standard*) as a tertiary step, followed 
by diaminobenzidine (DAB) (Sigma-Aldrich). Sections were counterstained and 
mounted using VectaMount™ AQ Mounting Medium or Pertex mounting medium 
(CellPath, UK).  
 
2.5.5. Detection of PrPSc by PET blotting 
Spleen, LN, or brain were fixed in 2 % PLP and embedded in paraffin wax. 6 μm 
sections were cut on a microtome and mounted onto a nitrocellulose membrane (Bio-
Rad Laboratories Ltd., Hertfordshire, UK). Sections were deparaffinised before 
treatment with Proteinase K 20 µg/ml (Sigma-Aldrich) overnight at 55 ˚C. 3 mol/L 
guanidine isothiocyanate treatment was carried out prior to blocking with 2 % casein 
in TBS (pH 7.8) - 0.05 % Tween and incubation with antibodies (Table 2.3). 
Alkaline phosphatase-conjugated secondary antibodies were used prior to developing 











Table 2.1. Primary antibodies for immunohistochemical analysis of frozen sections  
and epidermal and dermal ear sheets. 




T8-754 1/10 M. Furuse, Kobe 



















HL3 1/100 BD Biosciences 550283 
CD21/CD35 
(CR2/CR1) 
7G6 1/100 BD Biosciences 553817 
CD45R (Ptprc) RA3-6B2- 
Biotin 





M1/70.15 1/100 AbD Serotec MCA74GA 
CD169 
(Siglec-1) 
MOMA-1 1/10 AbD Serotec MCA947 
Ly-6B.2 
(PMNs) 
7/4 1/70 AbD Serotec MCA771GA 
CD35 (CR1) 
 
8C12 1/100 BD Biosciences 558768 
PrP
c
 1B3 1/1000 Roslin Institute 


























Table 2.2. Secondary and tertiary antibodies for immunohistochemistry. 









Hamster IgG (H+L) 










































1/200 Invitrogen S21374 










2.5.6. Microscopy and analysis 
Confocal images were obtained by visualisation through a Zeiss LSM 5 Pascal 
Axioskop 2 microscope (Carl Zeiss Ltd, UK). Using the multitrack function of the 
confocal software, LSM5 Pascal version 3.2 SP2, images were captured using 
Helium Neon (HeNe) lasers 543 nm and 633 nm with LP560 and LP650 filters 
respectively (LASOS Lasertechnik GmbH, Germany) for Alexa Fluor® 546 or Alexa 
Fluor® 555 and Alexa Fluor® 647 or TO- PRO®-3 iodide, and an Argon-ion laser 
488 nm with Bp filter 505-550 for Alexa Fluor
®
 488.  
 
For light level microscopy, PET blot sections were examined using a Leica WLD 
MZ8 stereo light microscope and images were captured using Leica FireCam 3.0. 
Immunohistochemistry sections were examined using a Nikon Eclipse E800 (Nikon, 
UK) and captured using Image-Pro Plus version 6.2 (Media Cybernetics, Inc., USA).  
 
 
2.5.7. Western Blot analysis 
Spinal cord was dissected, snap frozen in liquid nitrogen, and stored at - 80 ºC. 
Samples were stored on ice throughout. Tissues were weighed, and a 10 % 
homogenate was made up with NP40 lysis buffer. Equal volumes of homogenate 
were transferred into two separate 1.5 ml screw top tubes. 100 ng/ml final 
concentration of Proteinase K was added to one of half of the tubes, and samples 
placed at 37 ºC for 1 hr with constant agitation. 1 µl PMSF was added to the other 
half of the samples and these were centrifuged at 16,100 g for 20 min at 4 ºC. 
Supernatants were split into 50 µl aliquots and snap frozen in liquid nitrogen before 
storage at - 80 ºC. 1 µl PMSF was added to proteinase K treated samples before the 




Table 2.3. Antibodies for immunohistochemical analysis of PET blot sections 
Antigen Clone Dilution Source Catalogue no. 
PrP 6H4 1/1000 Prionics 01-010 
PrP 1B3 1/1000 Roslin Institute 





7G6 1/100 BD Biosciences 553817 
CD45R RA3-6B2- 
Biotin 






 1/400 Dako Z0334 





Table 2.4. Reagents used for Western blot analysis 
Reagents Source Catalogue no. 
NuPAGE®  4-12% Bis-Tris Gel 1.0mm x 15 well Invitrogen NP0323BOX 
NuPAGE®  MES SDS Running buffer (20X) Invitrogen NP0002 
NuPAGE®  Sample Reducing Agent (10X) Invitrogen NP0009 
NuPAGE®  LDS sample buffer (4x) Invitrogen NP0007 
NuPAGE®  Antioxidant Invitrogen NP0005 
NuPAGE®  Transfer Buffer (20X) Invitrogen NP0006-1 
Invitrolon™ PVDF⁄Filter Paper Sandwiches Invitrogen LC2005 
SeeBlue® Plus2 Pre-Stained Standard Invitrogen LC5925 
















Samples were thawed on ice, 40 % solutions were made up in NuPAGE® sample 
buffer, with sample reducing agent, diluted 1:10. Samples were denatured at 70 ºC 
for 15 min before centrifugation. 15 µl of sample were loaded onto NuPAGE® gels. 
Gels were electrophoresed and transferred onto PVDF membrane according to 
manufacturer’s instructions. 
 
The following steps were all carried out with constant agitation on The Belly 
Dancer
®
 (Stovall Life Sciences, Inc., USA). PVDF membranes were fixed in 
methanol, washed in water, then TBS, prior to blocking overnight in 10 % 
Marvel/TBS 0.1% Tween at 4 ºC, to reduce background noise. Blots were probed 
with rabbit polyclonal anti-PrP antibody, 1B3, 1/8000 for 1 hr. Blots received three 
15 min washes before probing with goat anti rabbit-IgG-HRP antibody (sc-2004, 
Santa Cruz Biotechnology, Inc.) for 1 hr. Blots received three 15 min washes before 
addition of Pierce enhanced chemiluminescence (ECL) substrate. Detection film was 
exposed to blots for predetermined lengths of time and developed using a medical 
film processor (Konica Minolta SRX-101A). 
 
2.5.8. Microarray analysis 
Tissues were collected into RNAlater (Ambion) and stored overnight at 4 ˚C before 
transfer to clean eppendorf tubes and storage at - 80 ˚C. RNA was extracted as 
follows. Tissues were added to 1 ml Tri Reagent in a Lysing Matrix D Tube (Fisher 
MBR-247-110Y), and homogenised in a FastPrep FP120 at 4 m/s for 20 s. Samples 
were incubated at RT for 5 min. 200 µl 1-bromo-3-chloropropane (BCP) (Sigma) 




Samples were centrifuged at 12,000 x g for 15 min at RT. Aqueous (upper) phase 
(approximately 500 µl) was transferred to a new tube. 500 µl propan-2-ol was added 
to each sample and vortexed before a 10 min incubation on ice. Samples were 
centrifuged at 12,000 x g for 30 min at RT. Supernatant was removed and pellets 
were washed with 1 ml 75 % ethanol. Samples were vortexed and centrifuged 12,000 
x g for 15 min at RT. Supernatants were removed and pellets were air-dried for 5-10 
min. Pellets were resuspended in 30 µl RNase-free water, vortexed and left on bench 
for 15 min, and stored at - 80 ºC. The following work was carried out by ARK-
Genomics (Roslin Institute). A Bioanalyzer (Agilent Technologies) was used to 
check RNA quality. RNA was reverse transcribed to cDNA and amplified using 
GeneChip IVT Express Kit (Affymetrix, UK), and cDNA was hybridised to Mouse 
430_2.0 Affymetrix™ chips for analysis on a GeneTitan®. 
 
Normalisation of raw data, annotation of probe sets, and Pearson correlation were 
carried out by Dr Neil Mabbott. Raw data (.cel) files were normalised using RMA 
express (http://rmaexpress.bmbolstad.com/). Probe sets were annotated using the 
latest libraries available from Affymetrix (http://www.affymetrix.com) and samples 
were arranged according to cell-type grouping to ease interpretation of the data. 
Normalised, non-log transformed gene expression data were imported into 
BIOLAYOUT EXPRESS 3D, a tool specifically designed for the visualisation of 
large network graphs (Freeman et al., 2007; Theocharidis et al., 2009). A sample-to-
sample correlation matrix was calculated and a graph was plotted using sample-to-
sample relationships > 0.9. In this context nodes represent individual data sets (cells) 




threshold. Next, a pairwise transcript-to transcript Pearson correlation matrix was 
calculated based on each transcript’s profile across all samples. A Pearson 
correlation coefficient cut-off threshold of r = 0.9 was selected and an undirected 
network graph of these data was generated. In this context nodes represent individual 
probe sets (genes/transcripts) and the edges between them Pearson correlation 
coefficients above the selected threshold. The network was clustered into groups of 
genes sharing similar profiles using the built-in Markov Clustering (MCL) algorithm 
at an MCL inflation value (which controls the granularity of clustering) (Freeman et 
al., 2007) set to 2.2. The graph of these combined data sets was explored to 
understand the significance of the gene clusters and functional relationships between 
the cell populations investigated.  
 
2.6. Statistical analysis  
Statistical analysis was carried out with guidance from Dr Darren Shaw (R(D)SVS, 
University of Edinburgh). Prior to consideration of results, normality of residuals 
was established. When samples were normally distributed, they were analysed using 
a one way analysis of variants. Samples that were not normally distributed were 
analysed using a non-parametric test, the Kruskal-Wallis test was used on sample 
medians.  Tests on power and sample size were carried out using one way analysis of 
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Mice are naturally resistant to DTX. This has permitted the creation of a transgenic 
mouse line where DTRs are expressed on the surface of target cells, allowing for the 
temporary depletion of these cells after a single injection of DTX. The CD11c-DTR 
mouse line enables the temporary conditional depletion of CD11c
+
 cells, traditionally 
believed to encompass DC subsets. CD11c
 
is expressed on a number of different 
cellular subsets within the various tissues such as the skin and peripheral lymphoid 
organs. By carrying out an analysis of skin and lymphoid tissues following DTX-
mediated depletion, it was possible to create a timeline for the depletion and 
repopulation of CD11c
+
 cells within these tissues. It was also possible to determine 
that the temporary depletion of these cells did not adversely affect lymphoid tissue 
microarchitecture within the mice. Epidermal LCs are radioresistant and remain of 
host origin up to 18 months post irradiation and reconstitution. By creating bone 
marrow chimeric mice through reconstitution of lethally γ-irradiated wildtype mice 
with CD11c-DTR transgenic bone marrow it was possible to analyse depletion and 
repopulation of CD11c
+
 cells with the exception of LCs. It is thereby possible to gain 
a better understanding of the different roles and functions of distinct skin resident DC 












The CD11c-DTR transgenic mouse line (Jung et al., 2002), allows for the temporary 
conditional depletion of CD11c
+
 cells, which repopulate tissues within a tissue 
specific time frame. This technology has been used to study the function of CD11c
+
 
cells in a range of diseases, such as Herpes Simplex virus (Kassim et al., 2006), 
Listeria (Waite et al., 2011), or even scrapie (Raymond et al., 2007). CD11c
+
 cells 
are located in a range of different tissues. As cells of the immune system there is a 
large proportion of these cells within the peripheral lymphoid tissues (Probst et al., 
2005), as well as non-lymphoid organs, notably the skin (Jung et al., 2002). It has 
been believed that the low level CD11c
 
expression on LCs was not sufficient to 
deplete these cells in the CD11c-DTR mouse. This chapter will clearly demonstrate 
that LCs are depleted following DTX treatment in CD11c-DTR mice, but it is 
possible to circumvent this. LCs are radioresistant (Merad et al., 2002), and will 
remain of host origin up to 18 months after lethal irradiation and bone marrow 
reconstitution. This is in contrast to other mononuclear phagocyte populations, which 
are radiosensitive, and are replenished from donor derived precursors following 
lethal irradiation and bone marrow reconstitution (Merad et al., 2002). 
 
While it was originally thought that CD11c was a marker exclusive to DCs (Hume, 
2008), immunohistochemical analysis determined that DCs as well as several 
macrophage populations were depleted following DTX treatment in CD11c-DTR 
mice (Bradford et al., 2011; Probst et al., 2005). Probst et al also determined that the 
different CD11c
+
 cellular subsets repopulated the tissues at varying rates. While 




(Jung et al., 2002), other cell types, such as marginal zone or metallophillic 
macrophages remained absent for up to ten days post DTX treatment (Probst et al., 
2005). 
 
The aim of this chapter is therefore to gain a better understanding of the depletion 
and repopulation of different CD11c
+
 cell populations in various tissues following 
DTX treatment. In doing so, it is hoped that this knowledge will help to provide a 
better understanding of the potential involvement of CD11c
+
 cells in scrapie 
pathogenesis, by using temporary conditional DTX-mediated depletion. Data from 
this chapter will determine depletion and repopulation dynamics of these different 
cell subsets after DTX treatment. These data will be utilised in Chapter 4 and 
Chapter 6 to determine the potential role of these different subsets in scrapie 

















3.3.1. Detection of the DTR transgene 
The presence of the DTR (Heparin binding EGF-like growth factor: Hbegf) transgene 
on the surface of CD11c
+
 cells in CD11c-DTR mice allows for the temporary 
depletion of CD11c
+
 cells through a single i.p. injection of DTX. These mice were 
utilised to study and determine a timeline for the depletion of CD11c
+
 cells in the 
skin and lymphoid tissues. Genotyping was routinely carried out on all CD11c-DTR 
mice to confirm presence of the DTR transgene before inclusion in any experiment. 
The two DTR oligonucleotides used produced a PCR product with a band size of 625 
base pairs, as shown in Fig. 3.1. The absence of the DTR transgene in a sample 
would have resulted in a complete absence of PCR product, a blank well (Fig. 3.1.).  
 
 3.3.2. Effect of DTX-mediated CD11c+ cell depletion on epidermal LCs 
To examine the effect of DTX on LCs of the epidermis, 3 CD11c-DTR mice from 
each of the following time points received a single i.p. injection of 100 ng DTX, or 
PB control, and tissues were collected for ex vivo analysis 0, 1, 2, 4, 6, 8, and 14 days 
post injection. Immunofluorescent analysis was carried out on epidermal sheets to 
determine the effect of DTX on LCs. Despite low level CD11c expression on LCs in 
the epidermis (Jung et al., 2002), a partial depletion was observed from 2 days after 
DTX injection (Fig. 3.2.). Depletion was not complete, as a number of areas were 
detected that still contained LCs. The morphological difference detected in the LCs 
can be seen in Fig. 3.3. The network created by LCs in the epidermis under steady 
state conditions (without stimulus) was observed in the untreated control mice. The 
LCs presented long, thin branched dendrites. By contrast, following DTX injection, 




observations resemble morphological changes observed in LCs following mechanical 










Figure 3.1. DTR PCR on CD11c-DTR mice. Lane 1: DNA ladder; lanes 1-6: samples from 
CD11c-DTR mice genotyped prior to inclusion in the experiment; lane 7: blank lane; 8: positive 






Figure 3.2. LC depletion timeline in ear epidermal sheets from CD11c-DTR mice. Mice received a single i.p. injection of DTX and epidermal ear sheets 
collected at the time points indicated were immunolabelled with the anti-langerin specific antibody (green). Only one field of view is represented, except for day 6 post 
injection, when two fields of view were selected to show the differences that were found in the same ear sheet. (A,F) Normal distribution of langerin
+
 cells within the 
epidermal sheets without DTX treatment. Two days after DTX injection, (B,G) a partial depletion of LCs was observed. By day 6 after DTX treatment (C,H,D,I), cells 
remained depleted, although this was not uniform throughout the tissues. F-J represent higher (2 x) magnification images of A-E, where it was clearer to distinguish 
the disruption to the morphology of the LCs. In mice treated with DTX there appeared to be more cellular debris and the cells’ dendritic processes appeared less intact. 
The LC network appeared more disrupted, not as many cells were observed and they did not appear intact, compared to the animals that had not received DTX. Images 








Figure 3.3. LC depletion in the epidermis of CD11c-DTR mice 4 days post DTX 
injection. CD11c-DTR mice were given a single i.p. injection of DTX, or PB control and epidermal 
ear sheets collected 4 days later. Immunofluorescent labelling of LCs with the anti-langerin specific 
antibody (green) and TO-PRO®-3 iodide nuclear counterstain (blue) revealed morphological changes 
of LCs in ear epidermal sheets following treatment with DTX or PB control. A shows healthy LCs, 
the cell bodies are elongated (▪ next to cell bodies), and long branched dendritic processes were 
observed (*). B shows effect of DTX on LCs. Cell numbers were reduced, cell bodies (▪) appeared 
more rounded and lacked their dendritic processes (*) compared to the LCs in untreated mice.   
Images are representative of observations in 3 different animals. A and B 200 x magnification. Inserts, 
















3.3.3. Depletion of CD11c+ cells 
To examine the depletion of CD11c
+
 cells in the CD11c-DTR mice, animals were 
given a single i.p. injection of 100 ng DTX, or PB control, and tissues were collected 
from 3 mice in each group, for ex vivo analysis at 0, 1, 2, 4, 6, 8, and 14 days post 
injection. Immunofluorescence analysis carried out on ear cross sections confirmed a 
reduction in the number of CD11c
+
 cells in both the epidermis and in the dermis 
following DTX injection (Fig. 3.4.). The CD11c
+
 cells in the epidermis were most 
likely LCs, (as illustrated in Figs. 3.2. and 3.3.), and were still depleted 6 days post 
DTX injection. Dermal DCs are less abundant than the LCs in the epidermis, and not 
as uniformly distributed (Nagao et al., 2009). This was evident in the untreated mice, 
panel A. A reduction in CD11c
+
 cell numbers in the dermis was observed by day 2 













 cell depletion in the skin. Mice were given a single i.p. injection of DTX and tissues collected at the times indicated were analysed by 
immunofluorescence with the anti-CD11c specific antibody (green). E and D indicate the epidermis and dermis, respectively, of the skin of the ear. Normal CD11c
+
 
LCs of the epidermis and CD11c
+
 DCs of the dermis can be visualised in A. B and C show reduced numbers of CD11c
+
 cells in both the epidermis and the dermis, up 
to 6 days post DTX injection. D: positive control spleen showing abundance of CD11c
+
 cells. Images are representative of observations in 3 different animals. Scale 







In accordance with previous studies (Jung et al., 2002; Probst et al., 2005; Raymond 
et al., 2007), immunohistochemical analysis of spleen, iLN and pLN shows that 
CD11c
+
 cells were partially depleted in all three tissues, two days after DTX 
treatment (Fig. 3.5.). The effect of DTX treatment on CD11c
+
 cells was transient, as 
cell numbers had started to increase by 6 days post injection.  
 
3.3.4. Effect of DTX treatment on other cell types 
To examine the effect of DTX on other cell types, spleen and iLN from DTX and PB 
injected animals were immunofluorescently analysed to determine any potential 
secondary effect of DTX on CD35 expressing FDCs and B lymphocytes. No 
differences were observed in the distribution of CD35 expression following DTX 
injection either 2 or 6 days post injection (Fig. 3.6.). 
 




 cells were 
partially depleted in the spleen two days post DTX injection (Fig. 3.7.). By six days 





 cells, indicative of metallophilic marginal zone 





 cells. Unlike the results observed with light microscopy ((Probst et 
al., 2005), and not shown) this is not a complete depletion. CD11c expression is very 




 cells (Phan et al., 2009) and there is no observable 




Figure 3.5. DTX-mediated depletion of CD11c
+
 cells in the spleen, iLN and pLN of CD11c-DTR mice. Mice were given a single i.p. injection of DTX, 
or PB control, and tissues collected at the times indicated were analysed by immunohistochemistry using the anti-CD11c specific antibody (red). Sections were 
counterstained with haematoxylin Z (blue). (A,H,O) Normal distribution of CD11c
+
 cells in the three lymphoid tissues in PB control treated mice. A partial depletion 
of CD11c
+
 cells was observed from 1 day post DTX treatment (B,I,P). Cells numbers had started to increase by 6 days post DTX treatment (E,L,S), and had regained 







Figure 3.6. Effect of DTX injection on CD35 expression in the spleen. Mice were given a 
single i.p. injection of DTX and spleens collected at the times indicated were immunofluorescently 
labelled with the anti-CD35 specific antibody to detect FDCs and CD35-expressing B lymphocytes 
(red). D-F 400 x magnification of A-C (100 x magnification). Normal distribution of CD35 
expressing cells were observed in the lymphoid follicles of the spleen both at 2 (B,E) and 6 (C,F) 
days post DTX injection. Images are representative of observations in 3 animals/time point. Scale bar: 
















 cells in the spleens of 
CD11c-DTR mice. Mice were given a single i.p. injection of DTX and tissues collected at the time 
points indicated were immunolabelled with the anti-CD11c (HL3) specific (green) and the anti- 
CD169 (MOMA-1) specific (red) antibodies. F-I are higher magnification (200 x) images of the top 









the spleen without DTX treatment. Two days after DTX treatment, (B,G) a partial depletion was 




 cells numbers had 














 (E,J). Images are representative of observations in 3 animals/time point. 
















3.3.5. Depletion of langerin+ cells in lymphoid tissues 
Immunofluorescent analysis of iLNs and pLNs (not shown) indicated that langerin
+
 
cells were partially depleted in CD11c-DTR mice following DTX treatment (Fig. 
3.8.). In contrast to the CD11c
+
 cells shown in Fig. 3.5., the langerin
+
 cells in the 
iLNs remained depleted for longer, and cell numbers appeared to have started to 
increase by 14 days post DTX injection. 
 
3.3.6. CD11c-DTR bone marrow chimeric mice 
C57BL/6 wildtype mice were lethally γ-irradiated 24 hr prior to receiving a full bone 
marrow reconstitution from CD11c-DTR transgenic mice, or C57BL/6 mice as a 
control. MNPs in the lymphoid tissues are radio sensitive and will be of donor origin 
8 weeks after bone marrow reconstitution (Fig. 3.9.). LCs are radio resistant, and are 
host derived up to 18 months post irradiation (Merad et al., 2002). LCs should, 
therefore, not express the DTR transgene as they are of host origin, while the other 
CD11c
+
 cells are donor derived, express the DTR transgene, and are susceptible to 
depletion following DTX treatment (Table 3.1.). Three groups were established (Fig. 
3.9. and Table 3.1.) and will hereafter be referred to as WT→WT+DTX (wildtype 
mouse reconstituted with wildtype bone marrow, injected with DTX); CD11c-
DTR→WT+DTX (wildtype mouse reconstituted with CD11c-DTR transgenic bone 
marrow, injected with DTX); and CD11c-DTR→WT+PB (wildtype mouse 








 cell depletion in the iLN. Mice were given a single i.p. injection of DTX, 
or PB control, and tissues collected at the time points indicated were immunolabelled with the anti-
langerin specific antibody (green). F-J represent higher magnification (200 x) images of A-D (100 x). 
(A,E) Normal distribution of the langerin+ cells within the iLN without DTX treatment. A partial 
depletion of langerin
+
 cells was observed in the iLN (B,F). By day 14 after DTX treatment, (D,H) 
cells had not reached pre-depleted numbers. Images are representative of observations in 3 









Figure 3.9. Model of irradiation and bone marrow reconstitution. C57BL/6 wildtype mice 
were lethally γ-irradiated 24 hr prior to receiving a bone marrow graft (grey) from either C57BL/6 
mice, as a control, or CD11c-DTR mice. After 8 weeks mice were split into three groups. Mice that 
received wildtype bone marrow were injected with DTX as a control. Mice that received transgenic 





Table 3.1. Depletion status of cells following lethal irradiation and reconstitution with 
CD11c-DTR or wildtype bone marrow. 























WT WT yes no no no no 
WT CD11c-DTR yes yes yes yes no 











3.3.7. Confirmation of successful CD11c-DTR bone marrow transplantation 
To confirm presence of the DTR (Hbegf) transgene, and presence of the Prnp gene 
following lethal γ-irradiation and bone marrow reconstitution, frozen spleen and tail 
samples from mice in each group were analysed by PCR. The DTR transgene (625 
bp) was detected in all animals reconstituted with CD11c-DTR bone marrow. The 
observed bands were stronger from the spleen samples, compared to tail samples, but 
this could be accounted for by the abundance of CD11c
+
 cells in the spleen. The 
Prnp gene (765 bp) was detected in all the spleen and tail samples (Fig. 3.10.). 
 
3.3.8. Effect of DTX injection on langerin+ cells in CD11c-DTR bone marrow 
chimeric mice 
Ear epidermal sheets and iLNs were analysed by immunofluorescent histochemistry 
using the anti-langerin specific antibody to determine the effect of DTX injection on 
langerin
+
 cell status.  A partial depletion of langerin
+
 cells was confirmed in the iLN 
of DTX treated mice reconstituted with CD11c-DTR bone marrow, consistent with 
previous results in the CD11c-DTR mouse (Fig. 3.11.). No LC depletion was 
observed in the epidermis following DTX injection, regardless of whether the 












Figure 3.10. DTR and PrP PCR. The DTR transgene was detected in the spleen and tail of mice 
that had received CD11c-DTR transgenic bone marrow. The Prnp gene was detected in the spleen and 






 cells in the iLN, but not LCs in the epidermis, were depleted in 
bone marrow chimeric mice following DTX treatment. Mice were given a single i.p. injection 
of DTX, or PB control, and epidermal sheets and iLNs collected two days later were immunolabelled 
with the anti-langerin specific antibody (green). Epidermal sheets were counterstained with TO-
PRO®-3 iodide (blue). A-C: Normal distribution of langerin
+
 LCs in all three groups. E: Partial 
depletion of langerin
+
 cells in the iLN of CD11c-DTR→WT+DTX mice in comparison to both control 





3.3.9. Effect of DTX treatment on CD11c+ cell status in wildtype mice 
reconstituted with CD11c-DTR bone marrow  









 cells were partially depleted in the spleens and iLNs of CD11c-
DTR→WT+DTX mice. No cellular depletion was observed in either of the control 
groups (Fig. 3.12.). In contrast with the CD11c-DTR mice (Fig. 3.7.), CD11c
+
 cell 
depletion in these bone marrow chimeras did not appear to be as extensive, but 
CD11c
+
 cell numbers were reduced 2 days post DTX injection, compared to the two 
control groups (Fig. 3.12.). 
 
3.3.10. Lethal irradiation, bone marrow reconstitution, and DTX injection has 
no effect of FDC status 
In order to verify that no changes had occurred to modify the lymphoid tissue 
microarchitecture following irradiation, bone marrow reconstitution, and DTX 
injection, further analysis was carried out on spleen and iLNs. Tissues from 3 mice in 
each of the groups outlined in Fig. 3.9. were collected for ex vivo analysis two days 
after DTX injection. The tissues were immunolabelled to detect B lymphocyte 
subsets and FDCs. Spleen and iLNs were also immunolabelled to detect PrP
c
, to 
determine whether expression was influenced by DTX treatment. No differences 
were observed for the intensity or location of labelling for the FDCs and B 
lymphocytes in the CD11c-DTR→WT+DTX animals compared to the two control 
groups. Equally, the expression of PrP
c
 on FDC networks was not affected in the 
CD11c-DTR→WT+DTX mice, when compared to the control animals in either the 









 depletion two days post DTX injection. 
Mice were given a single i.p. injection of DTX and spleens collected two days later were 
immunolabelled with the anti-CD11c specific (green) and the anti-CD169 specific (red) antibodies. D-
F represent higher magnification (200 x) images of the top row (100 x). WT→WT+DTX (A,D) and 









 that correlates with previous controls. (B,E) CD11c-








 cell subsets were partially depleted. 













Figure 3.13. DTX treatment had no effect on FDC and B lymphocyte status in the 
spleen. Mice were given a single i.p. injection of DTX, and spleens collected two days later were 
immunolabelled with the anti-CD45R specific antibody to detect B lymphocytes (green, A,E,I); the 
anti-CD35 specific antibody to detect FDCs and CD35-expressing B lymphocytes (red, C,G,K); and 
the  pAb 1B3 to detect PrP
c
 (blue, B,F,J). Comparison between the 3 groups indicated no effect of 
irradiation, bone marrow reconstitution, or DTX, or PB injection on presence of PrP
c
 on FDCs in the 
B cell zone of the spleen. D,H,L merged images of all three antibodies. Images are representative of 






Figure 3.14. DTX treatment had no effect on FDC and B lymphocyte status in the iLN. 
Mice were given a single i.p. injection of DTX, and iLNs collected two days later were 
immunolabelled with with the anti-CD45R specific antibody to detect B lymphocytes (green, A,E,I);; 
the anti-CD35 specific antibody to detect FDCs and CD35-expressing B lymphocytes (red, C,G,K); 
and the  pAb 1B3 to detect PrP
c
 (blue, B,F,J). Comparison between the 3 groups indicated no effect of 
irradiation, bone marrow reconstitution, or DTX, or PB injection on presence of PrP
c
 on FDCs in the 
B cell zone of the spleen. D,H,L merged images of all three antibodies. Images are representative of 














In this chapter characterisation studies were carried out on the CD11c-DTR 
transgenic mouse line to determine a timeline for depletion and repopulation of 
CD11c
+
 cells following DTX injection. This was achieved through collection of 
tissues for ex vivo analysis at various time points following a single i.p. injection of 
DTX, or PB control. Depletion and repopulation, as a result of DTX injection, was 
further analysed in mice following lethal irradiation and reconstitution with bone 
marrow from CD11c-DTR transgenic mice. Through this characterisation, it has 
been possible to determine that CD11c
+
 cells were partially depleted in the skin and 
lymphoid tissues within 2 days of DTX injection until six days post injection.  
 
Upon closer examination it is possible to confirm that different subsets of CD11c
+
 
cells exist in lymphoid tissues. Some CD11c
+/hi
 cells, classically termed DCs, were 
observed to be repopulating tissues such as the spleen from six days post injection. 
Other, CD11c
low/med
 cells such as the marginal zone and metallophillic macrophages, 
and subcapsular sinus macrophages in the LN, identified by their expression of 
CD169, were much slower to repopulate the tissues following DTX injection (Probst 
et al., 2005). These cells were also depleted (to a lesser extent), following DTX 
injection in the lethally irradiated and reconstituted mice. 
 
DTX as a toxin does not affect mice (Morris and Saelinger, 1983), but the mass 
depletion of cells, especially in the lymphoid tissues could have repercussions on 
other cell types especially those cells which are part of the immune system. Using the 




was possible to determine that FDC networks, within the B cell areas of lymphoid 
tissues were not adversely affected by DTX injection, or the resultant CD11c
+
 cell 
depletion and repopulation. 
 
Irradiation and reconstitution of wildtype mice with wildtype or CD11c-DTR 
transgenic bone marrow had no major effect on the depletion of CD11c
+
 cells 
(excluding LCs), nor did it affect FDCs or B lymphocytes, located in the lymphoid 
follicles of the iLN or spleen. The animals were lethally γ-irradiated (1000 rad) and 
reconstituted with age and sex-matched bone marrow 24 hr later. Animals were 
maintained for 8 weeks post bone marrow transfer before DTX injection and tissues 
were collected for analysis. After 8 weeks the reconstitution and establishment of the 
CD11c-DTR transgenic cell population would be complete, with the exception of the 
LCs (Merad et al., 2002). Following injection of DTX or PB into these animals there 
were no observable differences in the expression of PrP
c
 on the FDCs, or the 
structure of the FDC networks or the B-cell follicles. These results thereby indicate 
that injection of DTX into the lethally irradiated, bone marrow reconstituted mice, 
and the subsequent CD11c
+
 cell depletion, did not have wide-ranging, non-specific 
effects in the affected tissues. 
 
The presence of LCs in the epidermis makes them a likely candidate for the potential 
capture and transport of the scrapie agent from the skin (Mohan et al., 2005c). 
Mohan et al found that XS106 cells, a DC cell line isolated from the mouse 
epidermis, with characteristics of mature LCs, degraded the scrapie agent following 




scrapie agent, which might not replicate in vivo situations. More importantly, during 
scrapie infection via the skin, LCs in the epidermis are immature, and only mature as 
they migrate from the epidermis, and the added injury of scarification might trigger 
different maturation responses in the LCs at the time when they would encounter the 
scrapie agent in the skin. LCs have previously been linked to transport of pathogens, 
such as HIV (de Jong and Geijtenbeek, 2010) or Dengue virus (Wu et al., 2000) from 
the skin. LCs express CD11c on their surface (Ginhoux et al., 2007; Jung et al., 
2002) and are therefore potentially depleted following DTX injection in the CD11c-
DTR mice. Epidermal sheets of the mouse ears were analysed for the depletion of 
LCs following DTX injection into these animals. Partial LC depletion was confirmed 
in these mice following DTX injection. In contrast, LCs were not depleted in the 
lethally irradiated mice following reconstitution and DTX injection, as the LCs are 
radioresistant and remain of host origin up to 18 months after lethal irradiation 
(Merad et al., 2002). By isolating the epidermal LCs from depletion prior to scrapie 
infection via skin scarification, it will be possible to determine whether CD11c
+
 cells 
other than LCs might play a role in the transport of the scrapie agent from the skin. 
Depletion of several different cellular subsets from the skin at the time of infection 
would simply obscure the results. LCs, and their potential role in scrapie infection 
via the skin will be fully investigated in Chapter 8. 
 
As well as the LCs in the epidermis, low numbers of migratory LCs were found in 
the skin draining LNs. Langerin
+
 DCs that have migrated from the dermis can also be 
found in the LNs. In the skin, LCs only express CD11c at a very low level, as they 




Although langerin expression is down-regulated during migration and maturation, 
the marker can still be detected on the cells in the skin draining LNs (Kissenpfennig 
et al., 2005b). Through their CD11c expression langerin
+
 cells within the LNs were 
also affected by the DTX. As with other subtypes, shown above, only a partial 
depletion of langerin
+
 cells was observed, but cell numbers are markedly reduced, 
and remain depleted for longer than other CD11c expressing cells. 
 
In conclusion, these data indicate that CD11c
+
 cells can be successfully depleted in 
lethally irradiated mice reconstituted with CD11c-DTR bone marrow. This 
temporary depletion confirms that these mice can serve as a useful model for 
investigating the role of CD11c
+
 cells in the uptake and transport of the ME7 scrapie 
agent from the skin. Data in this chapter indicate that 2 days post DTX treatment is 
the most suitable time at which to infect the mice with scrapie via skin scarification. 
At this time, the majority of cells have been depleted and remain depleted for several 
days following scarification, before they start to repopulate the tissues. Furthermore, 
any potential effect on scrapie pathogenesis, observed following DTX treatment, will 
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Dendritic cells have been implicated in the transport of the scrapie agent from the gut 
lumen to the gut associated lymphoid tissues, as well as in other aspects of disease 
pathogenesis. TSEs can be readily experimentally transmitted via the skin or mucosa 
through the presence of small abrasions on the skin or within the mouth. Following 
infection via the skin, the scrapie agent, PrP
Sc
, accumulates in the draining LNs. The 
skin is the body’s first line of defence, and as such, there is an abundance of immune 
cells, including different DC subsets, within the skin. These cells could therefore 
play a potential role in the transport of the scrapie agent from the skin to the draining 
LN following infection via the skin. Temporary conditional depletion of DC subsets, 
excluding epidermal LCs, prior to scrapie infection via the skin delayed the 
accumulation of PrP
Sc
 in the draining iLN at the early time point following infection, 
when compared to control animals. PrP
Sc
 had not yet spread to non-draining 
lymphoid tissues at the early time point. Despite the delay in early PrP
Sc
 
accumulation in mice depleted of DC subsets prior to scrapie infection via the skin, 
no differences were observed in the disease incubation period of these mice, when 













In Chapter 3, CD11c-DTR animals (Jung et al., 2002) and CD11c-DTR chimeric 
animals were analysed to determine a timeline for CD11c
+
 cell depletion, and to 
determine whether injection of DTX or depletion of CD11c
+
 cells had an adverse 
effect on the cellular environment within the skin or the secondary lymphoid system. 
Depletion of these CD11c
+ 
cells prior to oral scapie challenge has previously blocked 
early scrapie agent accumulation in the gut associated lymphoid tissues and reduced 
the susceptibility to disease (Raymond et al., 2007). Equally, scrapie infection via the 
skin leads to the accumulation of PrP
Sc
 and infectivity in the draining LNs and spleen 
at early time points after infection (Glaysher and Mabbott, 2007a; Mohan et al., 
2004; Mohan et al., 2005b). Three different bone marrow chimeric groups were 
created: WT→WT+DTX, CD11c-DTR→WT+DTX, and CD11c-DTR→WT+PB. 
These chimeric animals allowed for the depletion of DC subsets, without affecting 
epidermal LCs, which are radioresistant and would have remained of host origin 
(Merad et al., 2002). The effect of LCs on scrapie infection via the skin will be 
discussed in Chapter 8. Chapter 4 will describe how these bone marrow chimeric 
groups were used to determine whether depletion of CD11c
+
cells prior to infection 
with the ME7 scrapie agent by skin scarification affected the uptake and transport of 
the scrapie agent from the skin. The chapter will also look at whether the absence of 
these cells at the time of infection had an effect on the incubation period of disease. 
Experiments discussed in Chapter 3 demonstrated that the optimal time for scrapie 
infection was two days post DTX injection. In bone marrow chimeric animals, 
CD11c
+
 cells (excluding LCs), had been depleted in the skin, iLN, pLN and spleen, 




respective tissues. B cell follicles, FDCs and PrP
c
 expression in the lymphoid 
follicles of spleen, draining and non-draining LNs were not differently affected by 
injection of DTX in the bone marrow chimeric mice. In this chapter, mice were 
injected with DTX or PB control, and two days later mice were infected with the 
ME7 scrapie agent via scarification of the left inner thigh.  In each of the three 
groups, 3 mice were sacrificed at each of the serial kill (SK) time points indicated in 
Fig. 4.1., and the remaining mice were maintained to reach disease endpoint. These 
results will allow us to determine whether CD11c
+
 cells play a role in scrapie 






















4.3.1. Effect of CD11c+ cell depletion on early PrPSc accumulation   
To determine the effect of CD11c
+
 cell depletion on the early accumulation of the 
scrapie agent in the lymphoid tissues, mice received a single i.p. injection of DTX, or 
PB control, 2 days prior to scrapie infection via skin scarification. Draining (left) and 
non-draining (right) iLNs, pLNs, and spleens were collected from 3 mice from each 
of the groups outlined in Fig. 3.9., 3 and 5 weeks after scrapie infection. 
Immunohistochemical analysis with the anti-PrP mAb 6H4 determined that while 
disease specific PrP (PrP
d
) deposition could be detected in the draining iLNs 5 weeks 
post infection (Fig. 4.2.), no PrP
d
 was detected in the non-draining (right) iLNs, left, 




 cells prior to scrapie infection reduced the number of PrP
d
 
positive follicles in the draining iLNs 5 weeks post infection. PrP
d
 was detected in 
two or more follicles in the draining iLNs of all 3 CD11c-DTR→WT+PB control 
mice (Fig. 4.2.), as well as 2 WT→WT+DTX mice (Fig. 4.2.). In the CD11c-
DTR→WT+DTX mice, PrP
d
 was only detected in 1 follicle from 1 of 3 animals (Fig. 
4.2.). Immunohistochemical analysis of the draining iLN confirmed that the PrP
d
 
accumulated upon FDCs in the B cell follicles (Fig. 4.2.). Following PrP
d
 detection, 
adjacent draining iLNs sections were analysed via PET blots. Digestion of the blots 
with proteinase K confirmed that the PrP
d
 detected in draining iLNs was resistant to 
proteinase K digestion, and was the disease associated form of the protein, PrP
Sc
 
(Fig. 4.3.). PET blot analysis was also carried out on spleen tissues to determine 
whether early low level PrP
Sc
 deposition, undetected by immunohistochemistry, was 
present. No PrP
Sc





Figure 4.1. Experimental timeline. Mice were given a single injection of DTX, or PB, two days 
prior to inoculation via skin scarification. SK: serial kill. Tissues were collected from unscarified mice 
from each of the three groups, at day 0 (as a control), 21, and 35 days after scrapie infection. In each 






 deposition in peripheral lymphoid tissues 3 weeks post infection.  
 
WT →WT + DTX CD11c-DTR→WT+DTX CD11c-DTR→WT+PB 
 
1 2 3 1 2 3 1 2 3 
draining (left) iLN – – – – – – – – – 
right iLN – – – – – – – – – 
left pLN  – – – – – – – – – 
right pLN – – – – – – – – – 
spleen – – – – – – – – – 
The numbers 1,2,3 represent animals in each group. PrP
d
 was not detected by immunohistochemistry 






 deposition in peripheral lymphoid tissues 5 weeks post scarification. 
Five weeks post scrapie infection PrP
d
 was only detected in the draining iLN, but had not spread to the 
non-draining LNs or spleens. 
 
WT →WT + DTX CD11c-DTR→WT+DTX CD11c-DTR→WT+PB 
 
1 2 3 1 2 3 1 2 3 
draining (left) iLN – + + – + – + + + 
non-draining iLN – – – – – – – – – 
draining pLN  – – – – – – – – – 
non-draining pLN – – – – – – – – – 
spleen – – – – – – – – – 
The numbers 1,2,3 represent animals in each group. Five weeks post scrapie infection PrP
d
 was only 







Figure 4.2. Delayed PrP
d
 accumulation in draining iLN of CD11c
+
 cell-depleted mice is 
not due to lack of B cells and FDCs.  Mice were inoculated with ME7 scrapie via skin 
scarification 2 days post DTX injection, or PB control. Draining iLNs were collected 5 weeks post 
scarification for immunohistochemical analysis. A-C: deposition of PrP
d
 (detected with 6H4 mAb) in 
all three groups (magnification 40 x). D-F: PrP
d
 (magnification 200 x). Detection of FDCs (CD21/35) 
(G-I) and B lymphocytes (CD45R) (J-L) in the draining iLNs confirmed that PrP
d
 accumulated upon 
FDCs in the B cell follicles. The lymphoid tissues were not lacking any cell populations that could 
have delayed PrP
d
 uptake from the skin and deposition in the iLN. Sections were counterstained with 







 accumulation in the draining iLN is impaired in the absence of 
CD11c
+
 cells at the time of exposure. Mice were inoculated with ME7 scrapie via skin 
scarification 2 days post DTX-mediated CD11c
+
 cell depletion. Draining iLNs were collected 5 weeks 
post scarification for immunohistochemical analysis.  A,B,D Accumulation of PrPd (mAb 6H4: red) in 
all three groups. In the CD11c-DTR→WT+DTX group only one of three mice showed PrP
d
 
deposition; C is representative of the other two animals in the CD11c-DTR→WT+DTX group, where 
no PrP
d
 accumulation was observed. Sections were counterstained with haematoxylin Z. E-H: 
Adjacent PET blot sections confirmed that PrP
d
 was proteinase K resistant PrP
Sc
 (blue staining). I: 
uninfected wildtype mouse spleen, J: PrP deficient mouse spleen, K: scrapie affected brain positive 
control. Scale bar: 500 µm. 
 
 
Figure 4.4. Absence of PrP
Sc
 deposition in mouse spleen 5 weeks post scarification. 
Mice were inoculated with ME7 scrapie via skin scarification 2 days post DTX injection, or PB 
control. Spleens were collected 5 weeks post scarification for immunohistochemical analysis. PET 
blot sections were labelled to detect proteinase K resistant PrP
Sc
. A-C: immunohistochemical analysis 
with 1B3 antibody failed to show any PrP
Sc
 deposition in the PET Blot sections. D: uninfected control, 
E: PrP Null control, F: scrapie affected brain positive control. Images are representative of 




4.3.2. Effect of CD11c+ cell depletion on the early accumulation of PrPSc in the 
spinal cord 
In order to determine whether PrP
Sc
 had reached the spinal cord by at the early time 
points investigated, spinal cords collected 3 and 5 weeks post scrapie infection were 
analysed by Western blot alongside spinal cords from terminally scrapie infected 
animals. Spinal cords were analysed from WT→WT mice. As PrP
Sc
 accumulation 
was delayed following CD11c
+
 cell depletion, PrP
Sc
 would be more likely to reach 
the spinal cords earlier in WT mice, (or CD11c-DTR→WT+PB mice). Samples were 
treated in the presence or absence of proteinase K, to determine the presence of 




 was detected in the spinal 
cords of any of these mice 7 weeks post scarification. Following proteinase K 
treatment, PrP
Sc
 was detected in the spinal cords of terminally scrapie affected mice 
(Fig. 4.5.). Proteinase K resistant samples exhibit the molecular weight shift of the 
di-, mono-, and unglycosylated proteins, characteristic of PrP
Sc
, following proteinase 












Figure 4.5. Absence of PrP
Sc
 in the spinal cord of WT→WT mice at early time points. 
Mice were infected with scrapie via the skin 2 days post DTX treatment. Spinal cord was collected 
from WT→WT animals 3 and 5 weeks post scrapie infection as well as at disease endpoint, and 
analysed by Western blot. Samples were treated in the presence (+) or absence (-) of proteinase K 
(PK) prior to electrophoresis. PrP
c
 was detected in all proteinase K untreated samples, using the 1B3 
pAb, but proteinase K resistant, disease specific, PrP
Sc
 was only detected in the spinal cords terminally 
scrapie affected WT→WT animals. Proteinase K treatment cleaves the N-terminus of PrP, resulting in 


















4.3.3. Effect of CD11c+ cell depletion on scrapie incubation period following 
infection via skin scarification  
To determine the effect of DTX injection and subsequent CD11c
+
 cell depletion on 
the scrapie incubation period, 8 mice from each of the three bone marrow chimera 
groups were infected with the scrapie agent via skin scarification 2 days after 
injection with DTX, or PB control. Survival times were recorded as the incubation 
period of the disease; the time elapsed (in days) between the day of inoculation and 
the clinical endpoint of the disease. The mean incubation periods for the two control 
groups were 328 days (n=7) for WT→WT+DTX mice, and 324 days (n=7) for 
CD11c-DTR→WT+PB mice. In the CD11c-DTR→WT+DTX group, where PrP
Sc
 
deposition in the draining iLN was delayed 5 weeks post scarification, the mean 
incubation period was 347 days (n=7).    
 
Statistical analysis of the mean incubation periods determined that the residuals were 
not normally distributed. A one way analysis of variants was not possible, a non-
parametric test is therefore required. The Kruskal-Wallis test used on sample 
medians, determined there to be no significant difference in incubation period 
between the three groups (p = 0.099, adjusted for ties). Despite an early delay in 
PrP
Sc
 accumulation in the draining iLN of CD11c-DTR→WT+DTX mice, this did 









Characteristic spongiform encephalopathy, PrP
d
 accumulation, and reactive 
astrocytes and microglia were detected in the brains of all clinically scrapie affected 
animals from each group, consistent with terminal scrapie disease (Fig. 4.6.). PET 
blot analysis of adjacent sections confirmed the PrP
d
 accumulations detected were 
proteinase K resistant PrP
Sc
 (Fig. 4.6.). The targeted distribution of vacuolation in the 
brains of each clinically-scrapie affected mouse was consistent with an infection with 
the ME7 scrapie agent via the skin. No major variation was observed between the 













Table 4.3. Effect of CD11c
+
 cell depletion on scrapie incubation period  
 after infection via the skin. 
Group Incidence Median incubation period 
WT → WT + DTX 7 335 
CD11c-DTR→WT + DTX 7 329 
CD11c-DTR→WT + PB 7 350 














Figure 4.6. Histopathological analysis of brain tissues from terminally scrapie affected 
mice. Mice were inoculated with scrapie via skin scarification 2 days post DTX-mediated CD11c+ 
cell depletion and brains from clinically scrapie-affected mice collected for immunohistochemical 
analysis. (A-C) Abundant PrP
d
 accumulations were detected in the hippocampi of mice from each 
group. (D-F) PET blot analysis confirmed the presence of proteinase K resistant PrP
Sc
. Gliosis was 
confirmed through labelling with the GFAP antibody (astrocytes) (G-I), and the Iba1 antibody 
(microglia) (M-O). Sections were counterstained with haematoxylin Z. (J-L) Haematoxylin and eosin 
(H&E) staining revealed extensive vacuolation in the brains from all mice.  Clin: clinical score; Path: 
pathological score, positive (+) or negative (-); d.p.i.: days post-inoculation on which tissues were 
taken for analysis. Images are representative of observations from 7 different animals. Scale bar: top 3 






Figure 4.7. Pathological targeting of vacuolation in the brains of terminally scrapie 
affected mice. Mice were inoculated with scrapie via skin scarification 2 days post DTX-mediated 
CD11c
+
 cell depletion and brains from each clinically scrapie affected mouse analysed by 
immunohistochemistry. A: WT→WT+DTX. B: CD11c-DTR→WT+DTX. C: CD11c-
DTR→WT+PB. Vacuolation in the brain was scored on a scale of 0-5 in the following grey matter 
areas: G1, dorsal medulla; G2, cerebella cortex; G3, superior colliculus; G4, hypothalamus; G5, 
thalamus; G6, hippocampus; G7, septum; G8, retrosplenial and adjacent motor cortex; G9, cingulate 









4.3.4. Effect of CD11c+ cell depletion on PrPSc accumulation in terminally 
scrapie affected mice 
Following scrapie inoculation via the skin, PrP
Sc
 accumulation occurs first in the 
draining LNs before spreading to the non-draining LNs and the spleen. High levels 
of PrP
Sc
 are maintained in these tissues for the duration of the disease (Glaysher and 
Mabbott, 2007a; Mohan et al., 2004). Immunohistochemical analysis of the spleens 
and draining iLNs from mice from all three groups further supported this. PrP
d
 
accumulations were detected in all spleens from clinically affected mice and 
appeared comparable across the groups (Fig 4.8.). PrP
d
 deposition in the draining 
iLNs appeared to be greatly increased in the CD11c-DTR→WT+DTX animals when 
compared to the two control groups (Fig. 4.8.). PET blot analysis of adjacent sections 
confirmed this to be proteinase K resistant PrP
Sc
 (Fig. 4.8.). The iLNs were further 
analysed to determine whether this increased deposition of PrP
Sc
 was linked to 
increased activation or expansion of the FDC networks. Immunohistochemical 
analysis suggested no significant difference in CD21/35 immunolabelling in these 
tissues from each group (Fig. 4.8.). 
 
Spinal cords were also collected from terminally scrapie-affected mice and PrP
Sc
 
levels determined by Western blot analysis. Samples were treated in the presence or 
absence of proteinase K, to determine the presence of disease specific PrP
Sc
. Spinal 
cords were found to contain large amounts of PrP
Sc
 in each of the three groups (Fig. 









Figure 4.8. Histopathological analysis of peripheral lymphoid tissues from terminally 
scrapie affected mice. Mice were infected with scrapie via skin scarification 2 days post DTX 
injection, or PB control. Spleen and iLN were collected from clinically scrapie-affected animals and 
PrP
d
 and CD21/35 expression determined by immunohistochemistry. PrP
d
 expression was detected in 
the spleen of animals in all three groups (A-C). PrP
d
 expression was greatly increased in the draining 
iLN at the endpoint of disease in mice depleted of CD11c
+
 cells (D-F). PET blots analysis of adjacent 
sections confirmed the presence of proteinase K resistant PrP
Sc
, which was increased in mice depleted 
of CD11c
+
 cells at the time of infection (G-H). The expression of CD21/35 appeared to be unaffected 
(J-L). Sections were counterstained with haematoxylin Z. Images are representative of observations in 









 accumulation in the spinal cord of terminally scrapie affected mice. 
Mice were inoculated with ME7 scrapie via skin scarification 2 days post DTX injection, or PB 
control. Spinal cord was collected from animals at the endpoint of disease and samples analysed via 
Western blot. Samples were treated in the presence (+) or absence (-) of proteinase K (PK) prior to 
electrophoresis. Proteinase K resistant, disease specific PrP
Sc
 was detected, using the 1B3 pAb, in the 
spinal cords of endpoint animals in all three groups. Clin: clinical score, positive (+) or negative (-); 
Path: pathological score, positive (+) or negative (-); d.p.i.: days post-inoculation on which tissues 


















In this chapter, C57BL/6 wildtype mice were lethally γ-irradiated before 
reconstitution with either wildtype or CD11c-DTR bone marrow. These mice were 
subsequently injected with DTX, or PB control, to deplete their CD11c
+
 cells (with 
the exception of LCs) 2 days prior to scrapie infection, via skin scarification of the 
inner thigh. Based on the timeline of depletion and repopulation of CD11c
+
 cells 
established in Chapter 3, this protocol suggests a 4 day time-window, after infection, 
before the majority of cells have started to repopulate the tissues. Experiments 
demonstrated that the accumulation of PrP
Sc
 was delayed in the draining iLN of mice 
in which the CD11c
+
 cells were depleted, when compared to controls. These results 
are consistent with previous work, where depletion of CD11c
+
 cells prior to oral 
inoculation with the ME7 scrapie agent blocked the early accumulation of PrP
d
 in the 
PPs of the gut (Raymond et al., 2007). Although DTX treatment of the mice used in 
this chapter did not completely deplete their CD11c
+
 cells (Chapter 3, Fig. 3.5. and 
Fig. 3.12.), CD11c
+
 cell numbers were diminished at the time of scarification with 
the ME7 scrapie agent. Despite, the difference in early stage PrP
Sc
 accumulation in 
the draining iLN, the incubation periods of the three groups all fit within the range of 
times established in previous models of scrapie infection via skin scarification 
(Glaysher and Mabbott, 2007a; Mohan et al., 2004; Mohan et al., 2005a; Mohan et 
al., 2005b; Taylor et al., 1996). The effects of treatment on scrapie pathogenesis 
were most likely related to effects on CD11c
+
 cells, as DTX treatment of control 
mice did not significantly influence disease pathogenesis. The mean incubation 




injected mice reconstituted with CD11c-DTR bone marrow were 328 days and 324 
days respectively.  
 
Following peripheral scrapie exposure in mice, PrP
Sc
 accumulates in the draining 
lymphoid tissues (spleen, LN, PP) before accumulation in the brain. Five weeks post 
scarification, PrP
d
 was not detected in any tissues other than the draining iLN either 
by immunohistochemistry or PET blot analysis regardless of whether CD11c
+
 cells 
were depleted or not. This time point was too early for PrP
d
 detection in non-draining 
lymphoid tissues. However, large amounts of PrP
Sc
 were detected in the spinal cords 
and the brains of all terminally scrapie affected mice.  
 
While accumulation of disease associated PrP in the spleens of terminally scrapie 
affected mice is found at similar levels throughout the three groups, PrP
Sc
 
accumulation in the draining iLN was much greater in those mice where CD11c
+
 
cells were depleted prior to scrapie infection. As PrP
Sc
 accumulation was delayed in 
the draining iLNs of these mice at the early time points after exposure, it is possible 
that the return of the CD11c
+
 cells (in the skin and lymphoid tissues) after DTX 
treatment triggered a ‘second wave’ of scrapie agent transport, or accelerated the 
accumulation process within the lymphoid tissues, for example, the sudden influx of 
CD11c
+
 cells into an area abundant with PrP
Sc
 might cause the transport of the 
protein to the draining iLN. PrP
d
 accumulation (McGovern et al., 2009) and disease 
infectivity (Kimberlin and Walker, 1979) reach a plateau between 7 and 10 weeks 




FDC networks and PrP
c
 expression was unchanged in the CD11c-DTR→WT+DTX 
animals at the time of scrapie agent exposure (Fig. 3.13. and 3.14.) or in those 
showing clinical signs of scrapie. These observations suggest it is unlikely that the 
effects observed on scrapie pathogenesis were due to a delayed immune reaction to 
the CD11c
+
 cell repopulation increasing immune activity on the FDCs, and 
triggering greater PrP accumulation on their surfaces. 
 
Despite a delay in early stage PrP
Sc
 accumulation in the draining iLN following 
CD11c
+
 cell depletion, no significant differences were observed between the 
incubation periods of each group. All the mice succumbed to disease. No major 
differences were observed between the lesion profiles of each group, and exhibit 
similar trends to those observed in other cases of scrapie infection via skin 
scarification (unpublished). Based on previous evidence that CD11c
+
 cell depletion 
reduced disease susceptibility (Raymond et al., 2007), and the delayed early stage 
PrP
Sc
 accumulation observed in this chapter it is possible that if the number of mice 
in each group had been higher, then a significant difference might have been 
observed. However, power tests were conducted on using the data obtained from the 
animals that were used. These indicated that based on the trends observed, 29 mice 
would have been required for significant differences. Given the nature and duration 
of the experiment (> 380 days) this would not have been feasible. 
 
The delay in PrP
Sc
 accumulation following CD11c
+
 cell depletion points towards a 
possible role of the CD11c
+
 cells in the skin (with the exception of LCs) in the 




in the skin are perhaps not as abundant as they are in other tissues, but as they have 
been linked to the transport of other disease associated antigens from the skin (de 
Jong and Geijtenbeek, 2010; Palucka, 2000; Wu et al., 2000), it is entirely possible 
that they also transport PrP
Sc
. There is evidence that langerin
+
 dDCs are able to 
cross-present antigens which they have picked up from keratinocytes, irrespective of 
the presence of LCs (Henri et al., 2010). It was previously thought that LCs passed 
on antigen to dDCs, although this appears not to be the case (Henri et al., 2010). This 
data supports earlier findings that dDCs rather than LCs play a role in antigen 
presentation (Henri et al., 2007). The absence of dDCs in the skin at the time of 
scrapie infection via the skin could therefore be a possible cause for the delay in 
PrP
Sc
 accumulation. However, it is also possible that the scrapie agent is transported 
from the skin to the draining iLN via a cell-free mechanism, and that it is the absence 
of one of the CD11c
+
 cell subsets in the LN that delays the accumulation of PrP
Sc
.   
 
As was demonstrated in Chapter 3, several CD11c
+


















 macrophages, also termed SCS 
macrophages, in the LNs play a role in the presentation of immune complexes to 
non-cognate B cells which in turn present these complexes to FDCs. As PrP
Sc
 
accumulation in lymphoid tissues occurs on FDCs (Brown et al., 1999), there is a 
possibility that these macrophages play a role in the transport of PrP
Sc
 from the skin 
to the FDCs within LNs. By creating the CD11c-DTR/C57BL/6 bone marrow 
chimeric mice, LCs were not affected by DTX treatment. However, in these bone 
marrow chimeras several different CD11c
+




of scarification, two days post DTX treatment. The observed delays in PrP
Sc
 
accumulation in the draining iLN, while it is as a result of CD11c
+
 cell depletion, 









 cells (Probst et al., 2005) and 
Chapter 3. In order to address the issue of different depleted cellular subsets, the 
different rates at which the cell types repopulate the tissues after depletion have been 
used to set up another study, where scarification occurs 6 days after DTX treatment, 
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Transgenic mouse models where target cells express the DTR on their surface, 
allows for the temporary depletion of these cell types in order to further determine 
the role and function of the target cells in specific tissues or disease models. The 
CD11c-DTR transgenic mouse model allows for the temporary conditional depletion 
of CD11c
+
 cells. CD11c was previously thought to be marker specific for DCs. It has 
been determined that CD11c is expressed on a number of different macrophage 
subsets, which are also depleted by DTX treatment in the CD11c-DTR mice. The 
different CD11c
+
 cellular subsets exhibit independent repopulation dynamics, and 
several macrophage subsets repopulate tissues much later than DC subsets. By 
waiting 6 days after DTX-mediated depletion, it was possible to analyse the effect of 
macrophage depletion in various tissues after DCs had repopulated the tissues. By 
excluding DCs from the analysis, it is possible to gain further insight into the role 
and function of CD11c
+




















Data in this thesis (Chapter 3, section 3.3.4.) and elsewhere (Probst et al., 2005) 
show that in addition to the depletion of CD11c
+





 cells, are also depleted in CD11c-DTR after 
DTX treatment. CD169, or siaoladhesin, is a transmembrane receptor (Oetke et al., 
2006) and a prototypic member of the Siglec family of sialic acid binding 
immunoglobulin-like lectins (Crocker et al., 1994). CD169 is expressed by marginal 
zone metallophillic macrophages in the spleen and the SCS macrophages in LNs 





 cells in CD11c-DTR mice, along with the metallophillic 
macrophages, through the SIGNR1 receptor. Data in Chapter 3 (Chapter 3, section 
3.3.10.) showed that following DTX-treatment of CD11c-DTR→WT mice, a partial 
depletion of CD169
+
 cells was observed when compared to the CD11c-DTR mice. In 




 macrophages remained completely 









 cells in tissues from CD11c-




 cells remained depleted for a 
longer period. 
 
FDCs trap and retain antigen on their surfaces in the form of immune complexes 
(Kosco-Vilbois, 2003). These immune complexes are bound to FDCs via 
complement receptors and via antibody Fc receptors (van den Berg et al., 1995). 
These complement receptors are considered to play an important role in TSE agent 




Bruce, 2001; Zabel et al., 2007). SCS macrophages are situated in a key location for 
B cell encounter with immune complexes (Phan et al., 2007), and as these cells were 
depleted at the time of scrapie scarification, it is not possible to rule out their 
potential role in the uptake and transport of the scrapie agent from the skin. It was 




 cells at 
the time of scrapie infection influenced the delay in scrapie agent accumulation to the 
draining lymphoid tissues in Chapter 4 (section 4.3.1.).  
 
This chapter therefore determined whether the differences observed in scrapie 






























C57BL/6 wildtype mice were lethally γ-irradiated before reconstitution with CD11c-
DTR bone marrow, as outlined in Chapter 3 (section 3.3.6.) (Fig. 5.1.).  
 
5.3.2. DTX-mediated depletion of CD11c+CD169+ cells in CD11c-DTR→WT mice  




 cells from 2 days 
post DTX treatment. Cell numbers did not start to increase until after day 6 post 




 cell numbers had started to increase 










 cells. DTX-mediated depletion of CD11c
+
 cell types in CD11c-
DTR→WT mice is outlined in Table 5.1. 
 
Groups of 3 CD11c-DTR→WT mice received a single i.p. injection of DTX or PB 





 cells are located within the sinusoids and medullary cords of 
LNs or at the marginal sinus of the spleen, forming a ring around the periarteriolar 
lymphoid sheath and follicular areas at the inner side of the marginal zones. A partial 




 was confirmed. CD169
+
 staining is 
disrupted within the SCS of the iLN (Fig. 5.2.). The distinctive ‘rings’ of staining 
around the marginal zones, characteristic of CD169 labelling, was very fragmented 
and much fewer CD169
+
 cells were present in these areas (Fig.5.3.). No observable 










Figure 5.1. Model of irradiation and bone marrow reconstitution. C57BL/6 wildtype mice 
were lethally γ-irradiated 24 hr prior to receiving a bone marrow graft (grey) from CD11c-DTR mice. 





Table 5.1. Depletion status of a range of CD11c
+
 cell populations in the skin and 
lymphoid tissues of CD11c-DTR mice, six days post DTX injection. 























WT CD11c-DTR yes yes cell numbers 
increase 
yes no 










 cell depletion in CD11c-DTR→WT six days after DTX 
treatment. Mice were given a single i.p. injection of DTX and iLNs collected six days later were 
immunolabelled with the anti-CD11c (HL3) specific (green) and the anti- CD169 (MOMA-1) specific 









 cells showed no depletion compared to the controls. CD11c-DTR→WT+PB 








 cells. Images are 









 cell depletion in CD11c-DTR→WT six days after DTX 
treatment. Mice were given a single i.p. injection of DTX and spleens collected six days later were 
immunolabelled with the anti-CD11c (HL3) specific (green) and the anti- CD169 (MOMA-1) specific 













 cells were 




 cells showed no depletion compared to the controls. 







5.3.3. Effect of DTX on langerin+ cells 
Section 3.3.8. confirmed that, as demonstrated in the literature, LCs present in the 
epidermis were unaffected by lethal irradiation and bone marrow reconstitution. As 
LCs are radioresistant, they were unaffected by DTX through their lack of transgene 
expression. To determine whether the LCs in the CD11c-DTR→WT+DTX mice 
were equally unaffected 6 days post DTX injection, immunohistochemical analysis 
was carried out on epidermal and dermal sheets from 3 CD11c-DTR→WT mice 
from each group. As anticipated, LCs in the epidermis were not depleted by DTX, 
since they derive from local wildtype precursors. Langerin
+
 dermal DCs were 
partially depleted, as these were derived from the donor CD11c-DTR bone marrow. 
Immunohistochemical analysis of the draining iLN also confirmed a partial depletion 
of langerin
+
 cells. These cells were likely to be LN-resident langerin
+
 cells. The 
majority of the remaining langerin
+
 cells in the iLN (Fig. 5.4.)  would have migrated 
from the epidermis, and express lower levels of CD11c than tissue resident langerin
+
 
DCs (Kissenpfennig et al., 2005b).  
 
5.3.4. DTX treatment of CD11c-DTR→WT mice bone marrow does not affect 
FDC status 
Immunofluorescence analysis was carried out to determine whether DTX-mediated 
CD11c
+
 cell depletion in CD11c-DTR→WT had any effect on FDC status, or their 
expression of PrP
c
. Analysis was carried out on spleen and iLN from 3 CD11c-
DTR→WT+DTX or 3 CD11c-DTR→WT+PB mice six days post injection. The 
experiment confirmed DTX treatment of CD11c-DTR→WT mice had no observable 







Figure 5.4. DTX-mediated langerin
+
 cell depletion in the skin and LNs of CD11c-
DTR→WT mice. CD11c-DTR→WT mice were given a single i.p. injection of DTX, or PB control, 
and tissues collected were immunolabelled with the anti-langerin antibody. (A,B) Normal distribution 
of langerin
+
 LCs in the epidermis 6 days after injection with DTX or PB. C: Partial depletion of 
langerin
+
 dermal DCs in CD11c-DTR→WT+DTX mice; D: normal distribution of langerin
+
 dermal 
DCs in the dermis. E: Partial depletion of langerin
+
 cells in the iLN following DTX injection. F: 
Normal distribution of langerin
+
 cells in the iLN. Images as representative of observations in 3 







Fig. 5.5. DTX treatment had no effect on FDC and B cell status in the spleen. Mice were 
given a single i.p. injection of DTX and tissues collected six days later were immunolabelled with the 
anti-CD45R (green, A,E), anti-PrP (1B3) (blue, B,F), and anti-CD35 (red, C,G) antibodies. FDC and 
B cell status were unaffected in both animal groups; PrP
c
 expression was, equally, unaffected on the 
FDCs following DTX treatment. D, H merged images of all three antibodies. Images are 





































In Chapter 3, characterisation studies were carried out on the CD11c-DTR transgenic 
mouse line to determine a timeline for depletion and repopulation of CD11c
+
 cells 










 cells in CD11c-DTR→WT mice was also studied. 
 




 cells were 





had returned to similar numbers compared to those observed in control mice. These 
data confirm those observed in DTX-treated CD11c-DTR mice in Chapter 3 and 
Probst et al (Probst et al., 2005). The delayed accumulation of the scrapie agent in 
the draining iLN following exposure via the skin, at the early time point observed in 
Chapter 4 could not be attributed to a single cell type, as both the classical CD11c
+
 




 SCS macrophages in the LNs (and marginal zone of the 
spleen) were depleted following DTX injection. In this chapter, data show that in the 




 cells are partially depleted for a longer 
period than the classical DCs. This suggests it is possible to study the effects of a 









 classical DCs. To do so, CD11c-DTR→WT mice could be exposed 









 cells remained partially depleted). This model could be 









cells influence the accumulation of PrP
Sc




determine whether the absence of either of these cells types, on their own, might be 
responsible for the delayed accumulation of PrP
Sc
 at the early time points. 
 
As was previously confirmed in the epidermis of CD11c-DTR→WT mice were 
unaffected by DTX injection since they lacked expression of DTR, as the cells 
remained of host origin following lethal γ-irradiation (Merad et al., 2002). In 
contrast, langerin
+
 dDCs in the dermis, as well as langerin
+
 cells in the LNs were 
partially depleted following DTX injection, as these cells are derived from the donor 







) DCs, and were still absent 6 days post DTX. These cells 
also need to be taken into consideration when assessing the effects of DTX treatment 
on the potential cell roles delaying the uptake and transport of the scrapie agent to the 
draining iLN. The potential role of these langerin
+
 cells in scrapie pathogenesis will 
be examined further in Chapters 7 and 8.  
 
Irradiation and reconstitution of wildtype mice with wildtype or CD11c-DTR 
transgenic bone marrow did not affect other cells such as the FDCs or B lymphocytes 
located in the lymphoid follicles of the iLN or spleen. The animals were lethally γ-
irradiated (1000 rad) and reconstituted with age and sex-matched bone marrow 24 hr 
later. Animals were maintained for 8 weeks post bone marrow transfer before DTX 
injection and tissues were collected for analysis. After 8 weeks the reconstitution and 
establishment of the CD11c-DTR transgenic cell population would be complete, with 
the exception of the LCs (Merad et al., 2002). Following injection of DTX or PBS 




the FDCs, or the structure of the FDC networks or the B-cell follicles. These results 
thereby indicate that injection of DTX into CD11c-DTR→WT mice, did not have 
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Temporary DTX-mediated depletion of CD11c
+
 cells prior to oral scrapie infection 
blocked early TSE agent accumulation in the gut-associated lymphoid tissues, and 
reduced susceptibility to disease. Similarly, DTX-mediated CD11c
+
 cell depletion 
prior to scrapie infection via skin scarification delayed PrP
Sc
 accumulation in the 
draining iLN. Contrary to earlier belief, CD11c is not exclusively expressed on DCs, 
and various macrophage populations are also depleted following DTX treatment. The 
delays in PrP
Sc
 accumulation observed as a result of the absence of CD11c
+
 cells at 
the time of infection can therefore not be specifically attributed to DCs. Different cell 





 cells (classical DCs) to repopulate tissues, it was possible 





still absent. The absence of these cells at the time of scarification did not affect early 
scrapie agent accumulation in the draining iLN. It was not possible to detect a 
difference in disease susceptibility, due to small sample size, but it is unlikely to 
have been the case. Therefore delays observed in early PrP
Sc
 accumulation in the 
















In Chapter 3 CD11c-DTR mice and CD11c-DTR chimeric mice were analysed to 
determine the effects of DTX injection on CD11c
+
 cells in the lymphoid tissues and 
the skin. Chapter 4 looked to determine whether the depletion of CD11c
+
 cells prior 
to scrapie infection via the skin had an effect on early scrapie agent accumulation in 
lymphoid tissues and the spread of disease to the brain. CD11c was previously 
thought to be a marker exclusive to DCs (Hume, 2008), and a great tool for 
identifying and isolating these cells. More recent evidence has shown that CD11c is 
not exclusive to DCs (Mabbott et al., 2010), and that a number of other cell types are 
also depleted following DTX injection in the CD11c-DTR mice (Bradford et al., 
2011; Probst et al., 2005). As such, the results obtained in Chapter 4 cannot be solely 
attributed to DCs. As other cell types remain depleted for longer than DCs, it is 
entirely possible that the results observed in Chapter 4 are due to the absence of other 
CD11c
+
 cell types.  
 




 SCS macrophages were also 
partially depleted following injection of DTX in CD11c-DTR mice and remained 




 cells (Fig. 3.7.). The lymphoid tissues of 
CD11c-DTR chimeric mice were analysed in Chapter 5 to determine the effect of 









 cells had repopulated the tissues by this time 
point. LCs in the epidermis were not affected by DTX, as they were radioresistant 
and did not express the DTR (Fig. 5.3.). Langerin
+




partially depleted (Fig. 5.3.). FDC status was also analysed and confirmed to be 
unaffected by DTX injection in the CD11c-DTR chimeric mice (Fig. 5.4.). 
 
FDCs trap and retain antigen, in the form of immune complexes, which are stored on 
their surfaces for long periods (Kosco-Vilbois, 2003). These immune complexes are 
bound to FDCs via complement receptors in naïve mice, whereas in immunised mice 
they are also bound via antibody Fc receptors (van den Berg et al., 1995). These 
complement receptors, as well as complement components C1q and C3 are 
considered to play an important role in TSE agent localisation to FDCs (Flores-





 cells are located within the marginal zones of the spleen, and 




 SCS macrophages capture 
antigen-containing immune complexes arriving in the LN via their cell processes that 
they extend into the lumen of the SCS (Carrasco and Batista, 2007; Junt et al., 2007; 
Phan et al., 2009; Phan et al., 2007; Roozendaal et al., 2009). In contrast to other 
macrophage subsets, SCS macrophages retain immune complexes on their surfaces 
for rapid translocation through the floor of the SCS to underlying, non-cognate (non-
specific) follicular B cells (Phan et al., 2009). These B cells acquire the immune 
complexes via their complement receptors and deliver them to FDCs.  The higher 
immune complex-binding affinities of FDCs most likely relieve the B cells of their 
cargo.  Thus, the SCS macrophage-B cell immune complex relay represents an 
efficient route through which antigens are delivered to FDCs (Carrasco and Batista, 
2007; Junt et al., 2007; Phan et al., 2009; Phan et al., 2007; Roozendaal et al., 2009). 






expression in aged mice, reduced the ability of aged FDCs to acquire and replicate 
TSE agents (Brown et al., 2009). PrP
d
 has also been linked to FDC morphological 
changes during scrapie infection (McGovern et al., 2009), where abnormal immune 
complexes colocalised with PrP
d
 accumulations. These data further support the idea 
that PrP
d
 reaches FDCs via immune complexes. These SCS macrophages could 
therefore play a potential role in the transport of the scrapie agent from the skin to 
the FDCs within the lymphoid follicles of the LRS. 
 
By infecting CD11c-DTR chimeric mice with scrapie via skin scarification, 6 days 
after DTX injection (Fig. 6.1.), it is possible to determine whether the results 




 cells (typical of DCs), or 




 cells at the time of 

















6.3.1. Effect of CD11c+CD169+ cell depletion on early PrPSc accumulation   









 cells) on the early accumulation of the scrapie agent in the lymphoid 
tissues, draining (left) and non-draining (right) iLNs, left and right pLNs, and spleen 
were collected from 3 mice from each group as outlined in Chapter 5 (Fig. 5.1.), 5 
and 7 weeks post scrapie infection (Fig. 6.1.). Immunohistochemical analysis with 
the anti-PrP mAb 6H4 determined that accumulations of PrP
d
 could be detected in all 
the draining iLNs from CD11c-DTR→WT+DTX and from 2 of the 3 CD11c-
DTR→WT+PB animals 5 weeks post scarification (Fig. 6.2.). The intensity of the 
immune-labelling appeared to be stronger in the CD11c-DTR→WT+DTX mice 
when compared to the controls. No PrP
d
 accumulations were detected in the non-
draining iLN, left, or right pLN or spleen (Table 6.1.). Analysis of the 7 week time 
point tissues showed similar patterns of PrP
d
 deposition as in the 5 week time point 
draining iLNs (Fig. 6.2.). In addition, PrP
d
 was detected in the spleen and left pLN of 
one mouse CD11c-DTR→WT+DTX mouse and the non-draining (right) iLN of one 










Figure 6.1. Experimental timeline following for scarification following DTX injection.  
CD11c-DTR→WT mice were given a single injection of DTX, or PB, six days prior to scrapie 




 cells (typical of DCs) were no longer 




 cells remained depleted. Tissues were collected from 3 animals from 
each group at day 0 (with respect to TSE infection), 35, and 49 days after scrapie infection. In each 





 accumulation in peripheral lymphoid tissues 5 weeks  
post scrapie infection.  
 
CD11c-DTR→WT + DTX CD11c-DTR→WT + PB 
 
1 2 3 1 2 3 
draining (left) iLN + + + – + + 
right iLN – – – – – – 
left pLN  – – – – – – 
right pLN – – – – – – 
spleen – – – – – – 
The numbers 1,2,3 represent individual animals in each group. PrP
d
 was detected by 
immunohistochemistry, only in the draining iLNs 5 weeks post infection. PrP
d
  









 accumulation in peripheral lymphoid tissues 7 weeks  
post scrapie infection.  
 
CD11c-DTR→WT + DTX CD11c-DTR→WT + PB 
 
1 2 3 1 2 3 
draining (left) iLN + + + + –  + 
right iLN – – – – –  + 
left pLN  – – + – – – 
right pLN – – – – – – 
spleen – – + – – – 
The numbers 1,2,3 represent individual animals in each group. PrP
d
 was detected  
by immunohistochemistry, in the draining iLNs of animals in both groups, and  
also detected in the spleen and left pLN of one  CD11c-DTR→WT+DTX mouse  









 cells prior to scrapie infection did not affect the 
number of PrP
d
 positive follicles in the draining iLN. PrP
d
 was detected in two or 
more follicles in the draining iLN of all three CD11c-DTR→WT+DTX mice, as well 
as two of the three CD11c-DTR→WT+PB mice (Fig. 6.2.).  
 
Immunohistochemical analysis of the draining iLN confirmed that PrP
d
 accumulated 
upon FDCs in the B cell follicles (Fig. 6.2.). Observation of the labelling of PrP
d
 at a 
higher magnification (200 x, compared to 40 x), showed a ‘punctate’ pattern of 
labelling. PrP
d
 appeared to be associated with tingible body macrophages (*) as well 
as FDC networks (+). These results were comparable between the two groups, at 




 accumulations observed in the draining iLNs were analysed by adjacent 
PET Blot sections of the same tissues. Digestion of the PET blots with proteinase K 
was used to confirm that the PrP
d
 detected in the draining iLNs was resistant to 
proteinase K digestion and was therefore the disease associated form of the protein, 
PrP
Sc
 (Fig. 6.3.). PET blot analysis was also carried out on spleen tissues to 
determine whether early low level PrP
Sc
 deposition, undetected by 
immunohistochemistry, was present. No PrP was detected in the spleen by PET blot 















depletion. Mice were infected with scrapie via skin scarification 6 days post DTX injection, or PB 
control. Draining iLNs were collected 5 and 7 weeks post scarification for immunohistochemical 
analysis.  A-D: deposition of PrPd (detected with 6H4 mAb) in both groups at both time points 
(magnification: 40 x). E-H: PrP
d
 accumulations (magnification: 200 x). Detection of FDCs (CD21/35) 
(I-L) and B lymphocytes (CD45R) (M-P) in the draining iLNs confirmed that PrP
d
 accumulated upon 
FDCs in the B cell follicles. PrP
d
 was detected both on FDC networks (+) and within tingible body 
macrophages (*). Sections were counterstained with haematoxylin Z (blue). Images are representative 









Figure 6.3. Confirmation of PrP
Sc 
accumulation in the draining iLN following scrapie 
infection via the skin. Mice were infected with scrapie via skin scarification 6 days post DTX 
injection, or PB control. Draining iLNs were collected 5 and 7 weeks post scarification for 
immunohistochemical analysis.  A-D: deposition of PrPd (detected with 6H4 mAb) in both groups at 
both time points. E-H: Adjacent PET blot sections confirmed that PrP detected by 6H4 was proteinase 
K resistant, disease-specific, PrP
Sc
. Sections were counterstained with haematoxylin Z (blue). Images 




Figure 6.4. Absence of PrP
Sc
 deposition in spleen 5 and 7 weeks post scarification. 
Mice were infected with scrapie via skin scarification 6 days post DTX injection, or PB control. 
Spleens were collected 5 and 7 weeks post scarification for immunohistochemical analysis. PET blot 
sections were labelled to detect proteinase K resistant PrP
Sc
. A-D: immunohistochemical analysis with 
1B3 antibody failed to show any PrP
Sc
 deposition in the PET Blot sections. Images are representative  










6.3.2. Effect of CD11c+CD169+ cell depletion on scrapie incubation period 
following inoculation via skin scarification 
To determine the effect of DTX-mediated CD11c
+
 cell depletion on scrapie 
incubation period following transmission through skin scarification, 8 mice from 
each bone marrow chimeric group were infected with the scrapie agent via skin 
scarification 6 days after injection with DTX, or PB control. Incubation period was 
determined on mice that were found to be both clinically and pathologically positive. 
In both groups a number of animals died or were culled before they reached disease 
endpoint. Several animals that were culled following two positive clinical scores 
were subsequently found to be pathologically negative for scrapie (via vacuolation). 
Mean group incubation periods could not be determined in this experiment, as only 1 
and 3 clinically positive, pathologically positive animals were identified in the 
CD11c-DTR→WT+DTX and the CD11c-DTR→WT+PB groups, respectively. The 
incubation periods for the individual mice were 328 (CD11c-DTR→WT+DTX); 
320, 335, and 335 days (CD11c-DTR→WT+PB). 
 
Immunohistochemical analysis of the brain revealed characteristic spongiform 
encephalopathy and PrP
d
 accumulation in the hippocampi of mice which developed 
clinical signs of scrapie. Reactive astrocytes and microglia were detected in 
terminally scrapie affected mice, consistent with terminal scrapie disease (Fig. 6.5.). 
Reactive astrocytes and microglia were also detected to varying degrees in mice 
showing negative pathology for scrapie (Fig. 6.5.). PET blot analysis of adjacent 
sections confirmed PrP
d
 accumulation, to be proteinase K resistant PrP
Sc
 (Fig. 6.5.). 
The targeted distribution of vacuolation in the brains was consistent with ME7 




Immunohistochemical analysis of the non-terminally scrapie affected animals 




 on brain sections from clinically negative, 
pathological negative animals as well as in the clinically positive, pathological 
negative animals (Fig. 6.5.). Analysis also confirmed varying degrees of reactive 
astrocytes and microglia in these animals (Fig. 6.5.). 
 
Following scrapie inoculation via the skin, PrP
Sc
 accumulation occurs first in the 
draining LNs before spreading to the non-draining LNs and the spleen; high levels of 
PrP
Sc
 can still be detected in these tissues from mice terminally affected by scrapie 
(Glaysher and Mabbott, 2007a; Mohan et al., 2004). Immunohistochemical analysis 
of the spleen and draining iLN of mice in both groups further supported this. Levels 
of PrP
d
 deposition in the spleen were comparable in both groups, regardless of 
whether animals had shown clinical or pathological signs of disease or not (Table 
6.3.). PET blot analysis of adjacent sections confirmed this to be proteinase K 
resistant PrP
Sc
 (Table 6.3.). The iLNs were further analysed and no difference was 















Figure 6.5. Histopathological analysis of brain tissues from terminally scrapie affected 





 cell depletion and brains from each clinically scrapie affected mouse analysed by 
immunohistochemistry. Abundant PrP
d
 accumulations were detected in the hippocampi of clinically 
and pathologically positive mice from each group (A,D) and to a lesser extent in the clinically 
positive, pathologically negative mice (B,E). No PrP
d
 was detected in the clinically negative mice 
(C,F). (G-L) PET blot analysis confirmed the presence of proteinase K resistant PrP
Sc
 in tissues where 
PrP
d
 was detected. Varying degrees of gliosis were confirmed, consistent with PrP
Sc
 accumulation and 
clinical scores, through labelling with the GFAP antibody (astrocytes) (M-R), and the Iba1 antibody 
(microglia) (Y-DD). Sections were counterstained with haematoxylin Z. (S-X) Haematoxylin and 
eosin (H&E) staining revealed extensive vacuolation in the brains from clinically and pathologically 
positive mice.  Clin: clinical score; path: pathological score, positive (+) or negative (-); d.p.i.: days 
post-inoculation on which tissues were taken for analysis. Images are representative of observations 













Group Incubation period 

















CD11c-DTR→WT+DTX 328 yes yes yes yes 
CD11c-DTR→WT+DTX 308 yes no yes yes 
CD11c-DTR→WT+DTX n/a no no no yes 
CD11c-DTR→WT+PB 335 yes yes yes yes 
CD11c-DTR→WT+PB 301 yes no yes yes 














6.3.3. Effect of CD11c+CD169+ cell depletion on PrPSc accumulation in the 
spinal cord 
Several animals were unfortunately culled before manifestation of clinical signs or 
before reaching disease endpoint. Immunohistochemical analysis confirmed PrP
Sc
 
deposition in the brains of some of these animals. Spinal cords collected from these 
animals were therefore analysed for the presence of PrP
Sc
 through Western blot 
analysis. Samples were treated in the presence or absence of proteinase K, to 
determine the presence of disease specific PrP
Sc
. Spinal cords were found to contain 
varying amounts of PrP
Sc
 in both groups, dependant on their clinical and pathological 
score and the d.p.i. when the tissues were collected (Fig. 6.6.). The longer the mice 
survived after scrapie infection, the larger the quantities of PrP
Sc
 appeared to be 
present in their spinal cords. These results confirmed the presence of disease specific 
PrP
Sc
 in the CNS before a positive clinical score was determined. Disease specific 
PrP
Sc
 was also detected in the spinal cords of clinically positive mice that were found 
to be negative for scrapie pathology through vacuolation (Fig. 6.6). The three bands 
found between approx. 50-60 kDa are most likely dimers of PrP. 
 
Spinal cords were collected from terminally scrapie affected mice and analysed by 
Western blot. Samples were treated in the presence or absence of proteinase K, to 
determine the presence of disease specific PrP
Sc
. Spinal cords were found to contain 
large amounts of PrP
Sc









 accumulation in the spinal cord of mice suffering intercurrent deaths. 





depletion. Spinal cord was collected from animals that died before reaching disease endpoint, and 
samples analysed via Western blot. Samples were treated in the presence (+) or absence (-) of PK 
prior to electrophoresis. Proteinase K resistant, scrapie specific, PrPSc was detected, with pAb 1B3, in 
varying levels in the spinal cords of animals in both groups. Clin, clinical score; path, pathological 





Figure 6.7. PrPSc accumulation in the spinal cord of terminally scrapie affected mice. 





 cell depletion. Spinal cords were collected from terminally scrapie affected animals 
and analysed via Western blot. Samples were treated in the presence (+) or absence (-) of PK prior to 
electrophoresis. Proteinase K resistant, disease specific, PrPSc was detected, with pAb 1B3, in the 
spinal cords of endpoint animals in both groups. Clin: clinical score; path: pathological score, positive 





In this chapter C57BL/6 wildtype mice were lethally γ-irradiated before 
reconstitution with CD11c-DTR bone marrow. The mice were subsequently injected 
with DTX, or PB control, to deplete CD11c
+
 cells 6 days prior to scrapie exposure 





 cells (classical DCs) had repopulated the tissues. For other 




 cells, this had not occurred by 6 days post 
depletion, and these cells remained depleted at the time of scrapie infection. 
 
Unlike the results observed in Chapter 4, this experiment indicated no difference in 
levels of PrP
Sc
 accumulation in the draining iLNs 5 and 7 weeks after scrapie 
exposure via the skin. Examination of tissues at higher magnification indicated the 
accumulation of PrP
Sc
 within tingible body macrophages, as well as on the FDC 
networks. These results were observed at both the early time points, and in both the 






The number of clinically and pathologically scrapie positive mice was too low, in 
each group, to determine mean incubation times for the groups. However, 
immunohistochemical and Western blot analysis of lymphoid tissues and CNS 
confirmed the presence of PrP
Sc
 accumulation in these animals consistent with 
development of scrapie in these mice. It is probable that these mice would have 
succumbed to the disease if they had lived for longer. The absence of a difference in 
PrP
Sc




would have been observed between the mean incubation times of the two groups, if 
sufficient numbers of mice had succumbed to clinical disease.  
 
In Chapter 4, the absence of CD11c
+
 cells at the time of scrapie exposure via the 
skin, delayed PrP
Sc
 accumulation in the draining iLN, 5 weeks post infection. No 
significant differences were observed in the incubation times between the groups, but 
larger group numbers may have confirmed a lengthening of the incubation time. 
These results could not be attributed solely to the absence of cells classically termed 
DCs, because other cell types were also depleted by injection of DTX (Bradford et 
al., 2011; Probst et al., 2005). The absence of any change in PrP
Sc
 accumulation at 
the early time points following scrapie infection 6 days post DTX injection indicates 





 cells.  
 
Complement receptors, as well as complement components C1q and C3 are 
considered to play an important role in TSE agent localisation to FDCs (Klein et al., 
2001; Mabbott et al., 2001; Zabel et al., 2007). Complement receptors on FDCs play 
a role in trapping immune complexes to the surface of FDCs (van den Berg et al., 
1995). It is therefore a possibility that PrP
Sc
 might reach the FDCs in lymphoid 
tissues via immune complexes. SCS macrophages have been linked to the transport 
of immune complexes from the SCS to the lymphoid follicles (Phan et al., 2007). If 
these cells were, similarly, involved in the transport of the scrapie agent, for example 
through immune complexes, their depletion prior to scrapie infection via the scrapie 
agent would affect PrP
Sc




alter the expected incubation time for these mice. Depletion of these cells prior to 
scrapie exposure via the skin failed to affect accumulation of PrP
Sc
 in the draining 
iLNs.  
 
While it is possible that the scrapie agent reaches the draining iLNs by first entering 
the SCS, the lack of effect on PrP
Sc
 accumulation in mice depleted of SCS 
macrophages, indicates that these cells do not play a role in the transport from the 
SCS to the lymphoid follicles. Alternatively, if this is a route of transport of the 
scrapie agent from the skin, then scrapie agent is not immediately transported from 
the skin. This possibility is ruled out based on the results in Chapter 4. Equally, Phan 
et al, described the appearance of antigen-immune complexes as early as 15 minutes 
after injection, thereby indicating that transport to the SCS is a rapid process. If the 
scrapie agent were not transported from the skin until after the SCS macrophage 





 cells would have repopulated tissues earlier than the SCS 
macrophages (as shown in Chapter 3), and there would not have been a delay in 
PrP
Sc
 accumulation in the draining iLN after CD11c
+
 cell depletion. 
 
The results in this chapter therefore indicate that SCS macrophages do not play a 
direct role in the accumulation of PrP
Sc
 in the draining LNs of mice following scrapie 
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7.1. Abstract                                                                                                                 
The skin is the body’s first line of defence against infection, as such there are a 
number of different immune cells resident within the layers of the skin. Langerin
+
 
epidermal LCs and langerin
+
 dermal DCs are two such cell types. The use of a 
transgenic mouse line (langerin-DTR) where langerin
+
 cells can be transiently 
depleted, by DTX injection, through their expression of DTR on their surfaces, 
allows for the characterisation of langerin
+ 
cell depletion and repopulation in the skin 
and lymphoid tissues. It was possible to establish a timeline for depletion and 
repopulation of langerin
+
 cells in the skin. Following DTX treatment LCs were 
depleted and had not fully repopulated the epidermis by 7 weeks after treatment. In 
contrast, langerin
+
 dDCs were depleted at the same time as LCs, but had repopulated 
the dermis much earlier than LCs. The creation of transgenic langerin-DTR/C56BL/6 
wildtype chimeric mice, where transgenic mice were reconstituted with wildtype 
bone marrow, or wildtype mice reconstituted with transgenic bone marrow allowed 
for the targeted depletion of either LCs or langerin
+
 dDCs, independently of each 
other. These findings can be further utilised to study the role of these two cellular 













Chapters 3 - 6 have dealt with the effects of the depletion of CD11c
+
 cells in scrapie 
transmission from the skin. CD11c is expressed on a wide range of cell types, and 
following DTX-mediated depletion of in CD11c-DTR→WT mice, CD11c
+
 cell 





 classical DCs by waiting for these cells to repopulate tissues. 
Equally it was possible to exclude the influence of the epidermal LCs from those 
studies by using CD11c-DTR transgenic bone marrow in wildtype mice, where the 
LCs were not depleted. Chapter 7 (and subsequently Chapter 8) will focus on the 
langerin
+
 cells by using the langerin-DTR mouse line (Kissenpfennig et al., 2005b), 
which was created in a similar way to the CD11c-DTR mouse line (Jung et al., 2002) 
described in previous chapters. The DTR transgene is expressed on langerin
+
 cells 
and as a consequence, these cells are specifically depleted through a single i.p. 
injection of DTX. 
 
Langerin is highly expressed by the LCs in the epidermis. The dermis contains two 
major DC subpopulations, one is langerin
+
 and the second one is langerin
-
 
subpopulation. Both these dDC subsets were depleted in CD11c-DTR and CD11c-
DTR→WT mice, but langerin expression, or lack thereof, will allow for experiments 
which differentiate between the two cell types and further expand knowledge of the 
potential differing roles between these subsets. 
 
Until a few years ago, studies from different laboratories investigating the role and 




(Kissenpfennig and Malissen, 2006). Some of these differences were attributed to the 
use of different inbred mouse strains, as a number of different cellular subsets were 
identified with differing langerin
+
 expression observed between the mouse lines 
(Flacher et al., 2008). Identification, in 2007, of langerin
+
 dDC (Bursch et al., 2007; 
Ginhoux et al., 2007; Poulin et al., 2007) unravelled the mystery of this ‘paradigm’. 
The presence of a second langerin-expressing cell type in the skin, that migrated 
from the skin at a faster rate than LCs (Kissenpfennig et al., 2005b; Nagao et al., 
2009), and repopulated their tissues of origin faster after DTX-mediated depletion 
(Bursch et al., 2007; Ginhoux et al., 2007; Nagao et al., 2009), explains why 
research into the role of langerin
+
 cells was sometimes contradictory. These langerin
+
 
dDCs also appear to carry out independent functions from epidermal LCs (Bennett et 
al., 2005; Fukunaga et al., 2008; Henri et al., 2010; Nagao et al., 2009; Poulin et al., 
2007; Shklovskaya et al., 2008). These findings help to explain the discrepancy 
previously observed between different research laboratories; some data can be 
attributed to a role for the epidermal LC, while other results can be attributed to the 
langerin
+
 dDCs.  
 
This chapter aims to gain an understanding of the potential involvement of LC and 
langerin
+
 dDCs in scrapie pathogenesis by using temporary conditional DTX-
mediated depletion. Data from this chapter will determine depletion and repopulation 
dynamics of these different cell subsets after DTX treatment. These data will be 
utilised in Chapter 8 to determine the potential role of these different subsets in 






7.3.1. Detection of the DTR transgene 
The presence of the DTR (Heparin binding EGF-like growth factor: Hbegf) transgene 
on the surface of langerin
+
 cells in langerin-DTR mice allows for the temporary 
depletion of langerin
+
 cells through a single i.p. injection of DTX. Genotyping was 
routinely carried on all langerin-DTR mice used to confirm presence of the DTR 
transgene before inclusion in any experiment. The DTR oligonucleotide, in 
combination with the two oligonucleotides for Cd207 (langerin), produced a PCR 
product with a band size of 866 base pairs, was present on the Cd207 gene (Fig. 
7.1.). In the case of a wildtype animal, the two Cd207 oligonucleotides produced a 
PCR product with a band size of 329 base pairs, consistent with the wildtype Cd207 








Figure 7.1. Confirmation of the presence of DTR and langerin in DNA from langerin-
DTR mice Lanes 1-4: langerin-DTR samples, 5: blank, 6: langerin-DTR positive control from 






7.3.2. Effect of DTX treatment on langerin+ cells in the skin and draining iLN 
To examine the effect of DTX treatment on langerin
+
 cells in the skin, langerin-DTR 
mice received a single i.p. injection of DTX, or PB control, and tissues were 
collected for ex vivo analysis from 4 mice/group at 0, 2, 7, 14, 22 days, and 7 weeks 
post injection. Immunofluorescent analysis of epidermal and dermal sheets with the 
anti-langerin specific antibody confirmed that LCs were completely depleted from 
the epidermis two days after DTX injection, and remained absent for at least 3 weeks 
(Fig. 7.2.). LCs started to reappear in large clusters by 7 weeks post DTX injection, 
but the tight LC network observed in untreated animals, was still disrupted (Fig. 
7.2.). Langerin
+
 cells in the dermis are not as uniformly distributed within the dermis 
(Nagao et al., 2009), but are readily visualised in dermal sheets. These cells were 
also depleted 2 days after DTX injection, but in contrast to epidermal LCs, they 
appeared to have returned to a similar density to that observed in untreated mice by 
14 days post treatment (Fig. 7.2.). These data are consistent with data from similar 
published studies (Bursch et al., 2007; Ginhoux et al., 2007; Nagao et al., 2009). 
 
Mice were injected according to the following groups 2 days prior to tissue collection 
for ex vivo analysis: WT+DTX; langerin-DTR+DTX, and langerin-DTR+PB (Table 
7.1.). Immunofluorescent analysis of ear epidermal and dermal sheets confirmed 
normal langerin
+
 cell distribution in WT+DTX or langerin-DTR+PB animals (not 
shown). LCs and langerin
+ 
dDCs were completely depleted (not shown), confirming 
that DTX-mediated langerin
+
 cell depletion, is specific to DTR transgenic animals. 
Immunofluorescent analysis of iLNs confirmed a partial depletion of langerin
+
 cells 







Figure 7.2. Timeline of DTX-mediated langerin
+
 cell depletion in the skin of langerin-DTR mice. Mice received a single i.p. injection of DTX and 
epidermal and dermal ear sheets collected at the time points indicated were immunolabelled with the anti-langerin specific antibody (green). (A,G) Normal distribution 
of LCs and langerin
+ 
dDCs in the epidermis and dermis in DTX untreated mice. Two days after DTX injection, (B) a complete depletion of LCs was observed. Cells 
had not returned by day 22 post DTX (E). LCs had reappeared in the epidermis in small organised clusters 7 weeks post DTX injection, the whole surface of the 
epidermis was not covered (F). Two days after DTX injection, (H) depletion of langerin
+
 dDCs was observed. Langerin
+
 dDCs numbers resembled controls by day 14 






Table 7.1. Depletion status of langerin
+
 cells in the skin of langerin-DTR or  
wildtype mice. 
               Depletion status 
Genotype DTX LCs langerin
+
 dermal DCs langerin
-
 dermal DCs 
WT yes no no no 
langerin-DTR yes yes yes no 







 cell depletion in the draining iLN following DTX injection. Mice 
were given a single i.p. injection of DTX, or PB control, and epidermal and dermal sheets collected 
two days later were immunolabelled with the anti-langerin specific antibody (green). (A,C) Normal 
distribution of langerin
+
 cells in the iLN in control groups. Partial depletion of langerin+ cells in the 
iLN of DTX treated mice, in comparison to control groups (B). Images are representative of 













7.3.3. Depletion of other cell types 
As well as skin-resident and migratory LCs and DCs, other langerin
+
 DC subsets in 
other organs are also depleted through DTX treatment in the langerin-DTR mouse. 
To determine a timeline for depletion of these cell populations, Lung, liver, heart, 
and kidney were also analysed. These subpopulations comprise a very small 
percentage of the cells in these tissues. Immunofluorescent analysis indicated that 
langerin
+
 cells were rare in these tissues (Fig. 7.4.), although they were more 
abundant in the liver and lungs compared to in the heart and kidney (Fig. 7.4.). There 
did not appear to be a sufficient number of langerin
+
 cells detected through 
immunofluorescence labelling to determine a potential effect of DTX on their status. 
 
Further immunohistochemical anlaysis was carried out on spleen and iLN (not 
shown) from DTX treated and untreated animals. Immunofluorescence analysis was 
used to determine any potential secondary effect of DTX treatment on CD35 
expressing FDCs and B lymphocytes. No differences were observed following DTX 











cells in the liver, lung, kidney, and heart. Tissues were collected from 
untreated mice and immunolabelled with the anti-langerin specific antibody (green) to assess normal 
distribution of langerin
+
 cells in non-lymphoid organs. Langerin expression on cells in the kidney (B) 
and heart (C) was very scarce. Langerin expression was more abundant in the liver (A) and lung (D). 





Figure 7.5. Effect of DTX injection on CD35-expressing cells in the langerin-DTR 
mouse. Mice were given a single i.p. injection of DTX and spleens collected at the times indicated 
were immunofluorescently labelled with the anti-CD35 specific antibody to detect FDCs and CD35-
expressing B lymphocytes (red). C and D are higher magnification images of A and B. Normal 
distribution of CD35 expressing cells were observed in the lymphoid follicles of the spleen 2 days 
post DTX injection (B,D), compared to untreated controls (A, C). Images are representative of 




7.3.4. Effect of DTX on FDC status 
To determine whether injection of DTX and depletion of large numbers of langerin
+
 
cells had an effect on langerin
-
 cell types such as FDCs, or their expression of PrP
c
, 
in lymphoid follicles, immunofluorescence analysis was carried out on spleen and 
iLNs from mice in each treatment group. Mice were injected as outlined in Figure 
7.6. and tissues were collected for ex vivo analysis two days post injection. Tissues 
were immunolabelled to detect B lymphocyte subsets and FDCs. Spleen and iLN 
were also immunolabelled to detect PrP
c
, to determine whether expression was 
influenced by DTX treatment.  Analysis confirmed no observable differences in 
labelling intensity or location of the FDCs and B lymphocytes in the langerin-
DTR+DTX animals compared to the two control groups (Fig. 7.6. and Fig. 7.7.). 
Equally, the expression of PrP
c
 on FDC networks was not affected in the langerin-
DTR+DTX mice, when compared to the control animals in either the spleen (Fig. 







Figure 7.6. DTX treatment of langerin-DTR mice had no effect on FDC and B cell status 
in the spleen. Mice were given a single i.p. injection of DTX and spleens collected two days later 
were immunolabelled with the anti-CD45R (green, A,E,I); the anti-CD35 (red, C,G,K); and anti-PrP 
(1B3) (blue, B,F,J) specific antibodies. FDC and B cell status were unaffected in each group; PrP
c
 
expression was, equally, unaffected on the FDCs, regardless of DTX or PB treatment D, H, L merged 








Figure 7.7. DTX treatment of langerin-DTR mice had no effect on FDC and B cell status 
in the draining iLN. Mice received a single i.p. injection of DTX and iLNs collected two days later 
were immunolabelled with the anti-CD45R (green, A,E,I); the anti-CD35 (red, C,G,K); and anti-PrP 
(1B3) (blue, B,F,J) specific antibodies. FDC and B cell status were unaffected in each group; PrP
c
 
expression was, equally, unaffected on the FDCs, regardless of DTX or PB treatment D, H, L merged 
















7.3.5. Langerin-DTR bone marrow chimeric mice 
A series of bone marrow reconstitution experiments were put in place to provide the 
opportunity to specifically deplete only the epidermal LCs or the langerin
+
 dDCs 
following DTX treatment. C57BL/6 wildtype or langerin-DTR transgenic mice were 
lethally γ-irradiated 24 hr prior to receiving a full bone marrow reconstitution from 
langerin-DTR mice or C57BL/6 wildtype mice, respectively. Eight weeks after bone 
marrow reconstitution the mice were injected with DTX, or PB control, as indicated 
in Fig. 7.8.  
 
Mononuclear phagocytes in the lymphoid tissues are radio sensitive and will be of 
donor origin 8 weeks after bone marrow reconstitution. LCs are relatively radio 
resistant, and are host derived up to 18 months post irradiation and bone marrow 
reconstitution (Merad et al., 2002). In the wildtype mice reconstituted with langerin-
DTR transgenic bone marrow (langerin-DTR→WT), the LCs, of host origin, did not 
express the DTR transgene. The other langerin
+
 cells were donor derived, expressed 
the DTR transgene, and were susceptible to depletion following DTX treatment 
(Table 7.2.). The langerin-DTR mice reconstituted with wildtype bone marrow 
(WT→langerin-DTR) contained DTR-expressing LCs, being of host origin. The 
other langerin
+
 cells were donor derived, did not express the transgene, and were not 








Figure 7.8. Model of irradiation and bone marrow reconstitution. C57BL/6 wildtype or 
langerin-DTR transgenic mice were lethally γ-irradiated 24 hr prior to receiving a bone marrow graft 
(grey) from langerin-DTR mice or C57BL/6 mice, respectively. After 8 weeks mice were split into 
four groups. Mice that received wildtype bone marrow were injected with DTX, or PB control. Mice 






Table 7.2. Depletion status of langerin
+
 cells in the skin following lethal  
irradiation and reconstitution. 
                         Depletion status 








WT langerin-DTR yes no yes no 
WT langerin-DTR no no no no 
langerin-DTR WT yes yes no no 





7.3.6. DTX-mediated langerin+ cell depletion in bone marrow chimeric mice 
To determine the effect of DTX injection on the status of langerin
+
 cells in langerin-
DTR bone marrow chimeric mice, 4 animals in each group described in Table 7.2. 
and Fig. 7.8. received a single i.p. injection of DTX and tissues collected for ex vivo 
analysis 2 days later. Immunofluorescent analysis was carried out on ear epidermal 
and dermal sheets with the anti-langerin specific antibody. As anticipated, LCs in the 
epidermis of langerin-DTR→WT+DTX were unaffected by DTX treatment, but the 
langerin
+
 dDCs were almost completely depleted (Fig. 7.9.). In contrast, the LCs in 
the epidermis of WT→langerin-DTR+DTX mice were depleted but had started to 
repopulate in small clusters of 5 or 6 cells (Fig. 7.9.). Larger clusters of LCs could be 
found in the epidermal sheets of some of the mice (not shown), indicating that maybe 
a small number of LC progenitor cells were of donor origin. As anticipated, langerin
+
 
dDCs were unaffected by the DTX injection in these mice (Fig. 7.9.). Following 
DTX-mediated depletion, langerin
+
 dDCs did not show a clustering effect of cells 
like that observed for the LCs. Immunofluorescent analysis of the iLN following 
DTX injection confirmed a partial depletion of langerin
+
 cells in the langerin-
DTR→WT+DTX mice (Fig. 7.10.). Langerin
+
 cells in the iLN of WT→langerin-
DTR+DTX mice were unaffected by DTX treatment (Fig. 7.10.). Further 
immunofluorescent analysis of the draining iLN, with the anti-langerin specific 
antibody confirmed a partial depletion langerin
+
 cells in the langerin-DTR→WT 








 cell depletion in the epidermis and dermis of bone marrow 
chimeric mice. Mice were given a single i.p. injection of DTX, and epidermal and dermal sheets 
collected two days later were immunolabelled with the anti-langerin specific antibody (green). (A) 
Normal distribution of LCs was observed in the epidermis of langerin-DTR→WT mice following 
DTX injection. Langerin
+
 dDCs in the dermis were almost completely depleted (C). In the 
WT→langerin-DTR mice, LCs were depleted in the epidermis, except for a few small clusters of cells 
following DTX injection (B), whereas the langerin
+
 dDCs in the dermis were unaffected by DTX (D). 









 cell depletion in the draining iLN of bone marrow chimeric mice 
following DTX treatment. Mice were given a single i.p. injection of DTX, and iLNs collected two 
days later were immunolabelled with the anti-langerin specific antibody (green). A: Partial depletion 
of langerin
+
 cells in the iLN of WT→langerin-DTR mice following DTX injection. B: Normal 
distribution of langerin
+
 in the iLN of langerin-DTR→WT mice following DTX treatment. Images as 




7.3.7. DTX treatment of langerin-DTR bone marrow chimeric mice does not 
affect FDC status  
Immunofluorescence analysis was carried out to determine whether DTX-mediated 
langerin
+
 cell depletion langerin-DTR→WT and WT→langerin-DTR mice had any 
effect on FDC status, or their expression of PrP
c
. Analysis was carried out on spleen 
and iLNs from 4 mice from each group 2 days post DTX treatment. The experiment 
confirmed that DTX treatment of langerin-DTR→WT and WT→langerin-DTR mice 
had no observable effect on the status and distribution of FDCs in the lymphoid 
follicles in either the spleen (Fig. 7.11.) or the iLN (Fig. 7.12.). Equally, PrP
c
 
expression on FDC networks was not affected in either of the chimeric mouse groups 









Figure 7.11. DTX treatment had no effect on FDC and B cell status in the spleens of 
bone marrow chimeric mice. Mice were given a single i.p. injection of DTX and spleens 
collected two days later were immunolabelled with the anti-CD45R (green, A,E), anti-PrP (1B3) 
(blue, B,F), and anti-CD35 (red, C,G) antibodies. FDC and B cell status were unaffected in both 
animal groups; PrP
c
 expression was, equally, unaffected on the FDCs following DTX treatment. D, H 
merged images of all three antibodies. Images are representative of observations in 3 animals. Scale 







Figure 7.12. DTX treatment had no effect on FDC and B cell status in the iLNs of bone 
marrow chimeric mice. Mice were given a single i.p. injection of DTX and iLNs collected two 
days later were immunolabelled with anti-CD45R (green, A,E), anti-PrP (1B3) (blue, B,F), and anti-
CD35 (red, C,G) antibodies. FDC and B cell status were unaffected in both animal groups; PrP
c
 
expression was, equally, unaffected on the FDCs following DTX treatment. D, H merged images of 
















In this chapter, characterisation studies were carried out on the langerin-DTR 
transgenic mouse line to determine a timeline for the depletion and repopulation of 
langerin
+
 cells following DTX injection. Tissues were collected for ex vivo analysis 
at various time points following a single i.p. injection of DTX, or PB control. 
Epidermal and dermal sheet analysis confirmed depletion of LCs as well langerin
+
 
cells in both the dermis and the epidermis following treatment of langerin-DTR mice, 
in accordance with previous results (Bursch et al., 2007; Ginhoux et al., 2007; 
Kissenpfennig et al., 2005b; Nagao et al., 2009). As was described in previous 
studies, the two langerin
+
 cell types within the skin display very different 
repopulation dynamics (Bursch et al., 2007; Ginhoux et al., 2007; Nagao et al., 
2009), highlighting how different these cells are, and how different their potential 
roles in skin immunity might be. LCs had not completely repopulated the epidermis 
by 7 weeks post DTX injection, further highlighting their slow turnover rate (Merad 
et al., 2002), in comparison to other DC subsets, including the langerin
+
 dDCs in the 
dermis, which repopulated the skin in under 2 weeks (Nagao et al., 2009). 
 
Langerin was also expressed on non-lymphoid tissues other than the skin (Douillard 
et al., 2005; Valladeau et al., 2002), and this was also reproduced in this chapter, 
although the cell numbers detected by immunofluorescent analysis were not 
sufficient to carry out a visual comparison of the effects of DTX treatment on their 
status. To confirm whether DTX-mediated depletion has a substantial impact on non-






The depletion of langerin
+
 cells in the LNs was not complete, even though a large 
number of cells were depleted. The results resemble those observed in Chapters 3 
and 5 in CD11c-DTR→WT mice, where these cells were depleted through their 
expression of CD11c. DTX-mediated depletion in the bone marrow chimeric mice 
further outlined the radiosensitive nature of the large proportion of LN-resident 
langerin
+
 DCs compared to epidermal LCs. These cells were not depleted in 
langerin-DTR mice reconstituted with wildtype bone marrow and vice versa.  
 
Data from the studies of the bone marrow chimeric mice did establish that it was 
possible to carry out DTX-mediated depletion of LCs independently of the langerin
+
 
dDCs and vice versa. LCs were clearly depleted in langerin-DTR mice reconstituted 
with wildtype bone marrow. In contrast to LC depletion described earlier in this 
chapter and in Chapter 3 (section 3.3.2.) small clusters of 5-10 LCs were observed in 
the epidermis only 2 days post DTX injection. This phenomenon has been previously 
observed in other studies (Nagao et al., 2009). These results therefore indicate that a 
small number of LC precursors might be of donor origin, leading to the production of 
small numbers of donor derived LCs. 
 
In parallel with Chapters 3 and 5, the distribution of other cell types within the 
lymphoid tissues was also analysed following DTX-mediated depletion or bone 
marrow reconstitution. CD35 expression within B cell follicles was unaffected by 
DTX injection in langerin-DTR mice when compared to controls. DTX-mediated 
depletion did not affect FDC status or their expression of PrP
c




DTR mice, the langerin-DTR→WT or WT→ langerin-DTR mice. These results 
confirm that the depletion of langerin
+
 cells in the lymphoid tissues did not adversely 
affect FDC status in these mice. 
 
Analysis of the langerin-DTR mice established a timeline for the depletion and 
repopulation of langerin
+
 cells in the epidermis and the dermis of langerin-DTR 
mice. Langerin
+
 cell depletion was also confirmed in the iLN. Bone marrow chimeric 
mice were used to show that LCs and langerin
+
 dDCs could be depleted 
independently of each other. These data will be used to provide a useful foundation 
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8.1. Abstract                                                                                                                 
Following scrapie infection via the skin scarification, PrP
Sc
 accumuluation occurs 
first in the draining LNs before spreading to the non-draining LNs and the spleen. 
DC subsets have been implicated in PrP
Sc
 transport following oral scrapie infection 
in mice. Chapter 4 demonstrated a delay in the accumulation of PrP
Sc
 in the draining 
iLN following scrapie infection via skin scarification in mice depleted of CD11c
+
 
cells. Bone marrow chimerism in these mice allowed for the temporary depletion of 
CD11c
+
 cells, with the exception of epidermal LCs. A transgenic mouse model was 
used, which allows for the temporary depletion of langerin
+
 epidermal LCs and 
dDCs. It was, thereby, possible to determine that the absence of these langerin
+
 cells 
at the time of scrapie infection did not delay scrapie agent accumulation in the 
draining iLNs. In contrast to the results presented in Chapter 4, depletion of langerin
+
 
cells prior to scrapie infection increased PrP
Sc
 accumulation in the draining iLNs 
between 5 and 7 weeks post infection. By using bone marrow chimeric mice that 
contained the transgene for langerin
+
 cell depletion, it was possible to attribute this 
increase in PrP
Sc
 accumulation to the absence of epidermal LCs, regardless of 
whether the langerin
+
 dDCs were present or not. Scrapie incubation period was 
unaffected in these mice despite the increase in PrP
Sc
 accumulation, thereby 
indicating that the absence of LCs at the time of scrapie infection via the skin does 
not affect disease progression, and spread to the peripheral nervous system is likely 







8.2. Introduction                                                                                                 
Langerin-DTR mice were analysed in Chapter 7 to characterise the depletion and 
repopulation of langerin
+
 cells following DTX-mediated depletion. Chapters 4 and 6 
studied the role of CD11c
+
 dermal cells and SCS macrophages on scrapie 
transmission. The use of langerin-DTR mice in this chapter will allow for the 
identification of the potential role of langerin
+
 dDC and also epidermal LCs cells in 
scrapie transmission from the skin. The radioresistant nature of LCs, compared to 
other mononuclear phagocytes lineages allows for the creation of bone marrow 
chimeras whereby the specific depletion of LCs in the epidermis or the langerin
+
 
dDCs of the dermis can be achieved. These mice were created by lethal γ-irradiation 
of C57BL/6 wildtype mice and reconstitution with bone marrow from langerin-DTR 
mice or vice versa, creating: langerin-DTR→WT or WT→langerin-DTR mice, 
respectively. These chimeras were used to attempt to determine the involvement of 
epidermal LCs or the langerin
+
 dDCs in scrapie pathogenesis. 
 
The role of LCs in scrapie transmission from the skin has previously been 
investigated through in vitro studies (Mohan et al., 2005c), or by blocking their 
migration from the skin (Mohan et al., 2005b). These studies were carried out before 
the identification of the langerin
+
 dDCs (Bursch et al., 2007; Ginhoux et al., 2007; 
Poulin et al., 2007). Since then a lot of work has highlighted the potential role of 
these langerin
+
 cells in many functions previously attributed to LCs (Henri et al., 
2010; Henri et al., 2007; Schröder et al., 2006). In this chapter, by temporarily 
depleting each cell type independently of the other, it is possible to gain insight into 
the potential role of each of these langerin
+




the skin.  In Chapter 7, LCs were confirmed to be completely depleted in the 
epidermis following DTX injection in the langerin-DTR mice. Seven weeks post 
DTX injection these cells had not completely repopulated the epidermis (Fig. 7.2.). 
By contrast, the langerin
+
 cells of the dermis repopulated at a much more rapid rate 
than the LCs, and were present at similar levels to controls by 14 days post DTX 
injection (Fig. 7.2.).  
 
Scrapie transmission to the langerin-DTR mice was carried out as outlined in 
previous chapters. Mice were injected with DTX, or PB control, to deplete the cell 
population of interest.  Two days later mice were infected with scrapie via skin 
scarification (Fig. 8.1.). Draining and non-draining lymphoid tissues were collected 
at early time points from animals in each of the three groups outlined in Table 7.1. A 
number of animals in each group were maintained to reach disease endpoint, to study 
the effects of cell depletion on scrapie susceptibility. By infecting the langerin-DTR 
mice 2 days after DTX injection, it was possible to determine whether the absence of 
langerin
+
 cells at the time of infection affected the early accumulation of PrP
Sc
 in the 




Figure 8.1. Experimental timeline. Mice were given a single injection of DTX, or PB, two days 
prior to inoculation with the scrapie agent via skin scarification. SK: serial kill. From each of the three 
groups tissues were collected from uninfected mice, at day 0 (with respect to TSE infection), 35, and 





Several studies were carried out to determine the role of the different langerin
+
 cells 
in the role of early scrapie accumulation and subsequent transmission. Sections 
8.3.1.-8.3.3. describe the studies carried out in langerin-DTR mice. Section 8.3.4. 
describes the results obtained following scrapie infection via the skin of bone 
marrow chimeric mice (langerin-DTR→WT or WT→langerin-DTR), while sections 
8.3.5 and 8.3.6. focus on the langerin-DTR mice at the end stage of disease. 
 
8.3.1. Effect of langerin+ cell depletion on the early accumulation of PrPSc in 
lymphoid tissues 
To determine the effect of langerin
+
 cell depletion (both LC and langerin
+
 dDCs) on 
the early accumulation of the scrapie agent in lymphoid tissues, langerin-DTR mice 
were injected with DTX, or PB control, and infected with the scrapie agent via skin 
scarification 2 days later. As an additional control, DTX-treated wildtype mice were 
also used. Draining (left) and non-draining (right) iLNs, left and right pLNs, and 
spleens were collected from 3 mice from each group as outlined in Chapter 7 (Table 
7.1.) at 5 and 7 weeks post scrapie infection. Immunohistochemical analysis with the 
anti-PrP specific mAb 6H4 determined that accumulations of PrP
d
 could be detected 
in each of the 3 draining iLNs of all three groups 5 weeks post scrapie infection (Fig. 
8.2.). PET blot analysis of adjacent sections confirmed that the detected protein was 
the proteinase K resistant, disease specific PrP
Sc
 (Fig. 8.2.). Labelling with the anti-
CD21/35 specific antibody confirmed that PrP
Sc
 accumulation was occurring on 
FDCs within the lymphoid follicles (Fig. 8.2.). PrP
d
 was not detected in any other 






 cell depletion did not impair the early accumulation of the TSE agent in the 
draining iLN. 
 
By 7 weeks post scrapie infection, PrP
d
 had spread to the spleen in all the animals 
from each of the 3 groups. In addition, PrP
d
 was detected in the non-draining (right) 
iLNs of all three mice from the langerin
+
 cell-depleted (langerin-DTR+DTX) mice, 
as well as one left pLN from both the langerin-DTR+DTX and langerin-DTR+PB 
groups. Unfortunately a number of the pLN tissues were unavailable for analysis 
(Table 8.2.). While PrP
Sc
 was detected at a similar level throughout the draining iLNs 
5 weeks post scarification, the intensity of labelling observed in the draining iLNs of 
the langerin-DTR+DTX mice 7 weeks after scrapie infection, appeared to be greatly 
increased when compared to the two control groups (Fig. 8.3.).  
Further immunohistochemical analysis of the draining iLNs confirmed that PrP
d
 
accumulated upon FDCs in the B cell follicles (Fig. 8.3.). Coincident with the 
increased accumulation of PrP
d 
in the draining iLNs of the langerin-DTR+DTX mice, 
increased activation of CR1 and CR2 (CD21/35) was detected upon FDCs in the 
iLNs of these mice, when compared to the two control groups. When observed at a 
higher magnification (magnification 200 x, compared to 40 x), the PrP
d
 showed a 
‘punctate’ pattern. PrP
d
 appeared to be associated with tingible body macrophages (*) 
(Fig. 8.3.) as well as FDC networks (+) (Fig. 8.3.). These results were comparable 
between all 3 groups, at both the 5 (not shown) and 7 week time points (Fig. 8.3.). 
The increased intensity of PrP
Sc
 labelling in the langerin-DTR+DTX mice was also 






 accumulation in the iLNs of langerin
+
 cell depleted mice 7 weeks after scrapie 
infection (Fig. 8.4). 
 
Immunohistochemical analysis was also carried out on frozen sections from the 
draining iLN of day 0 (uninfected mice) to determine whether DTX treatment of 
langerin-DTR mice influenced any potential differences in CD21/35 expression by 
FDCs. No differences were observed in any of the three groups (Fig. 8.5.). 
Immunohistochemical analysis for CD21/35 expression in the non-draining (right) 
iLN 7 weeks post scarification, showed labelling indicative of slightly higher 
CD21/35 expression in langerin-DTR+DTX mice compared to the controls (Fig. 
8.6.), where PrP
d
 accumulation had also been detected by 7 weeks post scarification. 







 accumulation in peripheral lymphoid tissues 5 weeks post scrapie 
infection.  
 WT + DTX langerin-DTR+DTX langerin-DTR+PB 
 1 2 3 1 2 3 1 2 3 
draining (left) iLN + + + + + + + + + 
right iLN – – – – – – – – – 
left pLN  – – – – – – – – – 
right pLN – – – – – – – – – 
spleen – – – – – – – – – 
PrP
d





 accumulation in peripheral lymphoid tissues 7 weeks post scrapie 
infection.  
 WT + DTX langerin-DTR+DTX langerin-DTR+PB 
 1 2 3 1 2 3 1 2 3 
draining (left) iLN + + + + + + + + + 
right iLN – – – + + + – – + 
left pLN  n/a – – + – – – + n/a 
right pLN – – – – – n/a – n/a n/a 
spleen + + + + + + + + + 
PrP
d
 was detected in all draining iLNs and spleens 7 weeks after scarification. PrP
d
 was also detected 
in all non-draining (right) iLNs from langerin-DTR+DTX mice and one left pLN from each of the 









 accumulation in the draining iLN 5 weeks post scrapie infection was 
unaffected in langerin
+
 cell depleted mice. Mice were infected with the scrapie agent via skin 
scarification 2 days post DTX injection, or PB control. Draining iLNs were collected 5 weeks post 
infection for immunohistochemical analysis.  A-C: deposition of PrPd (detected with 6H4 mAb) in all 
3 groups. D-F: Adjacent PET blot sections confirmed that PrP
d
 was proteinase K resistant PrP
Sc
. 
Detection of FDCs (CD21/35) (G-I) in the draining iLNs confirmed that PrP
Sc
 accumulated upon 
FDCs. Sections were counterstained with haematoxylin Z (blue). Images are representative of 









Figure 8.3. Increased PrP
d
 accumulation, 7 weeks post scrapie infection, in the 
draining iLN of mice depleted of langerin
+
 cells at the time of exposure. Mice were 
infected with scrapie via skin scarification 2 days post DTX injection, or PB control. Draining iLNs 
were collected 7 weeks post scarification for immunohistochemical analysis.  A-C: deposition of PrPd 
(detected with 6H4 mAb) in all 3 groups. Labelling was much stronger in the langerin-DTR+DTX 
group compared to the two control groups (magnification: 40 x). D-F: PrP
d
 accumulations 
(magnification: 200 x). Detection of FDCs (CD21/35) (G-I) and B lymphocytes (CD45R) (J-L) in the 
draining iLNs confirmed that PrP
d
 accumulated upon FDCs in the B cell follicles. PrP
d
 was detected 
both on FDC networks (+) and within tingible body macrophages (*). Sections were counterstained 
with haematoxylin Z (blue). Images are representative of observations in 3 animals/group. Scale bar: 




Figure 8.4. Increased PrP
Sc
 accumulation, 7 weeks post scrapie infection, in the 
draining iLN of mice depleted of langerin
+
 cells at the time of exposure. Mice were 
infected with scrapie via skin scarification 2 days post DTX injection, or PB control. Draining iLNs 
were collected 7 weeks post scarification for immunohistochemical analysis. A-C: deposition of PrP
d
 
(detected with 6H4 mAb) in all 3 groups. Labelling was much stronger in the langerin-DTR+DTX 
group compared to the two control groups. Sections were counterstained with haematoxylin Z (blue). 
D-F: Adjacent PET blot sections confirmed that PrP
d
 was proteinase K resistant, disease specific 
PrP
Sc
. E: Increased PrP
Sc
 deposition was confirmed in the langerin-DTR+DTX mice. Images are 














Figure 8.5. Effect of DTX-treatment on CD21/35 immunolabelling. Mice received a single 
i.p. injection of DTX, or PB control. Inguinal LNs were collected two days post injection and 
immunolabelled with the anti-CD21/35 specific antibody (red) (A-C). No differences were observed 
in the expression of CD21/35 between the 3 groups. Sections were counterstained with haematoxylin 





Fig. 8.6. Effect of DTX-treatment on CD21/35 immunolabelling in the right iLN 7 weeks 
post infection. Mice were infected with scrapie via skin scarification 2 days post DTX injection, or 
PB control. Non-draining (right) iLNs were collected 7 weeks post scarification and immunolabelled 
with the anti-CD21/35 specific antibody (red) (A-C). Labelling was stronger in 2 of the 3 langerin-
DTR+DTX mice compared to the two control groups. Sections were counterstained with 












8.3.2. Effect of langerin+ cell depletion on the early accumulation of PrPSc in 
the spinal cord 
In Chapter 4 (section 4.3.2.), it was shown that PrP
Sc
 had not reached the spinal cord 
by 5 weeks after scrapie infection. Earlier in this chapter (Fig. 8.3.) 
immunohistochemical analysis showed increased PrP
Sc
 accumulation in the langerin-
DTR+DTX mice 7 weeks after scrapie infection. Spinal cords from these mice were 
analysed by Western blot to determine whether the increased PrP
Sc
 accumulation 
observed in the draining iLN of langerin-DTR+DTX after scrapie infection had 
accelerated the spread of PrP
Sc
 into the spinal cord. Samples were treated in the 
presence or absence of proteinase K, to determine the presence of proteinase K 




 was detected in the spinal cords of any of 













Figure 8.7. Absence of PrP
Sc
 in the spinal cord of langerin-DTR+DTX mice at early time 
points. Mice were infected with scrapie via the skin 2 days post DTX-mediated langerin+ cell 
depletion. Spinal cord was collected from langerin-DTR+DTX animals 7 weeks post scrapie infection 
and analysed by Western blot. Samples were treated in the presence (+) or absence (-) of proteinase K 
(PK) prior to electrophoresis. PrP
c
 was detected in all proteinase K untreated samples, using the 1B3 
pAb, but no proteinase K resistant, disease specific, PrP
Sc
 was detected in the spinal cords of langerin-
DTR+DTX animals 7 weeks post scarification.  Successful detection of proteinase K resistant PrP
Sc
 



















8.3.3. Exposure of langerin+ cell-depleted mice to normal brain (NB) 
homogenate via skin scarification does not influence FDC status 
A study was established to further investigate the cause of the apparent increase in 
PrP
Sc
 accumulation, and associated increased activation of complement receptors 
CR1 and CR2 in scrapie-exposed langerin
+
 cell-depleted mice. This experiment 
sought to determine whether the effects were caused by an immune response to skin 
scarification (injury), exposure to brain homogenate at the time of langerin
+
 cell 
depletion or whether PrP
Sc
 was accumulated faster due to the absence of cells that 
might normally process or degrade the scrapie agent. Groups of 4 langerin-DTR mice 
received a single i.p. injection of DTX, or PB control. Two days after DTX 
treatment, the mice were scarified with NB homogenate from an uninfected 
C57BL/Dk mouse. Tissues were collected for ex vivo analysis at day 0 (unscarified) 
and 7 weeks post scarification. Immunohistochemical analysis of epidermal and 
dermal sheets and iLN confirmed langerin
+
 cell depletion following DTX treatment 
of the langerin-DTR mice (not shown). Draining iLNs were immunolabelled with the 
anti-PrP pAb 1B3. Low levels of expression of PrP
c
 were detected, consistent with 
expression in uninfected tissues. These results were similar in both the DTX and PB 
treated groups (Fig. 8.8.). Immunohistochemical analysis with the anti-CD45R and 
anti-CD21/35 antibodies, confirmed PrP
c
 to be localised on FDCs within B cell 
follicles. In addition, no differences were observed in FDC status between the 
langerin-DTR+DTX and langerin-DTR+PB mice (Fig. 8.8.). These data suggest the 
increased PrP
Sc
 accumulation and CR2/CR1 activation observed following scrapie 
infection of langerin
+
 cell-depleted mice (Fig. 8.3), in langerin-DTR mice was not 




Figure 8.8. Normal distribution of PrP
c
, FDCs and B cells in the draining iLN of NB-
exposed langerin
+
 cell-depleted mice. Mice were exposed to NB homogenate via skin 
scarification 2 days post DTX injection, or PB control. Draining iLNs were collected 7 weeks post 
scarification for immunohistochemical analysis. Detection of B lymphocytes and FDCs in the iLN 
showed no increased cell activation as a result of DTX injection, skin injury, or exposure to NB. A,B: 
Normal PrP
c
 distribution in the lymphoid follicles of uninfected mice, detected with the anti-PrP pAb 
1B3 (red).  Detection of FDCs (CD21/35) (C-D) and B lymphocytes (CD45R) (E-F) in the draining 
iLNs confirmed that PrP
c
 was located on the FDC networks in the B cell follicles. Sections were 
counterstained with haematoxylin Z (blue). Images are representative of observations in 4 








8.3.4. Effect of LC or langerin+ dDC depletion on early accumulation of PrPSc in 
lymphoid tissues  
Experiments were performed to determine whether the increased accumulation of 
PrP
Sc
 in the draining iLN following scrapie infection via the skin could be attributed 
to depletion of a specific population of langerin
+
 cells. C57BL/6 wildtype mice were 
lethally irradiated 24 hr prior to reconstitution with langerin-DTR bone marrow, or 
vice versa. The following bone marrow chimeras were produced as a result: langerin-
DTR→WT and WT→langerin-DTR, where langerin
+
 dDCs or LCs, respectively, 
were depleted independently of each other following DTX injection (Table 8.3.). 
 
Groups of WT/langerin-DTR bone marrow chimeric mice were prepared as outlined 
in Table 8.3., 8 weeks after irradiation and bone marrow reconstitution. Specific 
depletion of LC or langerin
+
 dDC was achieved in the bone marrow chimeric mice 
through a single i.p. injection of DTX, or PB control. Two days after DTX treatment, 
mice were infected with the scrapie agent via skin scarification. Tissues were 





Table 8.3. Specific depletion of LCs or langerin
+
 dDCs in langerin-DTR/WT  
bone marrow chimeric mice. 
                         Depletion status 








WT langerin-DTR yes no yes no 
WT langerin-DTR no no no no 
langerin-DTR WT yes yes no no 




As shown in Chapter 7 (Fig. 7.11.), by using these chimeric mice it was possible to 





 cells in the iLNs of the langerin-DTR→WT+DTX 
mice. Immunohistochemical detection of PrP
d
 in the draining iLNs of these mice 7 
weeks post scrapie infection confirmed PrP
d
 accumulation in the draining iLNs of all 
the animals (Fig. 8.9.). Comparable to the observations in Fig. 8.2., PrP
d
 
accumulation was increased following DTX injection, when compared to PB injected 
animals, in the LC-depleted WT→langerin-DTR mice. No differences in PrP
d
 
accumulation were observed between the scrapie-infected DTX and PB treated 
animals in the langerin
+
 cell-depleted langerin-DTR→WT groups. The intensity of 
PrP
d
 labelling in the scrapie-infected langerin-DTR→WT mice was comparable to 
the WT→langerin-DTR+PB control mice. However, PrP
d
 labelling intensity was 
increased in WT→langerin-DTR+DTX mice when compared to the other 3 groups. 
These data suggest increased accumulation of PrP
d
 in the draining iLNs of the 
WT→langerin-DTR mice was a result of the absence of LCs, rather than the absence 
of langerin
+
 dDCs, or both. PET Blot analysis of these tissues confirmed that the 
PrP
d
 detected in the draining iLNs was resistant to proteinase K digestion and was 
therefore the disease-specific form, PrP
Sc
 (Fig. 8.10.). Taken together, these results 
suggest that the specific depletion of epidermal LCs prior to scrapie infection via the 
skin enhanced the early accumulation of PrP
Sc











Figure 8.9. Effect of specific LC or langerin
+
 dDC depletion on PrP
d
 accumulation in 
the draining LN. Mice were infected with the scrapie agent via skin scarification 2 days post DTX 
injection, or PB control. Draining iLNs were collected 7 weeks post scarification for 
immunohistochemical analysis. A-D: deposition of PrP
d
 (detected with mAb 6H4) in all 4 groups. 
PrP
d
 immunolabelling appeared to be much stronger in the WT→langerin-DTR+DTX group when 
compared to the other 3 groups. Detection of FDCs (CD21/35) (E-H) and B lymphocytes (CD45R) (I-
L) in the draining iLNs confirmed that PrP
d
 accumulated upon FDCs in the B cell follicles. Sections 
were counterstained with haematoxylin Z. Images are representative of observations in 4 










Figure 8.10. Effect of specific LC or langerin
+
 dDC depletion on PrP
Sc
 accumulation in 
the draining LN. Langerin-DTR/C57BL/6 bone marrow chimeric mice were infected with scrapie 
via skin scarification 2 days post DTX injection, or PB control. Draining iLNs were collected 7 weeks 
post infection for immunohistochemical analysis. (A,B) Deposition of PrP
d
 (detected with 6H4 mAb) 
in the langerin-DTR→WT group, no major differences observed between the two groups. (C) PrP
d
 
deposition in WT→langerin-DTR appeared to be much stronger following DTX treatment when 
compared to the other 3 groups. Sections were counterstained with haematoxylin Z (blue). (E-H) 
Adjacent PET blot sections confirmed that PrP
d
 detected by 6H4 was proteinase K resistant PrP
Sc
. 









8.3.5. Effect of langerin+ cell depletion on scrapie incubation period following 
infection via skin scarification 
To determine the effect of langerin
+
 cell depletion on the transmission of disease to 
the brain, groups of 8 langerin-DTR mice were treated with DTX, or PB as a control, 
and infected with the scrapie agent 2 days later. The disease incubation period was 
determined for mice that were found to be both clinically and pathologically positive 
for the signs of scrapie. All the animals in each group succumbed to clinical TSE 
disease, with mean incubation periods of 350 ± 35 days (WT+DTX), 347 ± 19 days 
(langerin-DTR+DTX), and 332 ±17 days (langerin-DTR+PB) (Table 8.4.). Statistical 
analysis of the mean incubation periods determined that the residuals were normally 
distributed (p = 0.154). A one way analysis of variants confirmed there was no 
significant difference between the disease incubation periods in each group (p = 
0.320). Therefore, despite an early increase in PrP
Sc
 accumulation in the draining 
iLN of langerin-DTR+DTX mice, this did not affect the incubation period of disease 









    Table 8.4. Effect of langerin+ cell depletion on scrapie incubation period  
 after infection via the skin. 
Group Incidence Mean incubation period 
WT + DTX 8 350 ± 35 
langerin-DTR + DTX 7 347 ± 19 
langerin-DTR + PB 8 332 ± 17 





Immunohistochemical analysis of the brain revealed characteristic spongiform 
encephalopathy, PrP
d
 accumulation, reactive astrocytes and microglia in all clinically 
scrapie affected animals from each group, consistent with development of terminal 
scrapie disease (Fig. 8.11.). PET blot analysis of adjacent sections confirmed the 
PrP
d
 accumulations detected were proteinase K resistant, PrP
Sc
 (Fig. 8.11.). The 
targeted distribution of vacuolation in the brains was consistent with an infection 
with the ME7 scrapie agent in each of the three groups. No major variation was 
observed between the lesion profiles of each of the two langerin-DTR groups. Small 
differences were detected in Area 4 and 9 of the WT+DTX mice compared to the 






Figure 8.11. Histopathological analysis of brain tissues from terminally scrapie-
affected mice. Mice were inoculated with ME7 scrapie via skin scarification 2 days post DTX-
mediated langerin
+
 cell depletion and brains from each clinically scrapie affected mouse analysed by 
immunohistochemistry. Abundant PrP
d
 accumulations were detected in the hippocampi of clinically 
and pathologically positive mice from each group (A-C). (D-F) PET blot analysis confirmed the 
presence of proteinase K resistant PrP
Sc
. Gliosis were confirmed through labelling with the GFAP 
antibody (astrocytes) (G-I), and the Iba1 antibody (microglia) (M-O). Sections were counterstained 
with haematoxylin Z (blue). (J-L) Haematoxylin and eosin (H&E) staining revealed extensive 
vacuolation in the brains from all mice.  Clin: clinical score; path: pathological score, positive (+) or 
negative (-); d.p.i.: days post-inoculation on which tissues were taken for analysis. Images are 
representative of observations from 8 (7) different animals. Scale bar: top 3 rows, 500 µm rows; and 





Figure 8.12. Pathological targeting of vacuolation in the brains of terminally scrapie-
affected mice. Mice were inoculated with scrapie via skin scarification 2 days post DTX injection, 
or PB control. A: WT+DTX. B: langerin-DTR+DTX. C: langerin-DTR+PB. Vacuolation in the brain 
was scored on a scale of 0-5 in the following grey matter areas: G1, dorsal medulla; G2, cerebella 
cortex; G3, superior colliculus; G4, hypothalamus; G5, thalamus; G6, hippocampus; G7, septum; G8, 
retrosplenial and adjacent motor cortex; G9, cingulate and adjacent motor cortex. Each point 





8.3.6. Effect of langerin+ cell depletion on late PrPSc accumulation  
Following scrapie inoculation via the skin, PrP
Sc
 accumulation occurs first in the 
draining LNs before spreading to the non-draining LNs and the spleen. High levels 
of PrP
Sc
 are maintained in these tissues until the terminal stages of disease (Glaysher 
and Mabbott, 2007a; Mohan et al., 2004). Immunohistochemical analysis of the 
spleen and draining iLN of clinically scrapie-affected mice from all three groups 
further supported this. The levels of PrP
d
 deposition in the spleen were comparable 
across all the groups (Fig 8.13.). PrP
d
 deposition in the draining iLNs was likewise 
comparable across these groups (Fig. 8.13.). PET blot analysis of adjacent iLN 
sections confirmed this to be proteinase K resistant PrP
Sc
 (Fig. 8.13.). The iLNs were 
further analysed, to determine that no major differences were observed in CD21/35 
labelling between the 3 groups (Fig. 8.13.). 
 
Spinal cords were also collected from terminally scrapie affected mice and analysed 
through Western blot analysis. Samples were treated in the presence or absence of 
proteinase K, to determine the presence of disease specific PrP
Sc
. As anticipated, 
spinal cords were found to contain large amounts of PrP
Sc
 in each of the three groups 








Figure 8.13. Histological analysis of PrP
Sc
 accumulation within peripheral lymphoid 
tissues from terminally scrapie-affected mice. Mice were inoculated with ME7 scrapie via 
skin scarification 2 days post DTX injection, or PB control. Spleen and iLN were collected from 
animals at the endpoint of disease, and immunohistochemical analysis was carried out for the 
detection of PrP and CD21/35. PrP expression was detected in the spleen of animals in all three 
groups (A-C). PrP expression was detected in the spleen of animals in all three groups (D-F). 
Adjacent PET blot sections confirmed the presence of proteinase K resistant PrP
Sc
 (G-H). CD21/35 
expression was consistent throughout the three groups at scrapie disease endpoint (J-L). Sections 
were counterstained with haematoxylin Z. Images are representative of observations in 8 (7) 








 accumulation in the spinal cord of terminally scrapie-affected mice.  
Mice were infected with scrapie via the skin 2 days post DTX-mediated langerin
+
 cell depletion. 
Spinal cords were collected from terminally scrapie-affected mice and analysed by Western blot. 
Samples were treated in the presence (+) or absence (-) of proteinase K (PK) prior to electrophoresis. 
Proteinase K resistant, disease specific, PrP
Sc
 was detected, using the 1B3 pAB, in the spinal cords of 




















In this chapter langerin-DTR transgenic mice were injected with DTX to specifically 
deplete their langerin
+
 cells prior to scrapie exposure via skin scarification of the 
inner thigh. In contrast to the delayed PrP
Sc
 accumulation observed following the 
depletion of CD11c
+
 cells in Chapter 4, the depletion of langerin
+
 cells in this chapter 
lead to the increased accumulation of PrP
Sc
 in the draining iLN 7 weeks post 
infection. No differences were observed in the level of PrP
Sc
 accumulation 5 weeks 
post infection, indicating that this was not a direct result of the absence of langerin
+
 




 accumulation in the spleen had occurred in all animals from all three groups by 
7 weeks post scrapie infection, a phenomenon not observed in the CD11c-
DTR→WT mice. In addition, PrP
d
 accumulation was detected in the non-draining 
(right) iLN of the langerin-DTR+DTX mice 7 weeks post scrapie infection. PrP
d 
was 
also detected in two left pLNs (langerin-DTR+DTX and langerin-DTR+PB).  
 
The increased accumulation of PrP
Sc
 7 weeks post infection, following depletion of 
langerin
+
 cells, was accompanied by an increased expression of CR1 and CR2 in the 
follicles of the draining iLN. However, no differences in CR1 and CR2 expression 
were detected in the draining iLNs at earlier time points. Equally, depletion of 
langerin
+
 cells prior to skin scarification with NB homogenate, did not affect CR1 
and CR2 levels in the draining iLNs 7 weeks post scarification. Increased labelling 
intensity associated with CR1 and CR2 was also detected in a number of non-






 had spread to the non-draining iLN by 7 weeks post infection. No differences in 
labelling of CR1 and CR2 were observed in the bone marrow chimera groups 7 
weeks post scrapie infection, although labelling was strong throughout all 4 groups, 
possibly a result of lethal γ-irradation and bone marrow reconstitution. By contrast, 
differences were observed in PrP
Sc
 labelling intensity in the draining iLN of bone 
marrow chimeric mice 7 weeks post scrapie infection. Increased PrP
Sc
 accumulation 
was restricted to the WT→langerin-DTR+DTX mice, where the radioresistant LCs 
were specifically depleted, but the donor-derived langerin
+
 dDCs were unaffected by 
DTX. These results indicate that the increased PrP
Sc
 accumulation in the draining 
iLN following scrapie infection via the skin was a specific consequence of the 




 accumulation and CR1/CR2 expression appeared to be linked. 
Both occurred as a result of the depletion of LCs prior to scrapie infection via skin 
scarification. Neither of these results were observed 5 weeks post infection, therefore 
an event is occurring between these two time points to trigger this effect. Following 
DTX-mediated depletion, LCs remain depleted for several weeks (Bennett et al., 
2005; Kissenpfennig et al., 2005b; Nagao et al., 2009) and Chapter 7. As the LCs 
repopulate the skin, it is plausible that residual traces of the scrapie inoculum left in 
the skin are being acquired by the repopulating LCs and transported to the draining 
iLN.  
 
Previous in vitro work (Mohan et al., 2005c) indicated that LCs degraded the scrapie 




skin to the draining iLN. The blocking of LC transport from the skin prior to scrapie 
infection via skin scarification did not impair the accumulation of scrapie infectivity 
in the draining iLN or inhibit disease (Mohan et al., 2005b). These results further 
support the findings from this chapter, that langerin
+
 cell depletion did not block TSE 
agent accumulation in the draining iLN, suggesting that LCs are not involved in the 
early delivery of the TSE agent from the skin to the draining iLN. LCs have also 
been shown to internalise antigen from the surface to the Birbeck granules, and 
degrades antigen such as HIV (Merad et al., 2008). Therefore, LCs may likewise 
phagocytose and gradually destroy PrP
Sc
. The absence of LCs following DTX-
mediated depletion might therefore explain the increased PrP
Sc
 deposition in the 
draining iLN, as these degradatory cells were absent at the time of scarification.  
 
It could be argued that the increase in PrP
Sc
 accumulation is a result of an immune-
mediated response to DTX-mediated cell death in the lymphoid tissues, especially 
considering the increased expression of CR1/CR2. An increase in CR1/CR2 
expression may lead to increased uptake of PrP
Sc
 by FDCs (Zabel et al., 2007). 
However, the scarification study with NB homogenate showed no increase in 
CR1/CR2 activity despite langerin
+
 cell depletion prior to scarification. This suggests 
the effects observed were not simply due to an immunological response to DTX-
mediated cellular depletion or injury caused by scarification.  
 
Despite all the changes that have occurred in the draining iLN as a result of langerin
+
 
cell depletion prior to scrapie infection, no differences were observed between the 




studies involving scrapie transmission via skin scarification indicate that infection 
may already have spread to the peripheral nervous system earlier than 42 days post 
infection (Mohan et al., 2005a). This could explain why the differences observed at 
the early time points are not reflected in the terminally scrapie-affected animals. The 
differences in PrP
Sc
 accumulation observed in the draining iLN of mice where 
langerin
+
 cells were depleted appear to occur between 5 and 7 weeks post 
scarification. The increased accumulation at 7 weeks post scarification therefore 
indicates a potential ‘second wave’ of PrP
Sc
 accumulating in the draining iLN, and 
also spreading to the non-draining LNs. If this is the case and neuroinvasion has 
already occurred, this could explain why the differences observed at the early time 
points are not reflected in the terminally-scrapie-affected animals. 
 
This chapter has determined that DTX-mediated depletion of langerin
+
 cells in the 
langerin-DTR transgenic mice prior to scrapie infection via skin scarification did not 
block TSE agent accumulation in the draining iLN. Between 5 and 7 weeks post 
PrP
Sc
 accumulation was increased in the draining iLNs of mice depleted of langerin
+
 
cells. Bone marrow chimerism determined that this difference can be attributed to the 
absence of LCs at the time of scrapie infection. Despite the increase in PrP
Sc
 
accumulation, incubation period was not affected in these mice, thereby indicating 
that the increase in PrP
Sc
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The previous chapters have studied the effect of MNP depletion on scrapie 
transmission from the skin following scarification. Little is known of the fate of the 
TSE agent within the skin following infection. This chapter will aim to address this 
question through histopathological and gene expression analysis of scarified skin. 
Scarification was found to be associated with a local inflammatory response, 
identified both by histopathology and gene expression analysis. Analysis also 
determined there to be no major gene expression changes following DTX-mediated 
depletion in either the CD11c-DTR→WT or the langerin-DTR mice.  Histopathology 
was also used to visualise the effects of scarification on the fate of fluorescently 
tagged PrP
Sc
 (from scrapie associated fibrils: SAFs) and to determine whether it was 
possible to track the inoculum in vivo following scarification. Alexa-PrP
Sc
 was 
detected on or below the skin, up to 72 hr post scarification. Small amounts were also 
















Technology is continually advancing and the use of fluorescent tags, for proteins or 
molecules of interest, has been around for a number of years. This technology has 
previously been used within the field of PrP research (Gossner et al., 2006). The 
development of the ‘very photostable’ Alexa-Fluor® succinimidyl ester dyes, helps 
to eliminate issues concerning the photostability of the dye or the strength of the 
molecular bonds between the dye and target molecule, as the molecular bonds that 
are formed in this reaction are as stable as peptide bonds (Banks and Paquette, 1995). 
Gousset et al (Gousset et al., 2009), fluorescently tagged PrP
Sc
 with Alexa-
Fluor®546 and used this to track PrP
Sc
 in cells in vitro. The authors carried out 
extensive steps to ensure the stability of the bonds and that specific binding to the 
desired protein was in place. These steps included saving samples from each step of 
the PrP
Sc
 isolation/tagging process for comparative analysis, fluorography imaging of 
protein electrophoresis gels that were subsequently transferred to nitrocellulose 
membrane and probed with anti-PrP antibodies (Western blot), to confirm that the 




 was extracted from brains of scrapie 
affected mice.  
 
There are numerous other proteins in the brain that the fluorescent dye could bind to, 
so it is of utmost importance to ensure that the target protein has been fluorescently 
labelled, and that samples do not contain a range of fluorescently tagged non-specific 
proteins. It was therefore decided that the work outlined in this chapter would 
describe Alexa Fluor®546 labelling of scrapie associated fibrils (SAF) (Merz et al., 






 was used in this chapter to determine whether it 
was possible to track the movement of the PrP
Sc
 from the skin to the draining iLN. 
This approach also provided the opportunity to determine how long PrP
Sc
 is present 
in the skin following infection via scarification.  
 
Little is known of the adipose tissue that surrounds lymphoid tissues (perinodal 
adipose tissue: PAT) and its potential role in immune responses, but the fatty acid 
content in PAT shows site-specific specialisation, which may influence inflammatory 
diseases (Knight, 2008). PAT contains a high number of DCs, in contrast to 
subcutaneous fat (Bedford et al., 2006). It is suggested that maturation, function or 
even migration into LNs of these DCs might be modulated by their fatty acid 
environment (Knight, 2008). When LNs are removed from the carcass, excess PAT 
is removed and discarded. This is often the case for tissues collected for 
immunohistochemical analysis of frozen sections, since the fat from PAT can destroy 
the LN microarchitecture. As such the potential influence of the PAT is often 
overlooked. However, studies suggest the PAT may play an important role in the 
immune response by its ability to modulate inflammation, through adipokines, or 
fatty acids and their metabolites (Knight, 2008).  
 
TSE agent accumulation within the fat of scrapie infected mice and CWD-infected 
deer has recently been reported (Race et al., 2008; Race et al., 2009). In light of these 
data, and the potential role for the PAT in immune responses, it would be important 
to investigate whether PrP
Sc




the skin. This has led to analysis of the PAT of mice infected with Alexa Fluor®546-
PrP by skin scarification. 
 
Microarray analysis permits the comparison of gene expression profiles from many 
different cell types or tissues, and the effects of treatments on those tissues. In this 
chapter, gene expression profiles were compared from animals in the different 
studies. Samples were taken from animals that were scarified in the ear (to examine 
the effect of scarification). Samples were also collected from CD11c-DTR and 
langerin-DTR mice two days post DTX-treatment (to examine the effect of DTX-
mediated cell depletion in the skin). Using this approach it was therefore possible to 
determine what genes and/or cell types were affected by the different treatments that 
the mice have undergone, throughout this thesis. These results can be put into context 
of the previous chapters where mice had undergone DTX treatment to deplete 
specific cells, and where mice were scarified in order to transmit scrapie via the skin. 
These results aim to determine whether other factors might play a role in determining 













9.3.1. Histopathological analysis of the effect of scarification on the skin 
To determine the effect of scarification on the skin, the pinna of the ear was selected 
as an appropriately flat surface, as presence of cartilage within the ear prevents the 
skin from curling during analysis. Furthermore, the epidermis and dermis can be 
readily discriminated. Mice were scarified on the ventral side of the ear, and tissues 
were collected for analysis 15 min and 2 hr post scarification. Histopathological 
analysis confirmed peracute localised dermatitis at the site of scarification by 15 min 
(Fig. 9.1.), becoming more obvious at two hours post scarification when an 
inflammatory exudate was identified at the site (Fig. 9.1.). Immunofluorescence 
analysis confirmed localised infiltration of neutrophils and CD11b
+
 cells (Fig. 9.1.), 





 Figure 9.1. Histopathological effects of scarification on the inner surface of the ear. 
Mice were scarified on the ventral side of the ear, and tissues collected for histological analysis 15 
min and 2 hr post scarification. Throughout the figure, a denotes the epidermis, b denotes dermis, and 
c denotes cartilage. Haematoxylin and eosin (H&E) staining revealed a localised inflammatory 
response to the scarification after 15 min (A,D). The site of scarification is marked by *. By 2 hr after 
scarification (B,E) inflammation was accompanied by the infiltration of neutrophils (red) (H) and 
CD11b
+
 cells (red) (K). These inflammatory responses were localised to the site of scarification, 
images captured distal to the scarification site show no inflammatory changes or cellular infiltration 
(C,F,I,L). Images are representative of observations in 4 animals per time point. Scale bar: top row, 






9.3.2. Microarray analysis  
To determine whether scarification or DTX-mediated depletion affected gene 
expression in the skin, ear samples were collected for mRNA extraction from 
langerin-DTR transgenic mice or CD11c-DTR→WT treated with DTX or PB, and 
from wildtype mice scarified on the ventral side of the ear (Table 9.1.). Gene 
expression within these samples was analysed on a single microarray platform 
(Affymetrix mouse genome 430-2 arrays). 
 
9.3.3. Clustering of co-expressed genes in distinct cell lineages 
Raw data sets (.cel files) were normalised during RMA and annotated using the latest 
libraries available from Affymetrix. A full probe set-to-probe set Pearson correlation 
matrix was calculated whereby the similarity in the expression profile of each 
transcript (probe set) represented on the array was compared across each of the 20 
samples. The matrix was imported into BIOLAYOUT EXPRESS
3D
 (Freeman et al., 
2007; Theocharidis et al., 2009), and a graph was created of the sample-to-sample 
correlations using relationships r > 0.9. to define edges (Fig. 9.2.). The network 
graph contained 8,792 nodes representing individual transcripts connected by 87,920 
edges indicating Pearson correlation values above the selected threshold of r = 0.90. 
After clustering, 177 clusters containing at least 7 nodes were obtained and their 
contents are provided in the attached CD-ROM. The network graph’s topology is 
complex and is derived from cliques of genes which are co-expressed (Fig. 9.2.). 
This analysis clearly shows that clusters containing genes with related expression 





The expression profile of the clusters helps to provide an indication of the biology 
they encode. Several, clusters, for example cluster 7 and 9, contained genes that were 
expressed in all 20 samples. These mostly contained genes involved in housekeeping 
functions, such as ribosome regulation (Table 9.2.).  
 
Several cell-specific gene clusters were also identified (Table 9.2.), and examples of 
the gene expression profiles where these clusters vary between treatment groups can 
be found in Figure 9.3. For example, cluster 2 and 6 are enriched in genes related to 
the function of phagocytes, such as Ccl21a,  Cd163, Cd47, Cd209f, Cd209g, Ccl8, 
Ccr2, Cd200r4, Cd40, Cd48, and Cd68. Cluster 12 is enriched in genes known to be 
associated with B lymphocytes, and antibody production, including Bank1, Blk, Btla, 
Igh6, Ighg, Ighv14-2. Clusters 8, 10, 18, and 44 contain genes that were only 
enriched in the samples from mice that had been scarified. These include genes 
associated with B cells, Bcl-10, Btg2, Bcr, and with inflammation, Ccr1,Ccl3, Ccl4, 
Clec4e, Il1b, and Trem1, but also contained genes associated with the regulation of 
inflammatory responses, including Crem, Socs3, Tnfaip3, and Wsb2. Clusters 19, 32, 
and 50 contain genes that were only enriched in langerin-DTR+DTX samples, and 
these genes appear to be associated with transcription. Equally, other clusters are 
only associated with genes enriched in the CD11c-DTR→WT samples. Scarification 





 cell depletion did not adversely affect gene expression 






     Table 9.1. Sources of ear skin samples where RNA was extracted for  
microarray analysis 
Mouse line treatment time point replicates 
C57BL/6 scarification 2 hr 3 
CD11c-DTR→WT PB 2 d 3 
CD11c-DTR→WT DTX 2 d 3 
CD11c-DTR→WT DTX 6 d 3 
langerin-DTR PB 0 d 2 
langerin-DTR DTX 2 d 3 






Figure 9.2.  Network analysis of mouse skin transcriptomics data. A Pearson correlation 
matrix was prepared by comparing data derived from all 20 samples used in this study performed on 
Affymetrix mouse genome 430-2 arrays. A graph was constructed using probe set-to-probe set 
relationships greater than r = 0.9. Nodes represent samples (individual chips) and edges coloured 
according to the strength of the correlation (red, r = 1.0; blue, r = 0.9). The graph was then clustered 
using a Markov clustering (MCL) inflation value of 2.2 and each cluster of samples assigned a 
different colour. Full descriptions of the sources of each data set are given in Table 9.1.  
 
 











Known markers present in cluster 
2 
 
CD11c-DTR→WT Phagocyte-related 136 C1qtnf2, C1ra, Ccl21a, Ccr2, CD163, Cd47, Cd209f, Cd209g, CD300, 
Clec10a, Csfr-1, Emr1, Grn, H2-Aa, H2-Ab1, IL10ra, Itgb2, Laptm5 
6 CD11c-DTR→WT Phagocyte-related 72 C1qa, C1qb, C1qc, Casp12, Ccl8, Ccr2, Cd200r4, Cd40, Cd48, Cd68, Clec4a2, 
Clec4a3, Clec4n, Ctsc, Ctss, Fcer1g, Fcgr2b 
7 All Ribosome-associated 54 Rpl10, Rpl11, Rpl15, Rpl19, Rpl23a, Rpl3, Rpl34, Rpl35, Rpl4, Rpl6 
8 Scarified samples Phagocyte-related 54 Atf3, Atf4, Btc, Crem, Nr4a1, Nr4a2, Socs3, Tnfaip3, Trib1, Wsb2 
9 All Ribosome-associated 32 Btf3, Rpl12, Rpl14, Rpl18, Rpl21, Rpl32, Rpl37 
10 Scarified samples Pro-inflammatory 
 
 Ccl3, Ccl4, Ccr1, Ccrl2, CD14, Clec4d, Clec4e, Csf2rb, Csf3r, Cxcl1, Cxcl2, 
Cxcl3, Il1b, Il6, Trem1, Trem3 
12 CD11c-DTR→WT+PB B cell-associated 36 Bank1, Blk, Btla, Cd5l, Cr2, Cxcr5, H2-Ob, Igh6, Ighg, Ighv14-2, Igj, Igl-V1, 
Ltb 
18 Scarified samples  Cell proliferation 23 Arc, Arl5b, Chchd4, Clcf1, Cyr61, Ddx21, Dusp7, Fosl1, Gm16516, Itga5, 
Lrrfip5, Sgms2, Siah2, Skil, Stk40, Tnfrsf12a, Zc3h12c 
19 Langerin-DTR+DTX Transcription-related 26 Ctnnal1, Erbb2ip, Irak1, Nup107, Ofd1, Pdk1, Ppip5k1, Prpf39, Pxmp3, Rbak, 
Scyl3, Siah1a, Slc35b3, Srebf1, Stk24, Zfp280c 
32 Langerin-DTR+DTX Transcription-related 14 Dph5, Hnrnpr, Mapk14, Phf20l1, Sbf2, Cdc37l1, Cpsf7, Hlf, Ppil6, Ptbp2, 
Tmem181a, Ube2i 
42 Langerin-DTR+PB B cell-associated 13 Ccr6, Cd19, Cd22, Cd37, Cd79b, Fcer2a, Fcrl1, Ms4a1, Pla2g2d, sipa1, spib, 
Wipf1 
44 Scarified samples B cell-associated 10 Bcl-10, Btg2, Bcr 








Figure 9.3. Gene expression profiles from distinct clusters. The gene expression profiles of 
a number of different clusters were selected for representation to cover the different types of clusters 
observed. The y-axis shows average expression for the cluster (intensity). A Expression profiles of 
one ‘housekeeping’ cluster: cluster 7. B Cluster 2: expression profile of a phagocyte-related gene 
cluster mainly enriched in the CD11c-DTR→WT samples. C Expression profiles of gene clusters 





9.3.4. Fluorescent labelling of the ME7 scrapie agent SAFs  
In order to gain further insight into how PrP
Sc
 reached the draining iLN following 
inoculation via the skin, PrP
Sc
 was fluorescently labelled prior to infection via the 
skin scarification, in order to determine whether it was possible to visually track the 
movement of PrP
Sc
 from the skin. Recent findings, using fluorescent labels, 
demonstrate the transport of immune complexes from the skin to the draining iLN as 
soon as 15 min after application or injection (Phan et al., 2009; Phan et al., 2007). By 
fluorescently tagging PrP
Sc
 prior to application via skin scarification, it may be 
possible to gain further insight into how PrP
Sc
 reaches the draining iLN. To 
determine whether it was possible to track the scrapie agent from the skin to the 
draining iLN, following infection via scarification, ME7 scrapie agent SAFs, 
extracted from pooled ME7 affected brain homogenates, were fluorescently tagged 
with Alexa-Fluor®546 to enable their visualisation in tissues ex vivo (Gousset et al., 
2009). Alexa- Fluor®546-PrP samples were treated in the presence or absence of 
proteinase K, to confirm the presence of disease specific PrP
Sc
 within the samples. 
Several tests were carried out to ensure that fluorescent labelling was bound to the 
SAFs. The samples were simultaneously separated by gel electrophoresis on two 
gels. One gel was further analysed via Western blot, with the anti-PrP mAb 8H4. 
Scrapie specific PrP
Sc
 was detected in both samples (Fig. 9.4.). The second gel was 
scanned on a fluorograph machine, to determine fluorescence within the 
electrophoresed samples. Fluorescence was detected in both samples, consistent with 
labelling of PrP
Sc
 with Alexa-Fluor®546 (Fig. 9.4.). Proteinase K untreated samples 
indicated some non-specific protein labelling (Fig. 9.4.), as well as 3 bands 
consistent with PrP
c




leaving three bands consistent with proteinase K resistant PrP
Sc
 (Fig. 9.4.). A silver 
stain was also carried out on the second gel (Fig. 9.4.). A lot more protein was 
detected in these samples than through the other two staining methods, (confirming 
that the fluorescence emission is very specific). These data show that although a lot 
of non-PrP
Sc
 protein was present in the samples, these proteins did not emit 
fluorescence after proteinase K digestion, nor did they immmunostain with the anti-
PrP mAb. Together, these data suggested that the proteinase K treated samples 
appeared to contain fluorescently labelled scrapie specific PrP
Sc
, hereafter referred to 
as Alexa-PrP
Sc
. This compound will be used to visualise spread of PrP
Sc
 from the 
skin, following inoculation via skin scarification. 
 
9.3.5. Tracking of Alexa-PrPSc in the skin following exposure by skin 
scarification 
To determine whether fluorescent tagging of PrP
Sc
 would enable visual tracking of 
the spread of PrP
Sc
 from the skin to the draining iLN, mice were infected with Alexa-
PrP
Sc
 by skin scarification. Skin sections of the scarification site and draining iLNs, 
with associated PAT, were collected 15 min, 2, 6.5, 24, 48, and 72 hr after exposure. 
Early changes were observed in the epidermis 2 hr post infection by haematoxylin 
and eosin (H&E) labelling, and the appearance of a crust on the epidermal surface 
was observed from 6.5 hr post scarification (Fig. 9.5.). 48 hr post scarification, the 
scarification site was not captured on the section, but was most-likely on adjacent 
sections, as higher magnification images showed evidence of epidermal hyperplasia 
at the site of Alexa-PrP
Sc
 accumulation (Fig. 9.5. and most evident on Fig. 9.9. 
highest magnification). Alexa-PrP
Sc
 was detected in the skin at each of the above 





Figure 9.4. Confirmation of fluorescently labelled PrP
Sc
 in SAFs. SAFs were extracted from 
ME7 affected brain homogenates and fluorescently labelled. Samples underwent gel electrophoresis 
and were further analysed by Western blot with the anti-PrP mAb 8H4, fluorograph scanning, and 
silver staining to confirm that fluorescence was specific to PrP
Sc

















In the tissues collected 72 hr post infection the scarification site was identified by the 
presence of a crust on the skin surface (Fig. 9.5.), but unlike in the other time point 
tissues, Alexa-PrP
Sc
 was not detected at or adjacent to the scarification site. At this 
time, Alexa-PrP
Sc
 was detected below the epidermal surface of the skin, distal to the 
site of scarification (area denoted by a * in Fig. 9.5). These findings are further 
illustrated in Fig. 9.6., where immunofluorescent labelling of LCs highlights the 




Analysis of the draining iLN and the PAT yielded inconclusive evidence of Alexa-
PrP
Sc
 transport from the skin via the fat. Some cells associated with inflammation, 
such as neutrophils, were detected in and around the iLNs but there was no clear 
effect of scarification or Alexa-PrP
Sc 
transport to the PAT or the iLNs, when 
compared to iLNs from unscarified mice (data not shown). Small specks of 
fluorescent labelling were detected in the PAT surrounding the draining iLN 15 min, 
2, 6.5, and 24 hr post infection (Fig. 9.7.). These specks were difficult to capture 
images of, due to their small size, but these specks were brighter than non-specific, 






Figure 9.5. Histopathological analysis of skin sections following exposure to Alexa-PrP
Sc
 via scarification. Mice were infected with the Alexa-PrPSc 
via skin scarification and sections from the site of scarification were collected at the above time points for histopathological analysis. Scarification site or area near 
scarification is indicated by arrowheads. Haematoxylin and eosin (H&E) staining of the scarification sites revealed: by 2 hr post scarification changes in the epidermal 
layer were observed (Q). Epidermal hyperplasia was present by 6.5 hr post scarification, below a sero-cellular crust (R,S,U). In absence of a crust, 48 hr post 
scarification, a hyperplastic epidermis was detected. The * in G denotes the location of Alexa-PrP
Sc
 which is distal to the scarification site (arrowhead), magnified in N 










Figure 9.6. Alexa-PrP detected distal to the scarification site 72 hrs post infection. Mice 
were infected with Alexa-PrP
Sc
 inoculum via skin scarification. Thigh skin from the site of 
scarification was collected 72 hr post infection for histopathological and immunofluorescent analysis. 
A,C,E: H&E staining. A: The scarification site is denoted by *. Red fluorescence, indicative of Alexa-
PrP
Sc
 (red) was not detected near the scarification site but was detected at the opposite end of the 
section, delineated by the box (A, B, D). Immunolabelling with the anti-langerin specific antibody 
(green) denotes epidermal LCs (elipse in A and B), distant from the Alexa-PrP
Sc
. C,E: higher power 
images of site of Alexa-PrP
Sc
. D,F: increased magnification of Alexa-PrP
Sc. Scale bar, left column: 




Figure 9.7. Detection of Alexa-PrP
Sc
 in the PAT of the draining iLN post exposure by scarification. Mice were infected with Alexa-PrPSc inoculum via 
skin scarification and draining iLNs collected from the above time points for immunofluorescent analysis, using TO-PRO®-3 iodide nuclear counterstain (blue).  A-E: 
Red fluorescence, indicative of Alexa-PrP
Sc
 (red) was detected in the perinodal fat of the draining iLN from 15 min post infection. E: Alexa-PrP
Sc
 detected in the 
proximity of the iLN (blue). D,F: increased magnification of Alexa-PrP







9.3.6. Alexa-PrPSc and other cell types 
To further gain knowledge of whether PrP
Sc
 moves from the skin by a cell-dependent 
mechanism, immunofluorescence analysis was used to determine which, if any, cell 
types in the skin were associated with Alexa-PrP
Sc
 after exposure by via skin 
scarification. Immunolabelling with the anti-langerin specific antibody revealed the 
LCs in the epidermis of the skin (Fig. 9.8.), and some langerin
+
 dermal cells. The 
LCs were observed near the Alexa-PrP
Sc
, usually under the crust formed at the site of 
scarification. Occasional cells were detected amongst the red fluorescence (Alexa-
PrP
Sc
) but there did not appear to be any direct interaction between the LCs and the 
Alexa-PrP
Sc
 inoculum between 15 min and 72 hr post scarification (Fig. 9.8.). 
 
Immunofluorescence analysis was also used to determine the extent of neutrophil 
infiltration following scarification (Fig. 9.9.). Neutrophil infiltration was observed 
from 2 hrs post scarification, and from 6.5 hr post scarification were associated with 
a neutrophilic crust at the scarification site (Fig. 9.10.). By 48 and 72 hr post 
infection the intensity of neutrophil labelling had started to decrease compared to the 






 did not colocalise with epidermal LCs following infection via scarification. Mice were infected with Alexa-PrPSc inoculum via 
skin scarification. Thigh skin from the site of scarification was collected at the above time points for histopathological and immunofluorescent analysis. Arrowheads 
indicate site of scarification, and highlight the same areas between the light level and fluorescent images. Discontinuous lines delineate the epidermis: E; for 
orientation, the area of the dermis is denoted by D. A-G: H&E staining of the scarification sites. H-N: Adjacent sections confirmed that presence of Alexa-PrP
Sc
 (red) 
at or adjacent to the scarification sites, with the exception of 72 hr post infection. The anti-langerin specific antibody revealed the presence of LCs in the epidermis 
(green). These LCs appeared to be located below the layer of Alexa-PrP
Sc
, occasional cells were detected interspersed within the Alexa-PrP
Sc
 but did not appear to be 
colocalised with this labelling. G shows the presence of LCs at the scarification site 72 hr post infection but no Alexa-PrP
Sc
 was detected at the site. Images are 
















Figure 9.9. Neutrophil accumulation in the skin following exposure to Alexa-PrP
Sc
 by 
scarification. Mice were infected with Alexa-PrPSc inoculum via skin scarification. Thigh skin from 
the site of scarification was collected at the above time points for histopathological and 
immunofluorescent analysis. Discontinuous lines delineate the epidermis: E; for orientation, the area 
of the dermis is denoted by D. Arrowheads indicate sites of scarification, and highlight the same areas 
between the light level and fluorescent images. A-G: H&E staining of the scarification sites. H-M: 
Adjacent sections confirmed that presence of Alexa-PrP
Sc
 (red) at or adjacent to the scarification sites, 
with the exception of 72 hr post infection. Neutrophil infiltration (green) was observed from 2 hr post 
infection (P,W) and was associated with the scarification site. Formation of a neutrophillic crust was 
observed 6.5 hr (Q,X) and 24 hr (R,Y) post  infection. Labelling was reduced from 48 hr post 
infection (Z). Images are representative of observations in 4 animals/group. Scale bar: top 3 rows, 100 

























9.3.7. Alexa-PrPSc infection via scarification of the ear 
To determine whether LCs might play a role in the degradation of PrP
Sc
 following 
inoculation via skin scarification, mice were infected with the Alexa-PrP
Sc
 via skin 
scarification of the ear. The pinna of the ear was selected as an appropriately flat 
surface, and allow for en face visualisation of both the epidermis and dermis, via 
separation of the dermal sheets. Ears were collected 15 min and 2 hrs after infection 
and separated into epidermal and dermal sheets. Sheets were labelled with the anti-
langerin antibody to detect langerin
+
 cells. Z-stacks were obtained at areas where 
Alexa-PrP
Sc
 was detected, but no colocalisation was observed between the Alexa-
PrP
Sc
 and LCs in the epidermis, or langerin
+
 dDCs in the dermis, at either time point 
(Fig. 9.10.). Some langerin
+
 dDCs are located near the site of scarification, it is 
unclear whether they have migrated towards the site or were positioned there when 
scarification was carried out. 
 
Faint areas of red fluorescence were observed in areas of the epidermis that 
resembled the tight junctions described by Kubo et al (Kubo et al., 2009) (Fig. 
9.11.). These distinct structures were difficult to image as immunofluorescence faded 









 failed to colocalise with langerin
+
 cells in the skin following 
exposure to PrP
Sc
 via skin scarification. Mice were infected with Alexa-PrPSc inoculum (red) 
via skin scarification of the ventral side of the ear. Epidermal and dermal ear sheets collected 15 min 
and 2 hr post infection were immunolabelled with the anti-langerin specific antibody (green). A: 15 
min post scarification Alexa-PrP
Sc
 was detected within epidermal sheets. Analysis of the Z-stacks 
showed that LCs did not appear interact to with Alexa-PrP
Sc
. Similar results were observed 2 hr post 
scarification, B. C and D: Alexa-PrP
Sc
 was detected along the site of scarification in the dermis. A few 
langerin
+
 cells were detected in close proximity to the Alexa-PrP
Sc
 at both time points. Images are 







 appears to associate with epidermal tight junctions. Mice were 
exposed to Alexa-PrP
Sc
 (red) via skin scarification of the ventral side of the ear, and epidermal ear 
sheets collected for immunofluorescent analysis 2 hr post scarification. A: Red fluorescence was 
detected in patterns that resembled epidermal tight junctions. B: Epidermal tight junctions detected 





Research in this chapter has highlighted the immediate and longer term effects 
associated with scarification of the skin. Both neutrophils and CD11b
+
 cells were 
shown to migrate to the site of scarification within a couple of hours. CD11b is a 
marker expressed by granulocytes, monocytes, NK cells, and tissues macrophages. 
This does not exclude the possibility of other cell types that migrate to the site at the 
time of scarification; they simply were not tested for here. However, these two 
markers cover the range of cells typically associated with inflammatory responses in 
the skin (Delavary et al., 2011). These results were further supported by analysis of 
the trafficking of Alexa-PrP
Sc
 after exposure by skin scarification, where neutrophil 
infiltration was observed from 2 hr post infection, and neutrophils were further 
associated with the formation of a crust at the site of scarification. The epidermis in 
which the LCs reside is a relatively thin tissue, where en face visualisation of 
epidermal sheets clearly outlined the cellular network created by these LCs. While 
the cells are not on a single plane, they do organise themselves in several layers, 
fitting within the constraints of the epidermis. It is therefore difficult to determine 
whether scarification stimulated LC accumulation to the site of trauma, but data in 
this chapter suggest this was unlikely. It was possible to observe a hyperplastic 
epidermis from 6.5 hr after scarification, by histopathological analysis. This indicates 
the presence of too many cells within the epidermis, and is associated with a ‘danger’ 
signal, a response to scarification. 
 
LCs did not appear to associate with Alexa-PrP
Sc
 following infection via skin 




These results do further support previous studies indicating that LCs do not play a 
role in TSE disease (Mohan et al., 2005b; Mohan et al., 2005c), and data in this 
thesis showing that disease incubation period was not affected in the absence of LCs 
at the time of scrapie infection (Chapter 8). 
 
Studies have shown that Alexa-PrP
Sc
 could be transferred between DCs and neurons 
in vitro (Gousset et al., 2009). Results observed in Chapter 4 point towards a role for 
DCs in early scrapie agent spread from the skin to the draining iLN. In contrast to the 
LCs of the epidermis, analysis of the dermal sheet from the ear scarified with Alexa-
PrP
Sc
 indicate a possible interaction between langerin
+
 dDCs and the Alexa-PrP
Sc
 
compound in the dermis as early as 15 min post scarification.  
 
While a lot of research is focused on determining potential cell types involved in 
scrapie agent transmission from the skin, the possibility of a cell free mechanism 
cannot be excluded. Knight (Knight, 2008) highlighted the potential role of the PAT 
in stimulating immune cells found within the PAT. Phan et al demonstrated the 
movement of fluorescently tagged immune complexes from the skin to the draining 
LNs within 15 min of exposure (Phan et al., 2007). In the current study, Alexa-PrP
Sc 
was detected in the PAT of the draining iLN as early as 15 min post scarification, 
thereby indicating that Alexa-PrP
Sc
 might travel to the draining iLN via a cell-free 
mechanism, as well as a cell-associated mechanism. The structure of the epidermis is 
maintained by a network of tight junctions between the cells within it (Kubo et al., 
2009). These tight junctions form a distinctive honeycomb structure, within which sit 




the tight junctions to pick up antigen in the extra-tight junction environment. 
Following scarification with Alexa-PrP
Sc
 in the ear, several areas of fluorescence 
were observed in a distinct honeycomb structure. Some of these areas were larger 
than others, but they were uniformly difficult to acquire images of. Fig. 9.11. is 
therefore just an example of what was observed, but clearly highlights the 
honeycomb structure associated with the tight junctions in the skin. These results 
point toward an alternative mechanism for the scrapie agent to potentially move from 
the surface of the skin following scarification.  
 
Gene profile analysis and the information it provides can shed a lot of light on 
biological function during and as a result of different events. In this chapter, this 
meta-analysis was used to help understand how gene function was affected by 
several events that have been described in previous chapters: scarification and DTX-




 cells. Previous data suggests no 
adverse/inflammatory response in the skin following DTX-mediated langerin
+
 cell 
depletion (Kissenpfennig et al., 2005b). Equally, no long-term defects or illness were 
associated with CD11c
+
 cell depletion (Jung et al., 2002). Microarray analysis 
carried out on skin samples from langerin-DTR or CD11c-DTR→WT mice support 
these findings. No inflammatory gene expression clusters were identified within 
DTX-treated tissues. No major gene profile changes were observed in CD11c-
DTR→WT mice specifically treated with DTX. Some changes were observed across 
the mouse line (including untreated controls) suggesting a possible effect due to bone 
marrow reconstitution. In langerin-DTR mice, there was one cluster where genes 




associated with transcription. As expected, scarification resulted in a much more 
specific response. The upregulated genes were mostly associated with expression 
clusters enriched for genes associated with inflammation and skin damage, and 
cluster 44 was associated with B lymphocytes. These data further support the results 
obtained through histopathological analysis of skin, demonstrating the effects of 
scarification in the skin. 
 
Data in this chapter, from the analysis of the trafficking of Alexa-PrP
Sc
 after 
scarification, suggests a lack of LC involvement following scrapie infection from the 
skin. These data are congruent with data in Chapter 8, showing depletion of LCs did 
not delay TSE neurinvasion from the skin. Whether other cell types such as langerin
+
 
dDCs play a role in scrapie agent transport from the skin is uncertain, data in this 
chapter also imply the possibility of cell-free transport from the skin, for example as 
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10.1. The role of CD11c+ cells in TSE transmission from skin 
How prions are propagated from the skin to the draining LN after exposure via skin 
scarification is uncertain.  Experimental TSE transmission had previously been 
established through scarification of the skin or in the mouth (Bartz et al., 2003; Carp, 
1982; Denkers et al., 2011; Glaysher and Mabbott, 2007a; Mohan et al., 2004; 
Mohan et al., 2005b; Taylor et al., 1996). Following experimental scrapie infection 
via scarification of the skin or tongue, PrP
Sc
 accumulated in the draining LNs prior to 
neuroinvasion (Bartz et al., 2003; Glaysher and Mabbott, 2007a; Mohan et al., 2004; 
Mohan et al., 2005b). LCs and dDCs are immune cells which acquire antigen within 
the skin before migrating to the skin draining LNs (Bursch et al., 2007; Ginhoux et 
al., 2007; Kissenpfennig et al., 2005b; Poulin et al., 2007), where they present the 
antigen. Based on previous evidence linking CD11c
+
 cells/DC subsets to PrP
Sc
 
transport (Cordier-Dirikoc and Chabry, 2008; Gousset et al., 2009; Huang et al., 
2002; Raymond et al., 2007; Sethi et al., 2007), the main aim of this thesis  was to 
establish whether these cells might also play a role in the transport of PrP
Sc
 from the 
skin to the draining iLN following scrapie infection via skin scarification. To address 
this question, transgenic mice were used which express DTR on target cells, and 
where the target cells could be temporarily depleted through a single injection of 
DTX (Jung et al., 2002). Following targeted cell depletion, these mice were infected 
with the ME7 strain of scrapie via skin scarification of the inner thigh. 
 
In order to study the role of LCs and dDCs and other CD11c
+
 MNP populations on 
scrapie transmission independently of each other, transgenic bone marrow chimeric 
mice were created where all the CD11c
+




treatment, with the exception of LCs (Chapters 3 and 5). Depletion of CD11c
+
 cells 
prior to scrapie infection via the skin, delayed early stage PrP
Sc
 infection compared 
to control groups (Chapter 4). The data presented in this thesis show that depletion of 
CD11c
+
 cells delays early PrP
Sc
 accumulation in the draining iLN following scrapie 
infection via the skin, although this did not affect disease susceptibility. Following 
infection via skin scarification in mice where CD11c
+
 DCs had returned but CD11c
+
 
SCS macrophages remained partially depleted following DTX treatment, there was 
no effect on early stage PrP
Sc
 accumulation in the draining iLN or on disease 
susceptibility. 
 
These results point towards a role for CD11c
+
 DCs in the initial transport of 
PrP
Sc 
from the skin to the draining iLN. It is therefore likely that transport occurs via 
the lymphatics rather than blood, as DCs migrate via the lymph. Equally, if PrP
Sc
 
were transported via the blood, it should reach all lymphoid tissues within a similar 
time frame, but following scrapie infection via scarification, PrP
Sc
 accumulates first 
in the draining lymphoid tissue before spreading to others (Glaysher and Mabbott, 
2007a; Mohan et al., 2005a). In contrast, the draining LN was only found to play a 
critical role in scrapie pathogenesis in a small cohort of hamsters infected with a low 
dose of inoculum following footpad injection (Kratzel et al., 2007). Scrapie infection 
via skin scarification uses only a very small amount of inoculum (6 µl). Results from 
Chapter 9 point towards a lot of inoculum remaining on the skin or being lost in the 
crust. This route of infection may therefore result in similar findings to low dose 
infections in hamsters infected via the footpad (Kratzel et al., 2007), as higher doses 






 cell depletion prior to oral scrapie challenge blocked 
early PrP
Sc
 accumulation in the gut associated lymphoid tissue, and reduced disease 
susceptibility (Raymond et al., 2007). Incubation period differences were near 200 
days in some mice, and the absence of these cells completely blocked early stage 
PrP
Sc
 accumulation compared to a delay following infection via the skin. This 
indicates that while CD11c
+
 cells play a major role in oral scrapie pathogenesis; it is 
likely that PrP
Sc
 arrives in the draining iLN via more than one route or cell type.  
 
Certain tissue macrophage populations such as those in the peritoneal cavity, the 
lamina propria of the intestine, the SCS and the splenic marginal zone also express 
low levels of CD11c.  Accordingly, these macrophage populations are likewise 
depleted in CD11c-DTR mice (Bradford et al., 2011; Probst et al., 2005).  The SCS 
macrophages are a distinct, poorly endocytic and degradative macrophage subset 
(Phan et al., 2009; Phan et al., 2007), and appear to be specialised to capture antigen-
containing immune complexes arriving in the LN via their cell processes that extend 
into the lumen of the SCS (Carrasco and Batista, 2007; Junt et al., 2007; Phan et al., 
2009; Phan et al., 2007; Roozendaal et al., 2009).  In contrast to other macrophage 
subsets, SCS macrophages retain these immune complexes on their surfaces for rapid 
translocation through the SCS floor to underlying, follicular B cells. These B cells 
then acquire the immune complexes via their complement receptors and deliver them 
to FDC.  The shuttling of immune complexes via the SCS macrophage-B cell cellular 
relay represents an efficient route through which antigens are delivered to FDC.  
Prions are also considered to be acquired by FDC as complement bound complexes 




2007).  This highlights the possibility that SCS macrophages in LNs (and their 
counterparts in the spleen) may also facilitate the delivery of complement-bound 
prions to FDC.  Indeed, disease-specific PrP has been detected in association with 
SCS macrophages in the mesenteric LNs of prion-exposed sheep (Jeffrey et al., 
2006).  PrP
Sc
 might therefore enter the draining LNs via the lymph without a cellular 
association. Studies in aged mice have determined that FDCs in these mice exhibited 
reduced immune complex trapping capacity, concurrent with a drop in cellular PrP
c
 
expression, reducing the ability of older mice to accumulate PrP
Sc
 (Brown et al., 
2009), further highlighting the possibility of PrP
Sc







 SCS macrophages were partially depleted following DTX treatment 
in CD11c-DTR bone marrow chimeric mice. These cells were absent at the time of 




 classical DCs, in the experiment 
described in Chapter 4. It was therefore not possible to determine whether the 
delayed accumulation of PrP
Sc
 was a result of absent DCs or absent macrophages. In 
Chapter 6, scrapie infection was not carried out until 6 days after DTX treatment, 









 cells played a 
direct role in the transport of the PrP
Sc
 from the lymph to the FDCs, one would 
expect PrP
Sc
 accumulation to be delayed in these mice. There was, however, no 
observable differences in PrP
Sc
 accumulation between the DTX treated and control 
group. These data suggest that the effects of DTX-treatment on the early 










 SCS macrophages.  Flow 
cytometric analysis of CD169
+









 macrophage population (Asano et al., 2011), situated within 
the cortical and paracortical sinus, and within the SCS respectively. Both cell types 
appeared to equally phagocytose subcutaneously injected antigen. The authors do not 




 cells are a subset of CD8α
+
 DCs 
(Asano et al., 2011). These findings further emphasise the influence of minor 
subpopulations within tissues, as has previously been highlighted throughout this 
thesis. Analysis in this thesis focused on immunohistochemical detection, rather than 





macrophages could play a role in the transport of PrP
Sc
 from the SCS of the LN to 
the FDCs, in addition to a cellular transport by CD11c
+
 DCs. This would explain 
why despite CD11c
+
 cell depletion, some PrP
Sc
 was still able to reach, and 
accumulate within, the draining iLN. 
 
10.2. The role of langerin+ cells in TSE transmission from skin 
The above studies could not exclude a role for LCs in TSE pathogenesis since these 
cells were unaffected in the DTX-treated CD11c-DTR→WT mice. LCs can be 
identified through their expression of langerin (Valladeau et al., 2002; Valladeau et 
al., 1999; Valladeau et al., 2000), but more recently a subset of dermal DC, termed 
langerin
+
 dDCs, has also been described (Bursch et al., 2007; Ginhoux et al., 2007; 
Poulin et al., 2007). To address the question of whether LCs play a role in the 
transport of the scrapie agent from the skin to the draining iLN, transgenic mice were 
used, which express DTR on langerin
+
 target cells (LCs and langerin
+






 cells in the skin draining LNs), and where these cells could be 
temporarily depleted through a single injection of DTX (Kissenpfennig et al., 
2005b). Following targeted cell depletion, these mice were infected with the ME7 




 cells in the skin prior to scrapie infection via skin scarification 
(Chapter 8) did not affect early stage PrP
Sc
 deposition in the draining iLN, 5 weeks 
post scarification (when a delay was observed following CD11c
+
 cell depletion). This 
implies that LCs are not involved in the initial delivery of the TSE agent to the 
draining LN. However, 7 weeks post infection, PrP
Sc
 accumulation and CD21/35 
expression was greatly increased compared to the two control groups. Despite these 
results, no differences were observed between incubation periods of the different 
groups.  
 
It is uncertain whether the observed increases in PrP
Sc
 and CD21/35 occurred 
simultaneously, as there was no indication of such changes two weeks prior to this. 
Evidence that PrP
Sc
 accumulation is dependent on CD21/35 expression on FDCs 
(Zabel et al., 2007), suggests that response to the LC-depletion had enhanced the 
expression of PrP
c
  and/or CD21/35, which accelerated PrP
Sc
 accumulation in the 
draining iLN. Equally, a potential sudden influx of PrP
Sc
 to the iLN, after 
repopulation of the LCs in the epidermis, might trigger this response. It could be 
argued that the depletion of large cell subsets might trigger an immune response in 
affected tissues, but this was not observed following CD11c
+
 cell depletion, in the 




langerin-DTR/C57BL/6 bone marrow chimeric mice. Equally, gene profile analysis 
did not show any major inflammatory type (or other) responses in the skin as a result 
of DTX treatment.   
 
Langerin causes the internalisation of antigen from the surface of LCs to the Birbeck 
granules (Merad et al., 2008). Langerin has also been shown to degrade HIV. 
Previous work has demonstrated a degradative effect of LCs on PrP
Sc
 in vitro 
(Mohan et al., 2005c). In addition, blocking the migration of LCs in CD40L
-/-
 mice 
or via caspase-1 inhibition shortened TSE disease incubation time (Mohan et al., 
2005b). Following scarification with the Alexa-PrP
Sc
 (Chapter 9) there was no 
observable association between LCs and Alexa-PrP
Sc
. Association between LCs and 
Alexa-PrP
Sc
 might be expected if LCs were degrading the protein (Mohan et al., 
2005c). The increase in PrP
Sc
 accumulation following LC depletion might suggest 
that LCs play a phagocytic role following scrapie infection via the skin, and therefore 
the absence of LCs accelerates this infection. One would then expect to observe 
accelerated PrP
Sc
 accumulation in the draining iLN even at the earlier 5 week time 
point.  
  
The results presented in Chapter 9, where mice were scarified with Alexa-PrP
Sc
 did 
not show any direct interaction between LCs and PrP
Sc
 by 2 hr after exposure. There 
may be a closer interaction between the langerin
+
 dDCs and fluorescent inoculum, 
but the results observed cannot determine whether these cells are migrating towards 
the site of scarification, or whether they were simply positioned there at the time of 
scarification. Small specks of Alexa-PrP
Sc




min post scarification. These results point towards cell-free movement of at least a 
small portion of Alexa-PrP
Sc
 from the skin towards the draining iLN, as skin resident 
cells typically only start to appear in the draining LN 24 hr after initial stimulation 
(Kissenpfennig et al., 2005b), compared to immune complexes which have been 
visualised in the draining LN as soon as 15min after exposure (Phan et al., 2007). 
 
The lack of incubation period effect after increased PrP
Sc
 accumulation in langerin
+
 
cell depleted mice, might be explained by the ‘second wave’ of PrP
Sc
 accumulation 
occurring after the start of neuroinvasion or spread to other lymphoid tissues, from 
the draining iLN. This correlates with previous data, where temporary blockade of 
the lymphotoxin-β receptor signalling pathway (causing FDC dedifferentiation) at 
early time points after scrapie infection via the skin significantly reduced disease 
susceptibility, but FDC dedifferentiation 42 days post infection failed to affect the 
incubation period (Mohan et al., 2005a). Further support for the theory of a ‘second 
wave’ of PrP
Sc
 accumulation could be considered following the increased PrP
Sc
 
accumulation observed in terminally scrapie affected mice, where CD11c
+
 cells were 
depleted prior to infection (Chapter 4). 
 
The structure of the epidermis is maintained by a network of tight junctions between 
the cells, which form a distinctive honeycomb structure, within which sit the LCs 
(Kubo et al., 2009). One could argue that because LCs form such a tight network in 
the epidermis, their complete depletion may significantly damage the integrity of the 
epidermis. Several attempts were made to determine whether tight junction structure 
(Kubo et al., 2009) was affected following DTX mediated langerin
+




The results presented in Chapter 9 indicate that after scarification damage to the 
epidermis might enable Alexa-PrP
Sc
 to pass through the tight junctions of the skin. It 
is, therefore, plausible that any disruptions to the skin, as a consequence of 
scarification, may lead to significant penetrance of prions into the underlying tissue 
and their dissemination via afferent lymph to the draining LN. If this was the direct, 
‘cell-free’ route of PrP
Sc 
from the skin towards the draining iLN, again, one would 
expect to see earlier increased PrP
Sc
 accumulation, as cell free transport from the skin 
is fairly rapid (Asano et al., 2011; Junt et al., 2007; Phan et al., 2009; Phan et al., 
2007). The timing of the increase in PrP
Sc
 accumulation, between 5 and 7 weeks post 
infection, point towards a possible link with langerin
+
 cell repopulation following 
DTX-mediated depletion. Under normal circumstances LCs might clear the scrapie 
inoculum from the site of scarification. However, in their absence, much of the PrP
Sc
 
remains within the skin until LCs start to return, which then carry the agent to the 
draining LN. Another possibility is that the sudden return of LCs triggers an immune 
reaction, which enhances CD21/35 expression within the draining LNs. These results 
do point towards a potential role of LCs in scrapie transmission from the skin, 
although it is not yet clear what their exact function is. 
 
 
10.3. Relevance of research for natural TSEs 
When working with a murine disease research model, one is often questioned about 
the relevance of the research to natural disease, which inevitably occurs in species 
other than mice. Mice are not naturally infected with scrapie, but they have proven to 
be a very effective model for the disease in a laboratory setting, without requiring 




TSE, such as BSE, which have been genetically addressed (Cancellotti et al., 2007). 
In addition, scrapie replication in the mouse follows similar patterns to those often 
observed in natural TSEs. 
 
The skin and oral mucosa present a likely route of transmission in several TSE 
diseases. Natural TSE infections might occur via lesions in the mouth and 
gastrointestinal tract through consumption of rough feed or birth-associated lesions 
to the skin or mucus membranes. These routes has proven successful in experimental 
transmission of scrapie and CWD (Bartz et al., 2003; Carp, 1982; Denkers et al., 
2011; Glaysher and Mabbott, 2007a; Mohan et al., 2004; Mohan et al., 2005b; 
Taylor et al., 1996). As infectivity has been readily detected in excreta and bodily 
fluids of both natural and experimentally transmitted TSEs (Gough and Maddison, 
2010; Haley et al., 2011; Haley et al., 2009; Kariv-Inbal et al., 2006; Ligios et al., 
2011; Mathiason et al., 2006; Saunders et al., 2008; Seeger et al., 2005), as well as 
infectivity being identified in the skin of TSE infected animals (Cunningham et al., 
2004; Notari et al., 2010; Thomzig et al., 2007), or even present in the environment 
(Gough and Maddison, 2010), these points highlight the potential risk of 
transmission via the skin that can occur. 
 
Much of this thesis has focused on the accumulation of PrP
Sc
 in the draining iLN 
following scrapie infection via skin scarification. LRS involvement in TSE disease is 
widespread in non-experimental situations. Widespread LRS involvement can be 
observed in CWD-infected animals (Keane et al., 2009; Keane et al., 2008; 




genotypes of scrapie-infected sheep (Andréoletti et al., 2000; Heggebø et al., 2002; 
Heggebø et al., 2000). Agent accumulation in lymphoid tissues is also a feature of 
vCJD patients (Foster et al., 2001; Hill et al., 1997) or BSE-infected sheep (Jeffrey et 
al., 2001c), even though BSE and scrapie pathogenesis display differently within 
sheep (Jeffrey et al., 2001a).  
 
In contrast, early LRS involvement is not a major feature of sCJD (Hill et al., 1999), 
nor in VRQ-heterozygous sheep genotypes (Schreuder et al., 1998). While little LRS 
involvement has been linked to BSE in cattle (Somerville et al., 1997), PrP
Sc
 and 
infectivity has been detected in the PPs of BSE-infected cattle (Buschmann and 
Groschup, 2005  although differences have been observed between natural and 
experimental transmission {Iwata, 2006 #263; Terry et al., 2003). 
 
The ME7 scrapie strain that was used for the experiments described in this thesis has 
been well utilised in numerous experiments conducted at the Neurobiology Division, 
The Roslin Institute, and its pathogenesis within the lymphoid system has been well 
documented. Disease pathogenesis in the mouse models replicates a route that likely 
often occurs in natural transmission. As experimental scrapie transmission involves 
PrP
Sc
 accumulation in the LRS following peripheral infection at a number of 
different sites (Glaysher and Mabbott, 2007a; Kimberlin and Walker, 1989a; 
Kimberlin and Walker, 1989b; Mohan et al., 2004; Mohan et al., 2005a), confirming 





The identification of disease infectivity in skin (Cunningham et al., 2004; Notari et 
al., 2010; Thomzig et al., 2007), fat (Race et al., 2008; Race et al., 2009), and antler 
velvet (Angers et al., 2009) of both naturally and experimentally TSE-infected 
animals draws attention to the potential risk this could pose to both animals and 
humans. Animals will always have altercations, and especially in the case of cervids, 
where reproductive dominance is often decided by clashing horns. Hunters are less 
likely to wear protective gloves when cutting up an animal (personal 
communication), and are more likely to be subjected to prolonged exposure to a 
potential source of infection by eating repeated meals from the same animals (Race 
et al., 2009). It was discussed at the Prion 2011 conference (Montreal, Canada) that 
people who hunted in CWD-affected areas would often not wait to consume the meat 
even if samples had been sent for TSE testing. As yet, CWD has not been linked to 
any prion disease in humans, but clearly some individuals are at high risk of 
exposure. These issues serve to highlight the potential importance of the skin as a 
route of TSE transmission, and why research should continue in order to further 
uncover how disease transmission occurs from this site. 
 
10.4. Future work 
There are of course a multitude of different possibilities to investigate in order to 
fully understand the mechanisms of spread of this disease from the site of exposure, 
such as the skin. The following section attempts to highlight a couple of these 








The work produced in this thesis has demonstrated that both LCs and dDCs influence 
scrapie agent transmission from the skin, albeit with potentially opposing roles. 
Despite the depletion of CD11c
+
 cells in the CD11c-DTR bone marrow chimeric 
mice prior to scrapie infection via the skin, PrP
Sc
 accumulation in the draining iLN 
was only delayed. In contrast, CD11c
+
 cell depletion prior to oral scrapie challenge 
blocked early stage PrP
Sc
 accumulation in the PPs, mesenteric LNs, and spleen up to 
15 weeks post scrapie challenge (Raymond et al., 2007). The above study elicited a 
much greater effect on overall disease susceptibility following CD11c
+
 cell 
depletion, compared to the results observed in Chapter 4. While CD11c
+
 cells appear 
to play a role in the initial transport of PrP
Sc
 from the skin to the draining iLN, other 
mechanisms or cell types are also likely involved in the scrapie transmission from the 
skin.  
 
The time course study described in Chapter 9 demonstrated a large influx of 
neutrophils to the site of scarification as early as 2 hr post scarification. Many of 
these neutrophils are associated with the crust that has formed at the site of 
scarification. A crust will likely fall off after a few days. However, a good number of 
macrophages are also found below the area of the crust within the skin. Following 
scrapie infection via skin scarification in sheep, the only cells that were associated 
with PrP
Sc 
following scarification, were neutrophils (Gossner et al., 2006).  
 
Neutrophils have been linked to transmission of Leishmaniasis from the skin 




produces local inflammatory response (Peters et al., 2008), which was associated 
with a sustained infiltration of neutrophils into the skin, accompanied by substantial 
macrophage recruitment (Peters et al., 2008). Once the neutrophils have served their 
purpose at the site of inflammation they are phagocytosed by macrophages, or 
expelled in the crust (Delavary et al., 2011). If PrP
Sc
-associated neutrophils were 
phagocytosed by macrophages following an inflammatory response, this highlights a 
potential role for neutrophils following scrapie infection via skin scarification. 
However, it has also been demonstrated that neutrophils can traffic to LNs following 
infection or immune stimulation (Appelberg, 2007; Maletto et al., 2006; Pesce et al., 
2008) as well as after intradermal vaccination (Abadie et al., 2005). Neutrophils may 
also transport PrP
Sc
 from the skin to the draining LN following scrapie infection via 
scarification. One of the sites of neutrophil accumulation in the draining LNs, is the 
SCS (Chtanova et al., 2008). The potential relevance of the SCS in TSE disease was 
highlighted in Chapter 6. In light of these findings, it would be useful to further 
investigate the potential role of neutrophils in scrapie transmission from the skin. 
 
10.4.2. Keratinocytes 
Keratinocytes are cells located within the epidermis. LCs elongate their dendrites 
between keratinocytes to comprise a dense network within the skin (Kubo et al., 
2009). There is emerging evidence of their importance in skin immune responses. 
They are one of the many cell types which express PrP
c
 on their surface (Sugaya et 
al., 2002). As PrP
c
 is essential for maintaining PrP
Sc
 infection, its presence on these 
cells could indicate their potential role in disease transmission from the skin. The 




present in the skin, and it was therefore considered that DC subsets, including LCs, 
were key in presenting antigens from the skin in order to mount appropriate immune 
responses, either in the skin or the draining LNs which they migrate to. However, the 
identification of langerin
+
 dDCs has forced the re-evaluation of LC function in many 
aspects of skin immunity (Romani et al., 2010). Langerin
+
 dDCs were found to carry 
out functions previously assigned to LCs (Romani et al., 2010). For example, it has 
been shown that a subpopulation of langerin
+
 dDCs were able to cross-present 
antigen from keratinocytes in the absence of LCs (Henri et al., 2010). In this sense it 
is important to remember that the increased PrP
Sc
 accumulation observed in the 
draining iLN following scrapie infection via the skin (Chapter 8) was only observed 
in the bone marrow chimeric mice where LCs alone were depleted. While it is likely 
that PrP
Sc
 from skin-associated infection has reached the draining iLN before 10 days 
(when langerin
+
 dDCs) had repopulated the dermis, Fluorescent tagging of PrP
Sc
 
demonstrated that this was present in the skin up to 72 hr after scarification, and all 
of it is therefore not cleared from the skin within a matter of hours. Keratinocytes 
have also been found to possibly play a role in presenting antigen directly to skin-
reactive T cells (Kim et al., 2009). Whether this is a function they carry out all the 
time, or simply due to the absence of both LCs and langerin
+
 dDCs in these 
experiments, is yet to be determined. It is, however, possible that keratinocytes might 
play a role in scrapie transmission from the skin, and these cells should also be 
investigated. For example keratinocytes cultivated in Epidermal Keratinocyte 3D 
medium (Millipore, UK) might provide a useful in vitro system to determine whether 








Data in this thesis point towards a role for CD11c
+
 cells in the initial transport of 
PrP
Sc
 from the site of exposure to the draining LN after exposure via the skin. The 
skin is a very robust defence system, and topical application of TSE inoculum 
without scarification or injury does not result in disease. Scarification induces a 
localised inflammatory response. This sets infection via the skin apart from other 
routes of transmission. Studies of the role of CD11c
+
 cells in oral TSE pathogenesis 
were investigated in the steady state. In contrast, as shown in this thesis, scarification 
elicits cellular migration to the site of exposure, which itself is likely to significantly 
influence the handling and processing of PrP
Sc
 and its delivery to the draining LN.  
 
Classical DC were efficiently depleted in DTX-treated CD11c-DTRWT mice, 
early PrP
Sc
 accumulation within the draining iLN was partially impaired, and the 
mice succumbed to clinical prion disease.  This suggests that other CD11c-
independent mechanisms contribute to the propagation of prions from the skin to the 
draining LN. By triggering an inflammatory response at the site of infection, 
scarification introduces a range of potential mechanisms that may aid the spread of 
the scrapie agent. Prions may also be delivered to the draining LN by other cell 
populations such as neutrophils.   Data in this thesis shows that neutrophil infiltration 
is a prominent feature after skin scarification. Collectively, these results indicate that 
identification of the precise cellular and molecular mechanisms by which prions are 
propagated from the site of exposure to the draining lymphoid tissues in which they 
replicate before neuroinvasion, may identify novel factors which influence disease 
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